MFA FINANCIAL, INC. - Quarter Report: 2018 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________
FORM 10-Q
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2018
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 1-13991
MFA FINANCIAL, INC.
(Exact name of registrant as specified in its charter)
_____________________________________________
Maryland | 13-3974868 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
350 Park Avenue, 20th Floor, New York, New York | 10022 | |
(Address of principal executive offices) | (Zip Code) | |
(212) 207-6400
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last period)
_____________________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer x | Accelerated filer o | |
Non-accelerated filer o | Smaller reporting company o | |
Emerging growth company o | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o
No x
449,546,435 shares of the registrant’s common stock, $0.01 par value, were outstanding as of October 31, 2018.
MFA FINANCIAL, INC.
TABLE OF CONTENTS
Page | ||
PART I | ||
FINANCIAL INFORMATION | ||
MFA FINANCIAL, INC. CONSOLIDATED BALANCE SHEETS | ||||||||
(In Thousands Except Per Share Amounts) | September 30, 2018 | December 31, 2017 | ||||||
(Unaudited) | ||||||||
Assets: | ||||||||
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | ||||||||
Agency MBS, at fair value ($2,795,273 and $2,727,510 pledged as collateral, respectively) | $ | 2,905,490 | $ | 2,824,681 | ||||
Non-Agency MBS, at fair value ($3,237,108 and $2,379,523 pledged as collateral, respectively) | 3,334,610 | 3,533,966 | ||||||
CRT securities, at fair value ($504,931 and $595,900 pledged as collateral, respectively) | 538,945 | 664,403 | ||||||
Mortgage servicing rights (“MSR”) related assets ($565,272 and $482,158 pledged as collateral, respectively) | 565,272 | 492,080 | ||||||
Residential whole loans, at carrying value ($1,149,293 and $448,689 pledged as collateral, respectively) (1) | 2,471,567 | 908,516 | ||||||
Residential whole loans, at fair value ($685,095 and $996,226 pledged as collateral, respectively) (1) | 1,449,365 | 1,325,115 | ||||||
Cash and cash equivalents | 104,186 | 449,757 | ||||||
Restricted cash | 6,489 | 13,307 | ||||||
Other assets | 406,069 | 742,909 | ||||||
Total Assets | $ | 11,781,993 | $ | 10,954,734 | ||||
Liabilities: | ||||||||
Repurchase agreements | $ | 7,278,270 | $ | 6,614,701 | ||||
Other liabilities | 951,483 | 1,078,397 | ||||||
Total Liabilities | $ | 8,229,753 | $ | 7,693,098 | ||||
Commitments and contingencies (See Note 10) | ||||||||
Stockholders’ Equity: | ||||||||
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference) | $ | 80 | $ | 80 | ||||
Common stock, $.01 par value; 886,950 shares authorized; 449,472 and 397,831 shares issued and outstanding, respectively | 4,495 | 3,978 | ||||||
Additional paid-in capital, in excess of par | 3,620,268 | 3,227,304 | ||||||
Accumulated deficit | (598,971 | ) | (578,950 | ) | ||||
Accumulated other comprehensive income | 526,368 | 609,224 | ||||||
Total Stockholders’ Equity | $ | 3,552,240 | $ | 3,261,636 | ||||
Total Liabilities and Stockholders’ Equity | $ | 11,781,993 | $ | 10,954,734 | ||||
(1) | Includes approximately $215.1 million and $183.2 million of Residential whole loans, at carrying value and $723.8 million and $289.3 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at September 30, 2018 and December 31, 2017, respectively. Such assets can be used only to settle the obligations of the VIEs. |
The accompanying notes are an integral part of the consolidated financial statements.
1
MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands, Except Per Share Amounts) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Interest Income: | ||||||||||||||||
Agency MBS | $ | 14,332 | $ | 15,533 | $ | 42,795 | $ | 50,014 | ||||||||
Non-Agency MBS | 58,667 | 63,252 | 169,812 | 212,728 | ||||||||||||
CRT securities | 7,748 | 8,676 | 25,939 | 22,898 | ||||||||||||
MSR related assets | 6,407 | 7,194 | 20,249 | 17,833 | ||||||||||||
Residential whole loans held at carrying value | 29,524 | 9,026 | 61,788 | 26,219 | ||||||||||||
Cash and cash equivalent investments | 754 | 1,452 | 2,348 | 2,854 | ||||||||||||
Interest Income | $ | 117,432 | $ | 105,133 | $ | 322,931 | $ | 332,546 | ||||||||
Interest Expense: | ||||||||||||||||
Repurchase agreements and other advances | $ | 50,881 | $ | 46,303 | $ | 142,832 | $ | 141,444 | ||||||||
Other interest expense | 7,997 | 2,972 | 18,410 | 7,202 | ||||||||||||
Interest Expense | $ | 58,878 | $ | 49,275 | $ | 161,242 | $ | 148,646 | ||||||||
Net Interest Income | $ | 58,554 | $ | 55,858 | $ | 161,689 | $ | 183,900 | ||||||||
Other Income, net: | ||||||||||||||||
Net gain on residential whole loans held at fair value | $ | 34,942 | $ | 18,679 | $ | 105,883 | $ | 48,660 | ||||||||
Net gain on sales of investment securities | 16,415 | 14,933 | 32,661 | 30,530 | ||||||||||||
Other, net | (2,998 | ) | (4,515 | ) | (1,519 | ) | 13,812 | |||||||||
Other Income, net | $ | 48,359 | $ | 29,097 | $ | 137,025 | $ | 93,002 | ||||||||
Operating and Other Expense: | ||||||||||||||||
Compensation and benefits | $ | 6,868 | $ | 10,892 | $ | 20,654 | $ | 26,258 | ||||||||
Other general and administrative expense | 4,155 | 4,081 | 13,569 | 14,060 | ||||||||||||
Loan servicing and other related operating expenses | 8,758 | 6,177 | 23,569 | 14,785 | ||||||||||||
Operating and Other Expense | $ | 19,781 | $ | 21,150 | $ | 57,792 | $ | 55,103 | ||||||||
Net Income | $ | 87,132 | $ | 63,805 | $ | 240,922 | $ | 221,799 | ||||||||
Less Preferred Stock Dividends | 3,750 | 3,750 | 11,250 | 11,250 | ||||||||||||
Net Income Available to Common Stock and Participating Securities | $ | 83,382 | $ | 60,055 | $ | 229,672 | $ | 210,549 | ||||||||
Earnings per Common Share - Basic and Diluted | $ | 0.19 | $ | 0.15 | $ | 0.56 | $ | 0.54 | ||||||||
Dividends Declared per Share of Common Stock | $ | 0.20 | $ | 0.20 | $ | 0.60 | $ | 0.60 | ||||||||
The accompanying notes are an integral part of the consolidated financial statements.
2
MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) (UNAUDITED) | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Net income | $ | 87,132 | $ | 63,805 | $ | 240,922 | $ | 221,799 | ||||||||
Other Comprehensive Income/(Loss): | ||||||||||||||||
Unrealized loss on Agency MBS, net | (9,177 | ) | (3,032 | ) | (27,507 | ) | (22,241 | ) | ||||||||
Unrealized (loss)/gain on Non-Agency MBS, net | (25,101 | ) | 10,020 | (62,743 | ) | 93,429 | ||||||||||
Reclassification adjustment for MBS sales included in net income | (9,455 | ) | (14,935 | ) | (25,580 | ) | (30,283 | ) | ||||||||
Reclassification adjustment for other-than-temporary impairments included in net income | — | — | — | (1,032 | ) | |||||||||||
Derivative hedging instrument fair value changes, net | 5,390 | 5,791 | 32,974 | 16,671 | ||||||||||||
Other Comprehensive (Loss)/Income | (38,343 | ) | (2,156 | ) | (82,856 | ) | 56,544 | |||||||||
Comprehensive income before preferred stock dividends | $ | 48,789 | $ | 61,649 | $ | 158,066 | $ | 278,343 | ||||||||
Dividends declared on preferred stock | (3,750 | ) | (3,750 | ) | (11,250 | ) | (11,250 | ) | ||||||||
Comprehensive Income Available to Common Stock and Participating Securities | $ | 45,039 | $ | 57,899 | $ | 146,816 | $ | 267,093 | ||||||||
The accompanying notes are an integral part of the consolidated financial statements.
3
MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) | ||||||||||||||||||||||||||||||
Nine Months Ended September 30, 2018 | ||||||||||||||||||||||||||||||
(In Thousands, Except Per Share Amounts) | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | Total | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||
Balance at December 31, 2017 | 8,000 | $ | 80 | 397,831 | $ | 3,978 | $ | 3,227,304 | $ | (578,950 | ) | $ | 609,224 | $ | 3,261,636 | |||||||||||||||
Cumulative effect adjustment on adoption of new accounting standard for revenue recognition | — | — | — | — | — | 295 | — | 295 | ||||||||||||||||||||||
Net income | — | — | — | — | — | 240,922 | — | 240,922 | ||||||||||||||||||||||
Issuance of common stock, net of expenses (1) | — | — | 51,892 | 517 | 391,065 | — | — | 391,582 | ||||||||||||||||||||||
Repurchase of shares of common stock (1) | — | — | (251 | ) | — | (1,957 | ) | — | — | (1,957 | ) | |||||||||||||||||||
Equity based compensation expense | — | — | — | — | 3,887 | — | — | 3,887 | ||||||||||||||||||||||
Accrued dividends attributable to stock-based awards | — | — | — | — | (31 | ) | — | — | (31 | ) | ||||||||||||||||||||
Dividends declared on common stock | — | — | — | — | — | (249,287 | ) | — | (249,287 | ) | ||||||||||||||||||||
Dividends declared on preferred stock | — | — | — | — | — | (11,250 | ) | — | (11,250 | ) | ||||||||||||||||||||
Dividends attributable to dividend equivalents | — | — | — | — | — | (701 | ) | — | (701 | ) | ||||||||||||||||||||
Change in unrealized gains on MBS, net | — | — | — | — | — | — | (115,830 | ) | (115,830 | ) | ||||||||||||||||||||
Derivative hedging instrument fair value changes, net | — | — | — | — | — | — | 32,974 | 32,974 | ||||||||||||||||||||||
Balance at September 30, 2018 | 8,000 | $ | 80 | 449,472 | $ | 4,495 | $ | 3,620,268 | $ | (598,971 | ) | $ | 526,368 | $ | 3,552,240 | |||||||||||||||
Nine Months Ended September 30, 2017 | ||||||||||||||||||||||||||||||
(In Thousands, Except Per Share Amounts) | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | Total | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||
Balance at December 31, 2016 | 8,000 | $ | 80 | 371,854 | $ | 3,719 | $ | 3,029,062 | $ | (572,641 | ) | $ | 573,682 | $ | 3,033,902 | |||||||||||||||
Net income | — | — | — | — | — | 221,799 | — | 221,799 | ||||||||||||||||||||||
Issuance of common stock, net of expenses (1) | — | — | 25,726 | 250 | 190,265 | — | — | 190,515 | ||||||||||||||||||||||
Repurchase of shares of common stock (1) | — | — | (641 | ) | — | (5,158 | ) | — | — | (5,158 | ) | |||||||||||||||||||
Equity based compensation expense | — | — | — | — | 5,209 | — | — | 5,209 | ||||||||||||||||||||||
Accrued dividends attributable to stock-based awards | — | — | — | — | 20 | — | — | 20 | ||||||||||||||||||||||
Dividends declared on common stock | — | — | — | — | — | (233,244 | ) | — | (233,244 | ) | ||||||||||||||||||||
Dividends declared on preferred stock | — | — | — | — | — | (11,250 | ) | — | (11,250 | ) | ||||||||||||||||||||
Dividends attributable to dividend equivalents | — | — | — | — | — | (686 | ) | — | (686 | ) | ||||||||||||||||||||
Change in unrealized gains on MBS, net | — | — | — | — | — | — | 39,873 | 39,873 | ||||||||||||||||||||||
Derivative hedging instruments fair value changes, net | — | — | — | — | — | — | 16,671 | 16,671 | ||||||||||||||||||||||
Balance at September 30, 2017 | 8,000 | $ | 80 | 396,939 | $ | 3,969 | $ | 3,219,398 | $ | (596,022 | ) | $ | 630,226 | $ | 3,257,651 | |||||||||||||||
(1) For the nine months ended September 30, 2018 and 2017, includes approximately $2.0 million (250,946 shares) and $5.2 million (640,748 shares), respectively surrendered for tax purposes related to equity-based compensation awards.
4
MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | ||||||||
Nine Months Ended September 30, | ||||||||
(In Thousands) | 2018 | 2017 | ||||||
Cash Flows From Operating Activities: | ||||||||
Net income | $ | 240,922 | $ | 221,799 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Gain on sales of MBS, CRT securities and U.S. Treasury securities | (32,661 | ) | (30,530 | ) | ||||
Gain on sales of real estate owned | (6,582 | ) | (2,844 | ) | ||||
Gain on liquidation of residential whole loans | (18,598 | ) | (7,178 | ) | ||||
Other-than-temporary impairment charges | — | 1,032 | ||||||
Accretion of purchase discounts on MBS and CRT securities, residential whole loans and MSR related assets | (64,211 | ) | (67,065 | ) | ||||
Amortization of purchase premiums on MBS, CRT securities, and residential whole loans | 21,141 | 23,766 | ||||||
Depreciation and amortization on real estate, fixed assets and other assets | 1,354 | 1,199 | ||||||
Equity-based compensation expense | 3,891 | 5,369 | ||||||
Unrealized gain on residential whole loans at fair value | (26,788 | ) | (12,499 | ) | ||||
Unrealized losses/(gains) on MBS, CRT securities and Swaps | 2,767 | (11,932 | ) | |||||
(Increase)/decrease in other assets and other | (31,018 | ) | 10,538 | |||||
Increase/(decrease) in other liabilities | 33 | (10,248 | ) | |||||
Net cash provided by operating activities | $ | 90,250 | $ | 121,407 | ||||
Cash Flows From Investing Activities: | ||||||||
Principal payments on MBS, CRT securities and MSR related assets | $ | 1,797,012 | $ | 3,387,673 | ||||
Proceeds from sales of MBS, CRT securities and U.S. Treasury securities | 341,589 | 222,143 | ||||||
Purchases of MBS, CRT securities, MSR related assets and U.S. Treasury securities | (2,021,914 | ) | (1,425,717 | ) | ||||
Purchases of residential whole loans and capitalized advances | (2,158,105 | ) | (391,613 | ) | ||||
Principal payments on residential whole loans | 345,917 | 105,549 | ||||||
Proceeds from sales of real estate owned | 93,635 | 51,834 | ||||||
Purchases of real estate owned and capital improvements | (10,179 | ) | (17,224 | ) | ||||
Redemption of Federal Home Loan Bank stock | — | 10,422 | ||||||
Additions to leasehold improvements, furniture and fixtures | (1,009 | ) | (596 | ) | ||||
Net cash (used in)/provided by investing activities | $ | (1,613,054 | ) | $ | 1,942,471 | |||
Cash Flows From Financing Activities: | ||||||||
Principal payments on repurchase agreements and other advances | $ | (48,988,034 | ) | $ | (57,118,263 | ) | ||
Proceeds from borrowings under repurchase agreements | 49,651,416 | 55,302,002 | ||||||
Proceeds from issuance of securitized debt | 419,970 | 147,847 | ||||||
Principal payments on securitized debt | (67,945 | ) | (9,140 | ) | ||||
Payments made for securitization related costs | (2,472 | ) | (1,520 | ) | ||||
Payments made for settlements on interest rate swap agreements (“Swaps”) | (40,885 | ) | (30,050 | ) | ||||
Proceeds from settlements on Swaps | 57,656 | — | ||||||
Proceeds from issuances of common stock | 391,932 | 190,928 | ||||||
Payments made for costs related to common stock issuances | (350 | ) | (412 | ) | ||||
Dividends paid on preferred stock | (11,250 | ) | (11,250 | ) | ||||
Dividends paid on common stock and dividend equivalents | (239,623 | ) | (228,982 | ) | ||||
Net cash provided by/(used in) financing activities | $ | 1,170,415 | $ | (1,758,840 | ) | |||
Net (decrease)/increase in cash, cash equivalents and restricted cash | $ | (352,389 | ) | $ | 305,038 | |||
Cash, cash equivalents and restricted cash at beginning of period | $ | 463,064 | $ | 318,575 | ||||
Cash, cash equivalents and restricted cash at end of period | $ | 110,675 | $ | 623,613 | ||||
Non-cash Investing and Financing Activities: | ||||||||
Net (decrease)/increase in securities obtained as collateral/obligation to return securities obtained as collateral | $ | (505,850 | ) | $ | 131,930 | |||
Transfer from residential whole loans to real estate owned | $ | 161,572 | $ | 97,388 | ||||
Dividends and dividend equivalents declared and unpaid | $ | 90,136 | $ | 79,605 | ||||
Payable for unsettled MBS and residential whole loans purchases | $ | 10,888 | $ | 124,006 | ||||
The accompanying notes are an integral part of the consolidated financial statements.
5
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
1. Organization
MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998. The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes. In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders. The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiary (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See Note 2(o))
2. Summary of Significant Accounting Policies
(a) Basis of Presentation and Consolidation
The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted according to these SEC rules and regulations. Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading. The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2018 and results of operations for all periods presented have been made. The results of operations for the three and nine months ended September 30, 2018 should not be construed as indicative of the results to be expected for the full year.
The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition. Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS, CRT securities and MSR related assets (See Notes 3 and 14), income recognition and valuation of residential whole loans (See Notes 4 and 14), valuation of derivative instruments (See Notes 5(c) and 14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount. (See Note 3) In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest. (See Note 2(o)) Actual results could differ from those estimates.
The Company has one reportable segment as it manages its business and analyzes and reports its results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets.
The consolidated financial statements of the Company include the accounts of all subsidiaries; all intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate transactions related to the acquisition and securitization of residential whole loans as well as MBS resecuritization transactions completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.
6
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
(b) MBS and CRT Securities
The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of previously securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including, for certain CRT securities, if the loans in the reference pool experience delinquencies exceeding specified thresholds.
Designation
MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.
Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.
The Company has elected the fair value option for certain of its Agency MBS that it does not intend to hold to maturity. These securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.
The Company has elected the fair value option for its CRT securities as it considers this method of accounting to more appropriately reflect the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.
Revenue Recognition, Premium Amortization and Discount Accretion
Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.
Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs. (See Note 3)
Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income. The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors. If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time. Conversely, if the performance of a security with
7
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.
Determination of Fair Value for MBS and CRT Securities
In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. (See Note 14)
Impairments/OTTI
When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired. The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.” If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date. If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the impairment related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets. Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings. Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings. However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income. The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections. As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change. (See Note 3)
Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS. The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants. As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS. In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date. The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes. Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date. The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.
Balance Sheet Presentation
The Company’s MBS and CRT Securities pledged as collateral against repurchase agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically. Purchases and sales of securities are recorded on the trade date.
(c) MSR Related Assets
The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR related assets, are discussed in more detail below. The Company’s MSR related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR related assets are recorded on the trade date. (See Notes 3, 6, 7 and 14)
8
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Term Notes Backed by MSR Related Collateral
The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.
The Company’s term notes backed by MSR related collateral are reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is then used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fair value of the related underlying MSR collateral and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.
Corporate Loans
The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower.
Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. Commitment fees received on the undrawn amount are deferred and recognized as interest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a quarterly basis considering various factors, including the current status of the loan, changes in the fair value of the MSRs that secure the loan and the recent financial performance of the borrower.
(d) Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)
Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions, with the majority at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for purchased credit impaired loans that are held at carrying value is typically utilized by the Company for purchased credit impaired loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company may also purchase newly or recently originated loans that are performing as of the purchase date. Such loans are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required loan loss reserves differ to those used for purchased credit impaired loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.
The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically. Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing
9
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction. (See Notes 4, 6, 7, 14 and 15)
Residential Whole Loans at Carrying Value
Purchased Credit Impaired Loans
The Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price with no allowance for loan losses. Subsequent to acquisition, the recorded amount for these loans reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.
Under the application of the accounting model for purchased credit impaired loans, the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition, and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans.
A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level, thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses generally represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. Under the accounting model applied to credit impaired loans, a significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield.
Other Loans at Carrying Value
The Company also has investments in loans that are not considered to be credit impaired at purchase. To date such loans have included newly or previously originated performing loans that are primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties and are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”), (collectively “Other Loans at Carrying Value”). The Company’s Other Loans at Carrying Value are initially recorded at their purchase price. Interest income on Other Loans at Carrying Value purchased at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any premium or discount and related servicing costs, and adjusted for actual prepayment activity.
10
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
An allowance for loan losses is recorded when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms of the loan agreement. Any required loan loss allowance would typically be measured based on fair value of the collateral securing the loan and would reduce the carrying value of the loan with a corresponding charge to earnings. Significant judgments are required in determining any allowance for loan loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful. When the ultimate collectability of the principal of an impaired loan is in doubt, all payments are applied to principal under the cost recovery method. When the ultimate collectability of the principal of an impaired loan is not in doubt, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged.
Residential Whole Loans at Fair Value
Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.
Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in Net gain on residential whole loans held at fair value.
(e) Cash and Cash Equivalents
Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less. Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement counterparties as a result of reverse margin calls (i.e., margin calls made by the Company). At September 30, 2018 and December 31, 2017, the Company had cash and cash equivalents of $104.2 million and $449.8 million, respectively. The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency, were $71.1 million and $354.0 million at September 30, 2018 and December 31, 2017, respectively. (See Notes 7 and 14)
(f) Restricted Cash
Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s repurchase agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to repurchase agreement counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the repurchase agreement. The Company had aggregate restricted cash held as collateral or otherwise in connection with its repurchase agreements of $6.5 million and $13.3 million at September 30, 2018 and December 31, 2017, respectively. (See Notes 5(c), 6, 7 and 14)
(g) Goodwill
At September 30, 2018 and December 31, 2017, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998. Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level. Through September 30, 2018, the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets.
11
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
(h) Real Estate Owned (“REO”)
REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 5(b))
(i) Depreciation
Leasehold Improvements and Other Depreciable Assets
Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term. Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase.
(j) Loan Securitization and Other Debt Issuance Costs
Loan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various financing transactions completed by the Company. Other debt issuance and related costs include costs incurred by the Company in connection with issuing 8% Senior Notes due 2042 (“Senior Notes”) and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees. Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.
(k) Repurchase Agreements
The Company finances the holdings of a significant portion of its residential mortgage assets with repurchase agreements. Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price. The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender. Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender. With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms. Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions. The Company also may make margin calls on counterparties when collateral values increase.
The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms. Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation. If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and
12
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral. (See Notes 6, 7 and 14)
In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company in prior periods entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty. Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price. The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower. In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement. No net cash was exchanged between the Company and counterparty at the inception of the transactions. Securities obtained and pledged as collateral are recorded in Other assets on the Company’s consolidated balance sheets. Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis. The Company’s liability to the counterparty in prior periods in connection with this financing arrangement is recorded in Other liabilities on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.” (See Note 5(a))
(l) Equity-Based Compensation
Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. For certain awards granted prior to January 1, 2017, compensation expense recognized included the impact of estimated forfeitures, with any changes in estimated forfeiture rates accounted for as a change in estimate. Upon adoption of new accounting guidance that was effective for the Company on January 1, 2017, the Company made a policy election to account for forfeitures as they occur.
Beginning in 2014, the Company has made annual grants of restricted stock units (“RSUs”) certain of which cliff vest after a three-year period and others of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period. The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.
The Company makes dividend equivalent payments in connection with certain of its equity-based awards. A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion. Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest. Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company. (See Notes 2(m) and 13)
(m) Earnings per Common Share (“EPS”)
Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares. In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period. For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method. Under the treasury stock method, common equivalent shares are calculated assuming that all
13
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period. (See Note 12)
(n) Comprehensive Income/(Loss)
The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.
(o) U.S. Federal Income Taxes
The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law. The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code. As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe. Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year. As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements. Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.
In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 20% of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company for the nine months ended September 30, 2018 and 2017, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not.
Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2018, December 31, 2017, or September 30, 2017. The Company filed its 2017 tax return prior to October 15, 2018. The Company’s tax returns for tax years 2015 through 2017 are open to examination.
14
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
(p) Derivative Financial Instruments
The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings.
Swaps
The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions. The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”
Swaps are carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value is positive, or in Other liabilities, if their fair value is negative. Beginning in January 2017, variation margin payments on the Company’s Swaps that have been novated to a clearing house are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. All of the Company’s Swaps have been novated to a central clearing house. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective. Changes in fair value for any ineffective amount of a Swap are recognized in earnings. The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness. Periodic payments accrued in connection with Swaps designated as hedges are included in interest expense, and are treated as an operating cash flow.
The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. (See Notes 5(c), 7 and 14)
Changes in the fair value of the Company’s Swaps not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statement of operations.
(q) Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities
The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability. The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability. This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value. In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date.
In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans, Agency MBS and CRT securities at time of acquisition. Subsequent changes in the fair value of these financial instruments are reported in Other income, net, in the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(b), 2(d), 3, 4 and 14)
15
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
(r) Variable Interest Entities
An entity is referred to as a VIE if it meets at least one of the following criteria: (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.
The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE. The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.
The Company has entered into several financing transactions which resulted in the Company consolidating the VIEs that were created to facilitate these transactions. In determining the accounting treatment to be applied to these transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated. If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sale or should be accounted for as secured financings under GAAP. (See Note 15)
The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.
(s) Offering Costs Related to Issuance and Redemption of Preferred Stock
Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.
(t) New Accounting Standards and Interpretations
Accounting Standards Adopted in 2018
Compensation - Stock Compensation - Scope of Modification Accounting
In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Scope of Modification Accounting (“ASU 2017-09”). The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all of the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified; (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award date is modified. The Company adopted ASU 2017-09 on January 1, 2018 and its adoption did not have an impact on its financial position or financial statement disclosures.
16
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Statement of Cash Flows - Restricted Cash
In November 2016, the FASB issued ASU 2016-18, Restricted Cash (“ASU 2016-18”). ASU 2016-18 clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows with the objective of reducing the existing diversity in practice. The amendments in ASU 2016-18 require restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of period total amounts shown on the statement of cash flows. The Company adopted ASU 2016-18 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.
Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments
In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The amendments in ASU 2016-15 provide guidance for eight specific cash flow classification issues, certain cash receipts and cash payments on the statement of cash flows with the objective of reducing the existing diversity in practice. The Company adopted ASU 2016-15 on January 1, 2018 and its adoption did not have a significant impact on its financial position or financial statement disclosures.
Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities
In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). The amendments in this ASU affect all entities that hold financial assets or owe financial liabilities, and address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The classification and measurement guidance of investments in debt securities and loans are not affected by the amendments in this ASU. ASU 2016-01 was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. The Company’s adoption of this ASU on January 1, 2018 did not have a significant impact on the Company’s financial position or financial statement disclosures as the classification and measurement of its investments in debt securities and loans were not affected by the amendments in this ASU.
Revenue from Contracts with Customers
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). The ASU requires an entity to recognize revenue in an amount that reflects the consideration to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 replaced most existing revenue recognition guidance in GAAP when it became effective. The Company adopted this ASU on January 1, 2018 and its adoption did not have a material impact on the Company’s financial position or financial statement disclosures as the majority of the Company’s revenues are generated by financial instruments that are explicitly scoped out of this ASU. On adoption of the new standard on January 1, 2018, the Company recorded a transition adjustment, under the modified retrospective approach, of approximately $295,000 to the opening balance of retained earnings in order to reflect the recognition of a gain on sale of REO that was previously deferred under the prior accounting guidance.
17
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
3. MBS, CRT Securities and MSR Related Assets
Agency and Non-Agency MBS
The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by: (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”), which have interest rates that reset annually or more frequently (collectively, “ARM-MBS”); and (iii) 15 and 30 year fixed-rate mortgages for Agency MBS and, for Non-Agency MBS, 30-year and longer-term fixed rate mortgages. In addition, the Company’s MBS are also comprised of MBS backed by securitized re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company’s RPL/NPL MBS are primarily structured with a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements and Swaps. (See Note 7)
Agency MBS: Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae. The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government. Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities.
Non-Agency MBS: The Company’s Non-Agency MBS are primarily secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation. Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral.
CRT Securities
CRT securities are debt obligations issued by Fannie Mae and Freddie Mac. The payments of principal and interest on the CRT securities are paid by Fannie Mae or Freddie Mac, as the case may be, on a monthly basis, and are dependent on the performance of loans in a reference pool of Agency MBS securitized by the issuing entity. As an investor in a CRT security, the Company may incur a loss if losses on the mortgage loans in the reference pool exceed the credit enhancement on the underlying CRT security owned by the Company. The Company assesses the credit risk associated with CRT securities by assessing the current and expected future performance of the associated reference pool. The Company pledges a portion of its CRT securities as collateral against its borrowings under repurchase agreements. (See Note 7)
18
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following tables present certain information about the Company’s MBS and CRT securities at September 30, 2018 and December 31, 2017:
September 30, 2018
(In Thousands) | Principal/ Current Face | Purchase Premiums | Accretable Purchase Discounts | Discount Designated as Credit Reserve and OTTI (1) | Amortized Cost (2) | Fair Value | Gross Unrealized Gains | Gross Unrealized Losses | Net Unrealized Gain/(Loss) | |||||||||||||||||||||||||||
Agency MBS: (3) | ||||||||||||||||||||||||||||||||||||
Fannie Mae | $ | 1,851,447 | $ | 70,882 | $ | (29 | ) | $ | — | $ | 1,922,300 | $ | 1,896,739 | $ | 14,650 | $ | (40,211 | ) | $ | (25,561 | ) | |||||||||||||||
Freddie Mac | 987,833 | 40,183 | — | — | 1,028,453 | 1,003,583 | 1,027 | (25,897 | ) | (24,870 | ) | |||||||||||||||||||||||||
Ginnie Mae | 5,028 | 92 | — | — | 5,120 | 5,168 | 48 | — | 48 | |||||||||||||||||||||||||||
Total Agency MBS | 2,844,308 | 111,157 | (29 | ) | — | 2,955,873 | 2,905,490 | 15,725 | (66,108 | ) | (50,383 | ) | ||||||||||||||||||||||||
Non-Agency MBS: | ||||||||||||||||||||||||||||||||||||
Expected to Recover Par (4)(5) | 1,343,835 | 41 | (23,835 | ) | — | 1,320,041 | 1,343,272 | 25,146 | (1,915 | ) | 23,231 | |||||||||||||||||||||||||
Expected to Recover Less than Par (4) | 2,165,454 | — | (167,910 | ) | (531,757 | ) | 1,465,787 | 1,991,338 | 525,770 | (219 | ) | 525,551 | ||||||||||||||||||||||||
Total Non-Agency MBS (6) | 3,509,289 | 41 | (191,745 | ) | (531,757 | ) | 2,785,828 | 3,334,610 | 550,916 | (2,134 | ) | 548,782 | ||||||||||||||||||||||||
Total MBS | 6,353,597 | 111,198 | (191,774 | ) | (531,757 | ) | 5,741,701 | 6,240,100 | 566,641 | (68,242 | ) | 498,399 | ||||||||||||||||||||||||
CRT securities (7) | 495,018 | 9,936 | (178 | ) | — | 504,776 | 538,945 | 34,173 | (4 | ) | 34,169 | |||||||||||||||||||||||||
Total MBS and CRT securities | $ | 6,848,615 | $ | 121,134 | $ | (191,952 | ) | $ | (531,757 | ) | $ | 6,246,477 | $ | 6,779,045 | $ | 600,814 | $ | (68,246 | ) | $ | 532,568 | |||||||||||||||
December 31, 2017
(In Thousands) | Principal/ Current Face | Purchase Premiums | Accretable Purchase Discounts | Discount Designated as Credit Reserve and OTTI (1) | Amortized Cost (2) | Fair Value | Gross Unrealized Gains | Gross Unrealized Losses | Net Unrealized Gain/(Loss) | |||||||||||||||||||||||||||
Agency MBS: (3) | ||||||||||||||||||||||||||||||||||||
Fannie Mae | $ | 2,170,974 | $ | 82,271 | $ | (40 | ) | $ | — | $ | 2,253,205 | $ | 2,246,600 | $ | 21,736 | $ | (28,341 | ) | $ | (6,605 | ) | |||||||||||||||
Freddie Mac | 561,346 | 21,683 | — | — | 584,920 | 571,748 | 1,624 | (14,796 | ) | (13,172 | ) | |||||||||||||||||||||||||
Ginnie Mae | 6,142 | 112 | — | — | 6,254 | 6,333 | 79 | — | 79 | |||||||||||||||||||||||||||
Total Agency MBS | 2,738,462 | 104,066 | (40 | ) | — | 2,844,379 | 2,824,681 | 23,439 | (43,137 | ) | (19,698 | ) | ||||||||||||||||||||||||
Non-Agency MBS: | ||||||||||||||||||||||||||||||||||||
Expected to Recover Par (4)(5) | 1,128,808 | 50 | (22,737 | ) | — | 1,106,121 | 1,132,205 | 26,518 | (434 | ) | 26,084 | |||||||||||||||||||||||||
Expected to Recover Less than Par (4) | 2,589,935 | — | (192,588 | ) | (593,227 | ) | 1,804,120 | 2,401,761 | 597,660 | (19 | ) | 597,641 | ||||||||||||||||||||||||
Total Non-Agency MBS (6) | 3,718,743 | 50 | (215,325 | ) | (593,227 | ) | 2,910,241 | 3,533,966 | 624,178 | (453 | ) | 623,725 | ||||||||||||||||||||||||
Total MBS | 6,457,205 | 104,116 | (215,365 | ) | (593,227 | ) | 5,754,620 | 6,358,647 | 647,617 | (43,590 | ) | 604,027 | ||||||||||||||||||||||||
CRT securities (7) | 602,799 | 8,887 | (3,550 | ) | — | 608,136 | 664,403 | 56,290 | (23 | ) | 56,267 | |||||||||||||||||||||||||
Total MBS and CRT securities | $ | 7,060,004 | $ | 113,003 | $ | (218,915 | ) | $ | (593,227 | ) | $ | 6,362,756 | $ | 7,023,050 | $ | 703,907 | $ | (43,613 | ) | $ | 660,294 | |||||||||||||||
(1) | Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at September 30, 2018 reflect Credit Reserve of $519.6 million and OTTI of $12.2 million. Amounts disclosed at December 31, 2017 reflect Credit Reserve of $579.0 million and OTTI of $14.2 million. |
(2) | Includes principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively, which are not included in the Principal/Current Face. |
(3) | Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million for which the fair value option has been elected. Such securities had no unrealized gains and gross unrealized losses of approximately $5.5 million at September 30, 2018. The Company did not have any Agency MBS for which the fair value option had been elected at December 31, 2017. |
(4) | Based on management’s current estimates of future principal cash flows expected to be received. |
(5) | Includes RPL/NPL MBS, which at September 30, 2018 had a $1.2 billion Principal/Current face, $1.2 billion amortized cost and $1.2 billion fair value. At December 31, 2017, RPL/NPL MBS had a $922.0 million Principal/Current face, $920.1 million amortized cost and $923.1 million fair value. |
(6) | At September 30, 2018 and December 31, 2017, the Company expected to recover approximately 85% and 84% of the then-current face amount of Non-Agency MBS, respectively. |
(7) | Amounts disclosed at September 30, 2018 includes CRT securities with a fair value of $538.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $34.2 million and gross unrealized losses of approximately $4,000 at September 30, 2018. Amounts disclosed at December 31, 2017 includes CRT securities with a fair value of $528.9 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $40.5 million and gross unrealized losses of approximately $23,000 at December 31, 2017. |
19
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Sales of MBS and CRT Securities
During the nine months ended September 30, 2018, the Company sold certain Agency MBS for $75.3 million realizing losses of $3.8 million. The Company also sold certain CRT securities during the three and nine months ended September 30, 2018 for $118.9 million and $222.9 million, realizing gains of $13.0 million and $24.2 million, respectively. In addition, during the three and nine months ended September 30, 2018, the Company sold certain Non-Agency MBS for $24.3 million and $43.7 million, realizing gains of $3.4 million and $12.2 million, respectively. During the three and nine months ended September 30, 2017, the Company sold certain Non-Agency MBS for $44.5 million and $83.1 million, realizing gains of $14.9 million and $30.8 million, respectively. The Company has no continuing involvement with any of the sold MBS.
Unrealized Losses on MBS and CRT Securities
The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at September 30, 2018:
Unrealized Loss Position For:
Less than 12 Months | 12 Months or more | Total | ||||||||||||||||||||||||||||
Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | |||||||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||||||
Agency MBS: (1) | ||||||||||||||||||||||||||||||
Fannie Mae | $ | 438,980 | $ | 4,293 | 105 | $ | 838,566 | $ | 35,918 | 251 | $ | 1,277,546 | $ | 40,211 | ||||||||||||||||
Freddie Mac | 668,566 | 6,020 | 37 | 298,083 | 19,877 | 103 | 966,649 | 25,897 | ||||||||||||||||||||||
Total Agency MBS | 1,107,546 | 10,313 | 142 | 1,136,649 | 55,795 | 354 | 2,244,195 | 66,108 | ||||||||||||||||||||||
Non-Agency MBS: | ||||||||||||||||||||||||||||||
Expected to Recover Par (2) | 435,011 | 1,849 | 15 | 3,877 | 66 | 7 | 438,888 | 1,915 | ||||||||||||||||||||||
Expected to Recover Less than Par (2) | 44,630 | 219 | 6 | — | — | — | 44,630 | 219 | ||||||||||||||||||||||
Total Non-Agency MBS | 479,641 | 2,068 | 21 | 3,877 | 66 | 7 | 483,518 | 2,134 | ||||||||||||||||||||||
Total MBS | 1,587,187 | 12,381 | 163 | 1,140,526 | 55,861 | 361 | 2,727,713 | 68,242 | ||||||||||||||||||||||
CRT securities (3) | 15,754 | 4 | 4 | — | — | — | 15,754 | 4 | ||||||||||||||||||||||
Total MBS and CRT securities | $ | 1,602,941 | $ | 12,385 | 167 | $ | 1,140,526 | $ | 55,861 | 361 | $ | 2,743,467 | $ | 68,246 | ||||||||||||||||
(1) | Amounts disclosed at September 30, 2018 include Agency MBS with a fair value of $746.7 million on which the fair value option has been elected. Such securities had unrealized losses of $5.5 million at September 30, 2018. |
(2) | Based on management’s current estimates of future principal cash flows expected to be received. |
(3) | Amounts disclosed at September 30, 2018 represent CRT securities on which the fair value option has been elected. |
At September 30, 2018, the Company did not intend to sell any of its investments that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity.
Gross unrealized losses on the Company’s Agency MBS were $66.1 million at September 30, 2018. Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at September 30, 2018 any unrealized losses on its Agency MBS were temporary.
Gross unrealized losses on the Company’s Non-Agency MBS were $2.1 million at September 30, 2018. Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTI and does not believe that
20
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
these unrealized losses are credit related, but are rather a reflection of current market yields and/or marketplace bid-ask spreads. The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.
The Company did not recognize any credit-related OTTI losses through earnings related to its Non-Agency MBS during the three and nine months ended September 30, 2018 and three months ended September 30, 2017. The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $1.0 million during the nine months ended September 30, 2017.
Non-Agency MBS on which OTTI is recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS. The Company considers information available about the structure of the securitization, including structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants. Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e., loans that prepay in full with no loss) have generally trended higher relative to the Company’s assumptions for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired.
The following table presents the composition of OTTI charges recorded by the Company for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Total OTTI losses | $ | — | $ | — | $ | — | $ | (63 | ) | |||||||
OTTI reclassified from OCI | — | — | — | (969 | ) | |||||||||||
OTTI recognized in earnings | $ | — | $ | — | $ | — | $ | (1,032 | ) | |||||||
The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI. Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
(In Thousands) | 2018 | 2018 | ||||||
Credit loss component of OTTI at beginning of period | $ | 38,337 | $ | 38,337 | ||||
Additions for credit related OTTI not previously recognized | — | — | ||||||
Subsequent additional credit related OTTI recorded | — | — | ||||||
Credit loss component of OTTI at end of period | $ | 38,337 | $ | 38,337 | ||||
21
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Purchase Discounts on Non-Agency MBS
The following tables present the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, 2018 | Three Months Ended September 30, 2017 | |||||||||||||||
(In Thousands) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | ||||||||||||
Balance at beginning of period | $ | (553,596 | ) | $ | (202,248 | ) | $ | (626,498 | ) | $ | (257,967 | ) | ||||
Impact of RMBS Issuer Settlement (2) | — | (2,734 | ) | — | — | |||||||||||
Accretion of discount | — | 20,115 | — | 18,621 | ||||||||||||
Realized credit losses | 12,042 | — | 13,982 | — | ||||||||||||
Purchases | (1,975 | ) | 1,368 | — | (1,929 | ) | ||||||||||
Sales | 1,552 | 1,974 | 4,620 | 11,244 | ||||||||||||
Transfers/release of credit reserve | 10,220 | (10,220 | ) | 14,762 | (14,762 | ) | ||||||||||
Balance at end of period | $ | (531,757 | ) | $ | (191,745 | ) | $ | (593,134 | ) | $ | (244,793 | ) | ||||
Nine Months Ended September 30, 2018 | Nine Months Ended September 30, 2017 | |||||||||||||||
(In Thousands) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | ||||||||||||
Balance at beginning of period | $ | (593,227 | ) | $ | (215,325 | ) | $ | (694,241 | ) | $ | (278,191 | ) | ||||
Impact of RMBS Issuer Settlement (2)(3) | — | (14,822 | ) | — | — | |||||||||||
Accretion of discount | — | 54,860 | — | 60,461 | ||||||||||||
Realized credit losses | 31,443 | — | 39,445 | — | ||||||||||||
Purchases | (2,510 | ) | 1,856 | (484 | ) | (3,449 | ) | |||||||||
Sales | 7,144 | 7,079 | 29,398 | 10,166 | ||||||||||||
Net impairment losses recognized in earnings | — | — | (1,032 | ) | — | |||||||||||
Transfers/release of credit reserve | 25,393 | (25,393 | ) | 33,780 | (33,780 | ) | ||||||||||
Balance at end of period | $ | (531,757 | ) | $ | (191,745 | ) | $ | (593,134 | ) | $ | (244,793 | ) | ||||
(1) | Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security. |
(2) | Includes the impact of approximately $2.7 million of cash proceeds (a one-time payment) received by the Company during the three and nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by Lehman Brothers Holdings Inc. |
(3) | Includes the impact of approximately $12.1 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. |
MSR Related Assets
(a) Term Notes Backed by MSR Related Collateral
At September 30, 2018 and December 31, 2017, the Company had $505.2 million and $381.8 million, respectively, of term notes issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered to be largely dependent on cash flows generated by the underlying MSRs, as this impacts the cash flows available to the SPV that issued the term notes.
22
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
At September 30, 2018, these term notes had an amortized cost of $504.3 million, gross unrealized gains of approximately $922,000, a weighted average yield of 5.15% and a weighted average term to maturity of 4.5 years. At December 31, 2017, the term notes had an amortized cost of $381.0 million, unrealized gains of $804,000, a weighted average yield of 5.80% and a weighted average term to maturity of 3.4 years.
(b) Corporate Loans
The Company has made or participated in loans to provide financing to entities that originate residential mortgage loans and own the related MSRs. These corporate loans are secured by MSRs, as well as certain other unencumbered assets owned by the borrower.
During the three months ended September 30, 2018, the Company participated in a loan where the Company committed to lend $100.0 million of which approximately $60.1 million was drawn at September 30, 2018. At September 30, 2018, the coupon paid by the borrower on the drawn amount is 5.64%, the remaining term associated with the loan is 1.9 years and the remaining commitment period on any undrawn amount is 1.9 years. During the remaining commitment period, the Company receives a commitment fee between 0.25% and 1.0% based on the undrawn amount of the loan.
In December 2016, the Company entered into a loan agreement under the terms of which it had committed to lend $130.0 million, of which approximately $124.2 million was drawn at March 31, 2018. This loan was paid in full during the three months ended June 30, 2018, at which time any remaining commitment was extinguished.
For the three and nine months ended September 30, 2018, the Company recognized interest income on its corporate loans of $138,000 and $3.8 million including discount accretion and commitment fee income of $19,000 and $1.3 million, respectively. In addition, the Company recorded $136,000 of Other Income consisting of deferred commitment fees recognized upon repayment of a corporate loan during the nine months ended September 30, 2018. For the three and nine months ended September 30, 2017, the Company recognized interest income on its corporate loans of approximately $2.1 million and $5.7 million including discount accretion and commitment fee income of approximately $76,000 and $212,000, respectively.
Impact of AFS Securities on AOCI
The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
AOCI from AFS securities: | ||||||||||||||||
Unrealized gain on AFS securities at beginning of period | $ | 548,551 | $ | 668,223 | $ | 620,648 | $ | 620,403 | ||||||||
Unrealized loss on Agency MBS, net | (9,177 | ) | (3,032 | ) | (27,507 | ) | (22,241 | ) | ||||||||
Unrealized (loss)/gain on Non-Agency MBS, net | (25,101 | ) | 10,020 | (62,743 | ) | 93,429 | ||||||||||
Reclassification adjustment for MBS sales included in net income | (9,455 | ) | (14,935 | ) | (25,580 | ) | (30,283 | ) | ||||||||
Reclassification adjustment for OTTI included in net income | — | — | — | (1,032 | ) | |||||||||||
Change in AOCI from AFS securities | (43,733 | ) | (7,947 | ) | (115,830 | ) | 39,873 | |||||||||
Balance at end of period | $ | 504,818 | $ | 660,276 | $ | 504,818 | $ | 660,276 | ||||||||
23
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Interest Income on MBS, CRT Securities and MSR Related Assets
The following table presents the components of interest income on the Company’s MBS, CRT securities and MSR related assets for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Agency MBS | ||||||||||||||||
Coupon interest | $ | 21,549 | $ | 23,473 | $ | 62,546 | $ | 74,589 | ||||||||
Effective yield adjustment (1) | (7,217 | ) | (7,940 | ) | (19,751 | ) | (24,575 | ) | ||||||||
Interest income | $ | 14,332 | $ | 15,533 | $ | 42,795 | $ | 50,014 | ||||||||
Legacy Non-Agency MBS | ||||||||||||||||
Coupon interest | $ | 27,026 | $ | 30,688 | $ | 83,791 | $ | 97,796 | ||||||||
Effective yield adjustment (2)(3) | 18,984 | 18,005 | 53,648 | 59,033 | ||||||||||||
Interest income | $ | 46,010 | $ | 48,693 | $ | 137,439 | $ | 156,829 | ||||||||
RPL/NPL MBS | ||||||||||||||||
Coupon interest | $ | 11,526 | $ | 13,947 | $ | 31,167 | $ | 54,475 | ||||||||
Effective yield adjustment (1)(4) | 1,131 | 612 | 1,206 | 1,424 | ||||||||||||
Interest income | $ | 12,657 | $ | 14,559 | $ | 32,373 | $ | 55,899 | ||||||||
CRT securities | ||||||||||||||||
Coupon interest | $ | 7,257 | $ | 7,868 | $ | 23,484 | $ | 19,712 | ||||||||
Effective yield adjustment (2) | 491 | 808 | 2,455 | 3,186 | ||||||||||||
Interest income | $ | 7,748 | $ | 8,676 | $ | 25,939 | $ | 22,898 | ||||||||
MSR related assets | ||||||||||||||||
Coupon interest | $ | 6,407 | $ | 7,117 | $ | 19,005 | $ | 17,621 | ||||||||
Effective yield adjustment (1) | — | 77 | 1,244 | 212 | ||||||||||||
Interest income | $ | 6,407 | $ | 7,194 | $ | 20,249 | $ | 17,833 | ||||||||
(1) Includes amortization of premium paid net of accretion of purchase discount. For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.
(2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.
(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $2.3 million during the three months ended September 30, 2018 and $2.3 million and $1.7 million during the nine months ended September 30, 2018 and 2017, respectively.
(4) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously been purchased at a discount of $1.1 million and $575,000 during the three months ended September 30, 2018 and 2017, respectively and $1.2 million during each of the nine months ended September 30, 2018 and 2017, respectively.
24
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
4. Residential Whole Loans
Included on the Company’s consolidated balance sheets at September 30, 2018 and December 31, 2017 are approximately $3.9 billion and $2.2 billion, respectively, of residential whole loans arising from the Company’s interests in certain trusts established to acquire the loans and certain entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated for financial reporting purposes.
Residential Whole Loans, at Carrying Value
The following table presents the components of the Company’s Residential whole loans, at carrying value at September 30, 2018 and December 31, 2017:
(Dollars In Thousands) | September 30, 2018 | December 31, 2017 | ||||||
Purchased credit impaired loans | $ | 825,614 | $ | 790,879 | ||||
Other loans at carrying value: | ||||||||
Non-QM loans | 989,818 | 55,612 | ||||||
Rehabilitation loans | 329,301 | 56,706 | ||||||
Single-family rental loans | 79,699 | 5,319 | ||||||
Seasoned performing loans | 247,135 | — | ||||||
Total other loans at carrying value | $ | 1,645,953 | $ | 117,637 | ||||
Total Residential whole loans, at carrying value | $ | 2,471,567 | $ | 908,516 | ||||
Number of loans | 9,900 | 4,800 | ||||||
The following table presents additional information regarding the Company’s Residential whole loans, at carrying value at September 30, 2018:
September 30, 2018
Carrying Value | Unpaid Principal Balance (“UPB”) | Weighted Average Coupon (1) | Weighted Average Term to Maturity (Months) | Weighted Average LTV Ratio (2) | Aging by UPB | |||||||||||||||||||||||||||
Past Due Days | ||||||||||||||||||||||||||||||||
(Dollars In Thousands) | Current | 30-59 | 60-89 | 90+ | ||||||||||||||||||||||||||||
Purchased credit impaired loans | $ | 825,614 | $ | 1,034,890 | 4.36 | % | 304 | 87 | % | N/A | N/A | N/A | N/A | |||||||||||||||||||
Other loans at carrying value:(3) | ||||||||||||||||||||||||||||||||
Non-QM loans | 989,818 | 956,162 | 6.18 | 358 | 66 | $ | 944,564 | $ | 8,564 | $ | 1,865 | $ | 1,169 | |||||||||||||||||||
Rehabilitation loans | 329,301 | 329,301 | 7.51 | 9 | 65 | 309,951 | 12,836 | 3,620 | 2,894 | |||||||||||||||||||||||
Single-family rental loans | 79,699 | 79,563 | 5.84 | 355 | 68 | 78,172 | 870 | — | 521 | |||||||||||||||||||||||
Seasoned performing loans | 240,362 | 260,770 | 4.05 | 194 | 49 | 239,025 | 20,373 | 635 | 737 | |||||||||||||||||||||||
Residential whole loans, at carrying value, total or weighted average | $ | 2,464,794 | $ | 2,660,686 | 5.46 | % | 278 | |||||||||||||||||||||||||
(1) Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.
(2) LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. For Rehabilitation loans, the LTV generally represents the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated after repaired value of the collateral securing the related loan. For certain Rehabilitation loans, an after repaired valuation is not obtained during loan underwriting. For these loans, the LTV represents the ratio of the current unpaid principal balance of the loan, to the “as is” estimated value of the collateral securing the related loan.
(3) Excluded from the table above are approximately $6.8 million of other loans held at carrying value for which the closing of the purchase transaction had not occurred as of September 30, 2018.
25
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Purchased Credit Impaired Loans
As of September 30, 2018, the Company had established an allowance for loan losses of approximately $461,000 on its purchased credit impaired loans held at carrying value. For the three and nine months ended September 30, 2018, a provision for loan losses of approximately $164,000 and $131,000 was recorded, respectively, which is included in Operating and Other expense on the Company’s consolidated statements of operations. For the three and nine months ended September 30, 2017, a net reversal of provision for loan losses of approximately $57,000 and $672,000 was recorded, respectively.
The following table presents the activity in the Company’s allowance for loan losses on its purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Balance at the beginning of period | $ | 297 | $ | 375 | $ | 330 | $ | 990 | ||||||||
Provisions/(reversal of provisions) for loan losses | 164 | (57 | ) | 131 | (672 | ) | ||||||||||
Balance at the end of period | $ | 461 | $ | 318 | $ | 461 | $ | 318 | ||||||||
The following table presents information regarding the estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the purchased credit impaired loans held at carrying value acquired by the Company for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, (1) | Nine Months Ended September 30, (1) | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Contractually required principal and interest | $ | 154,911 | $ | 185,234 | $ | 154,911 | $ | 185,234 | ||||||||
Contractual cash flows not expected to be collected (non-accretable yield) | (15,378 | ) | (33,448 | ) | (15,378 | ) | (33,448 | ) | ||||||||
Expected cash flows to be collected | 139,533 | 151,786 | 139,533 | 151,786 | ||||||||||||
Interest component of expected cash flows (accretable yield) | (41,947 | ) | (53,916 | ) | (41,947 | ) | (53,916 | ) | ||||||||
Fair value at the date of acquisition | $ | 97,586 | $ | 97,870 | $ | 97,586 | $ | 97,870 | ||||||||
(1) | Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months ended June 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2018 and 2017, respectively. |
26
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table presents accretable yield activity for the Company’s purchased credit impaired loans held at carrying value for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, (1) | Nine Months Ended September 30, (1) | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Balance at beginning of period | $ | 401,075 | $ | 318,125 | $ | 421,872 | $ | 334,379 | ||||||||
Additions | 41,947 | 53,916 | 41,947 | 53,916 | ||||||||||||
Accretion | (11,198 | ) | (9,026 | ) | (33,139 | ) | (26,219 | ) | ||||||||
Liquidations and other | (8,378 | ) | — | (23,388 | ) | — | ||||||||||
Reclassifications (to)/from non-accretable difference, net | 9,694 | 303 | 25,848 | 1,242 | ||||||||||||
Balance at end of period | $ | 433,140 | $ | 363,318 | $ | 433,140 | $ | 363,318 | ||||||||
(1) | Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $54.9 million and $97.9 million of purchase credit impaired loans held at carrying value the Company committed to purchase during the three months ended June 30, 2018 and 2017, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2018 and 2017, respectively. |
Accretable yield for purchased credit impaired residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represent the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the three and nine months ended September 30, 2018 is not necessarily indicative of future results.
Other Loans at Carrying Value
As of September 30, 2018, there were ten loans held at carrying value, that have been placed on non-accrual status as they are more than 90 days delinquent and had not yet become current with respect to the contractually required payments under the loan. Such loans have an unpaid balance of approximately $5.3 million. These non-performing loans represent approximately 0.3% of the total outstanding principal balance of all of the Company’s Other Loans at Carrying Value. Management has assessed the recoverability of these loans and based on estimates of the value of the underlying collateral, no allowance for loan loss reserves has been recorded as of September 30, 2018.
In connection with purchased Rehabilitation loans, the Company has unfunded commitments of $43.9 million.
27
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Residential Whole Loans, at Fair Value
Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.
The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2018 and December 31, 2017:
(Dollars in Thousands) | September 30, 2018 (1) | December 31, 2017 | ||||||
Less than 60 Days Past Due: | ||||||||
Outstanding principal balance | $ | 585,024 | $ | 488,600 | ||||
Aggregate fair value | $ | 544,890 | $ | 446,616 | ||||
Weighted Average LTV Ratio (2) | 76.17 | % | 74.98 | % | ||||
Number of loans | 2,775 | 2,323 | ||||||
60 Days to 89 Days Past Due: | ||||||||
Outstanding principal balance | $ | 70,018 | $ | 45,955 | ||||
Aggregate fair value | $ | 62,043 | $ | 37,927 | ||||
Weighted Average LTV Ratio (2) | 77.62 | % | 89.25 | % | ||||
Number of loans | 319 | 207 | ||||||
90 Days or More Past Due: | ||||||||
Outstanding principal balance | $ | 972,488 | $ | 1,027,818 | ||||
Aggregate fair value | $ | 840,634 | $ | 840,572 | ||||
Weighted Average LTV Ratio (2) | 89.48 | % | 94.50 | % | ||||
Number of loans | 3,416 | 3,984 | ||||||
Total Residential whole loans, at fair value | $ | 1,447,567 | $ | 1,325,115 | ||||
(1) | Excluded from the table above are approximately $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018. |
(2) | LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful. |
The following table presents the components of Net gain on residential whole loans held at fair value for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Coupon payments and other income received (1) | $ | 17,634 | $ | 9,824 | $ | 52,034 | $ | 27,971 | ||||||||
Net unrealized gains | 8,442 | 5,289 | 26,788 | 12,499 | ||||||||||||
Net gain on payoff/liquidation of loans | 3,251 | 1,456 | 10,203 | 3,076 | ||||||||||||
Net gain on transfers to REO | 5,615 | 2,110 | 16,858 | 5,114 | ||||||||||||
Total | $ | 34,942 | $ | 18,679 | $ | 105,883 | $ | 48,660 | ||||||||
(1) Primarily includes coupon interest payments received upon the liquidation of previously delinquent mortgage loans, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.
28
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
5. Other Assets
The following table presents the components of the Company’s Other assets at September 30, 2018 and December 31, 2017:
(In Thousands) | September 30, 2018 | December 31, 2017 | ||||||
Securities obtained and pledged as collateral, at fair value | $ | — | $ | 504,062 | ||||
REO | 223,105 | 152,356 | ||||||
MBS and loan related receivables | 101,578 | 54,640 | ||||||
Swaps, at fair value | 22,311 | 679 | ||||||
Goodwill | 7,189 | 7,189 | ||||||
Other | 51,886 | 23,983 | ||||||
Total Other Assets | $ | 406,069 | $ | 742,909 | ||||
(a) Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral
In connection with its financing strategy for Non-Agency MBS, in prior periods the Company obtained securities as collateral under collateralized financing arrangements. Securities obtained as collateral in connection with these transactions are recorded at fair value, with a liability, representing the obligation to return the collateral obtained, recorded in Other liabilities. While beneficial ownership of securities obtained remains with the counterparty, the Company had the right to transfer the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction. During the three months ended September 30, 2018, these financing arrangements were unwound and the related securities obtained as collateral were returned to the counterparty.
(b) Real Estate Owned
At September 30, 2018, the Company had 979 REO properties with an aggregate carrying value of $223.1 million. At December 31, 2017, the Company had 709 REO properties with an aggregate carrying value of $152.4 million.
During the three and nine months ended September 30, 2018, the Company reclassified to REO 240 and 795 mortgage loans, respectively at an aggregate estimated fair value less estimated selling costs of $58.1 million and $161.6 million, respectively, at the time of transfer. During the three and nine months ended September 30, 2017, the Company reclassified to REO 174 and 521 mortgage loans, respectively at an aggregate estimated fair value less estimated selling cost of $38.9 million and $97.4 million, respectively, at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction. From time to time, the Company also acquires REO in connection with transactions to acquire residential whole loans.
At September 30, 2018, $214.4 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $48.7 million of residential whole loans held at carrying value and $720.1 million of residential whole loans held at fair value at September 30, 2018.
During the three and nine months ended September 30, 2018, the Company sold 157 and 537 REO properties for consideration of $29.9 million and $96.0 million, realizing net gains of approximately $2.0 million and $6.6 million, respectively. During the three and nine months ended September 30, 2017, the Company sold 139 and 368 REO properties for consideration of $18.4 million and $53.0 million, realizing net gain of approximately $805,000 and $2.8 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of the third quarters of 2018 and 2017, downward adjustments of approximately $4.1 million and $3.1 million were recorded to reflect certain REO properties at the lower of cost or estimated fair value as of September 30, 2018 and 2017, respectively.
29
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Balance at beginning of period | $ | 192,162 | $ | 104,443 | $ | 152,356 | $ | 80,503 | ||||||||
Adjustments to record at lower of cost or fair value | (4,056 | ) | (3,129 | ) | (11,592 | ) | (7,306 | ) | ||||||||
Transfer from residential whole loans (1) | 58,051 | 38,944 | 161,572 | 97,388 | ||||||||||||
Purchases and capital improvements | 4,897 | 15,342 | 10,179 | 17,224 | ||||||||||||
Disposals | (27,949 | ) | (17,621 | ) | (89,410 | ) | (49,830 | ) | ||||||||
Balance at end of period | $ | 223,105 | $ | 137,979 | $ | 223,105 | $ | 137,979 | ||||||||
(1) Includes net gain recorded on transfer of approximately $5.8 million and $2.8 million, for the three months ended September 30, 2018 and 2017, respectively; and approximately $17.0 million and $5.3 million for the nine months ended September 30, 2018 and 2017, respectively.
(c) Derivative Instruments
The Company’s derivative instruments are currently comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings. In addition, in connection with managing risks associated with purchases of longer duration Agency MBS, the Company has also entered into Swaps that are not designated as hedges for accounting purposes. The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at September 30, 2018 and December 31, 2017:
September 30, 2018 | December 31, 2017 | |||||||||||||||||||
Derivative Instrument (1) | Designation | Balance Sheet Location | Notional Amount | Fair Value | Notional Amount | Fair Value | ||||||||||||||
(In Thousands) | ||||||||||||||||||||
Swaps | Hedging | Other assets | $ | 2,122,000 | $ | 18,650 | $ | 750,000 | $ | 679 | ||||||||||
Swaps | Hedging | Other liabilities | $ | — | $ | — | $ | 1,800,000 | $ | — | ||||||||||
Swaps | Non-Hedging | Other assets | $ | 515,000 | $ | 3,661 | $ | — | $ | — | ||||||||||
(1) Represents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties.
Swaps
The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2018 and December 31, 2017:
(In Thousands) | September 30, 2018 | December 31, 2017 | ||||||
Agency MBS, at fair value | $ | 2,877 | $ | 21,756 | ||||
Restricted cash | — | 6,405 | ||||||
Total assets pledged against Swaps | $ | 2,877 | $ | 28,161 | ||||
Swaps designated as hedges, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings. At September 30, 2018, all of the Company’s derivatives that were designated in a hedging relationship were deemed effective for hedging purposes.
The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities. To date, no cost has been incurred at the inception of a
30
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company did not recognize any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness during the three and nine months ended September 30, 2018 and 2017.
At September 30, 2018, the Company had Swaps with an aggregate notional amount of $2.6 billion and extended 32 months on average with a maximum term of approximately 121 months.
The following table presents information about the Company’s Swaps at September 30, 2018 and December 31, 2017:
September 30, 2018 | December 31, 2017 | ||||||||||||||||||||
Notional Amount | Weighted Average Fixed-Pay Interest Rate | Weighted Average Variable Interest Rate (2) | Notional Amount | Weighted Average Fixed-Pay Interest Rate | Weighted Average Variable Interest Rate (2) | ||||||||||||||||
Maturity (1) | |||||||||||||||||||||
(Dollars in Thousands) | |||||||||||||||||||||
Within 30 days | $ | — | — | % | — | % | $ | — | — | % | — | % | |||||||||
Over 30 days to 3 months | — | — | — | — | — | — | |||||||||||||||
Over 3 months to 6 months | 100,000 | 1.71 | 2.21 | 50,000 | 1.45 | 1.56 | |||||||||||||||
Over 6 months to 12 months | 100,000 | 1.71 | 2.21 | 500,000 | 1.50 | 1.46 | |||||||||||||||
Over 12 months to 24 months | 1,630,000 | 2.27 | 2.20 | 200,000 | 1.71 | 1.54 | |||||||||||||||
Over 24 months to 36 months | 322,000 | 2.34 | 2.17 | 1,500,000 | 2.22 | 1.51 | |||||||||||||||
Over 36 months to 48 months | — | — | — | 200,000 | 2.20 | 1.53 | |||||||||||||||
Over 48 months to 60 months | 355,000 | 2.85 | 2.28 | — | — | — | |||||||||||||||
Over 60 months to 72 months | — | — | — | 100,000 | 2.75 | 1.50 | |||||||||||||||
Over 72 months to 84 months | — | — | — | — | — | — | |||||||||||||||
Over 84 months | 130,000 | 2.94 | 2.32 | — | — | — | |||||||||||||||
Total Swaps | $ | 2,637,000 | 2.35 | % | 2.21 | % | $ | 2,550,000 | 2.04 | % | 1.50 | % | |||||||||
(1) Each maturity category reflects contractual amortization and/or maturity of notional amounts.
(2) Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.
The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(Dollars in Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Interest expense attributable to Swaps | $ | 547 | $ | 5,310 | $ | 4,187 | $ | 19,606 | ||||||||
Weighted average Swap rate paid | 2.19 | % | 2.04 | % | 2.09 | % | 1.96 | % | ||||||||
Weighted average Swap rate received | 2.09 | % | 1.23 | % | 1.86 | % | 1.00 | % | ||||||||
During the three and nine months ended September 30, 2018, the Company recorded net gains on Swaps not designated in hedging relationships of $4.0 million and $4.4 million, respectively. These amounts are included in Other income, net on the Company’s consolidated statements of operations. All of the Company’s Swaps were designated in hedging relationships during the three and nine months ended September 30, 2017.
31
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Impact of Derivative Hedging Instruments on AOCI
The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
AOCI from derivative hedging instruments: | ||||||||||||||||
Balance at beginning of period | $ | 16,160 | $ | (35,841 | ) | $ | (11,424 | ) | $ | (46,721 | ) | |||||
Net gain on Swaps | 5,390 | 5,791 | 32,974 | 16,671 | ||||||||||||
Balance at end of period | $ | 21,550 | $ | (30,050 | ) | $ | 21,550 | $ | (30,050 | ) | ||||||
6. Repurchase Agreements
The Company’s repurchase agreements are accounted for as secured borrowings and bear interest that is generally LIBOR-based. (See Notes 2(k) and 7) At September 30, 2018, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 25 days and an effective repricing period of 11 months, including the impact of related Swaps. At December 31, 2017, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 16 days and an effective repricing period of 11 months, including the impact of related Swaps.
32
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at September 30, 2018 and December 31, 2017:
(Dollars in Thousands) | September 30, 2018 | December 31, 2017 | ||||||
Repurchase agreement borrowings secured by Agency MBS | $ | 2,584,097 | $ | 2,501,340 | ||||
Fair value of Agency MBS pledged as collateral under repurchase agreements | $ | 2,792,396 | $ | 2,705,754 | ||||
Weighted average haircut on Agency MBS (1) | 4.48 | % | 4.65 | % | ||||
Repurchase agreement borrowings secured by Legacy Non-Agency MBS | $ | 1,592,067 | $ | 1,256,033 | ||||
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements | $ | 2,075,540 | $ | 1,652,983 | ||||
Weighted average haircut on Legacy Non-Agency MBS (1) | 21.70 | % | 21.87 | % | ||||
Repurchase agreement borrowings secured by RPL/NPL MBS | $ | 913,249 | $ | 567,140 | ||||
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements | $ | 1,161,568 | $ | 726,540 | ||||
Weighted average haircut on RPL/NPL MBS (1) | 21.22 | % | 22.05 | % | ||||
Repurchase agreements secured by U.S. Treasuries | $ | — | $ | 470,334 | ||||
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements | $ | — | $ | 472,095 | ||||
Weighted average haircut on U.S. Treasuries (1) | — | % | 1.47 | % | ||||
Repurchase agreements secured by CRT securities | $ | 405,168 | $ | 459,058 | ||||
Fair value of CRT securities pledged as collateral under repurchase agreements | $ | 504,931 | $ | 595,900 | ||||
Weighted average haircut on CRT securities (1) | 19.73 | % | 22.16 | % | ||||
Repurchase agreements secured by MSR related assets | $ | 435,762 | $ | 317,255 | ||||
Fair value of MSR related assets pledged as collateral under repurchase agreements | $ | 565,272 | $ | 482,158 | ||||
Weighted average haircut on MSR related assets (1) | 22.56 | % | 33.19 | % | ||||
Repurchase agreements secured by residential whole loans (2) | $ | 1,347,946 | $ | 1,043,747 | ||||
Fair value of residential whole loans pledged as collateral under repurchase agreements (3) | $ | 1,888,445 | $ | 1,474,704 | ||||
Weighted average haircut on residential whole loans (1) | 21.93 | % | 26.10 | % | ||||
(1) | Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount. |
(2) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.
(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.
The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at September 30, 2018 and December 31, 2017:
September 30, 2018 | December 31, 2017 | |||||||||||||
Balance | Weighted Average Interest Rate | Balance | Weighted Average Interest Rate | |||||||||||
Time Until Interest Rate Reset | ||||||||||||||
(Dollars in Thousands) | ||||||||||||||
Within 30 days | $ | 6,985,487 | 3.01 | % | $ | 6,161,008 | 2.39 | % | ||||||
Over 30 days to 3 months | 29,501 | 2.48 | 453,899 | 2.76 | ||||||||||
Over 3 months to 12 months | 263,301 | 3.09 | — | — | ||||||||||
Total repurchase agreements | 7,278,289 | 3.01 | % | 6,614,907 | 2.42 | % | ||||||||
Less debt issuance costs | 19 | 206 | ||||||||||||
Total repurchase agreements less debt issuance costs | $ | 7,278,270 | $ | 6,614,701 | ||||||||||
33
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at September 30, 2018, and does not reflect the impact of derivative contracts that hedge such repurchase agreements:
September 30, 2018 | ||||||||||||||||||||||||
Contractual Maturity | Overnight | Within 30 Days | Over 30 Days to 3 Months | Over 3 Months to 12 Months | Over 12 months | Total | ||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||
Agency MBS | $ | — | $ | 2,570,990 | $ | 13,107 | $ | — | $ | — | $ | 2,584,097 | ||||||||||||
Legacy Non-Agency MBS | — | 1,544,995 | 47,072 | — | — | 1,592,067 | ||||||||||||||||||
RPL/NPL MBS | — | 887,087 | 26,162 | — | — | 913,249 | ||||||||||||||||||
CRT securities | — | 399,064 | 6,104 | — | — | 405,168 | ||||||||||||||||||
MSR related assets | — | 342,704 | 93,058 | — | — | 435,762 | ||||||||||||||||||
Residential whole loans | — | 267,129 | 376,936 | 703,881 | — | 1,347,946 | ||||||||||||||||||
Total (1) | $ | — | $ | 6,011,969 | $ | 562,439 | $ | 703,881 | $ | — | $ | 7,278,289 | ||||||||||||
Weighted Average Interest Rate | — | % | 2.85 | % | 3.73 | % | 3.80 | % | — | % | 3.01 | % | ||||||||||||
Gross amount of recognized liabilities for repurchase agreements in Note 8 | $ | 7,278,289 | ||||||||||||||||||||||
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8 | $ | — | ||||||||||||||||||||||
(1) | Excludes $19,000 of unamortized debt issuance costs at September 30, 2018. |
Undrawn Financing Commitment
In connection with the financing of MSR related assets, the Company has obtained a financing commitment of up to $75.0 million, of which $45.1 million was utilized and was outstanding as of September 30, 2018. The Company pays a commitment fee ranging from 0.125% to 0.5% of the undrawn amount, depending on the amount of financing utilized.
34
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The Company had repurchase agreement borrowings with 28 and 31 counterparties at September 30, 2018 and December 31, 2017. The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2018:
September 30, 2018 | |||||||||||
Counterparty Rating (1) | Amount at Risk (2) | Weighted Average Months to Maturity for Repurchase Agreements | Percent of Stockholders’ Equity | ||||||||
Counterparty | |||||||||||
(Dollars in Thousands) | |||||||||||
Barclay's Bank | BBB/Aa3/A | $ | 346,185 | 4 | 9.8 | % | |||||
Goldman Sachs (3) | BBB+/A3/A | 305,862 | 1 | 8.6 | |||||||
Wells Fargo (4) | A+/Aa2/AA- | 252,651 | 5 | 7.1 | |||||||
RBC (5) | AA-/Aa2/AA | 243,731 | 1 | 6.9 | |||||||
(1) | As rated at September 30, 2018 by S&P, Moody’s and Fitch, Inc., respectively. The counterparty rating presented is the lowest published for these entities. |
(2) | The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities. |
(3) | Includes $171.3 million at risk with Goldman Sachs Bank USA and $134.6 million at risk with Goldman Sachs Lending Partners. |
(4) | Includes $241.0 million at risk with Wells Fargo Bank, NA and $11.7 million at risk with Wells Fargo Securities LLC. |
(5) | Includes $237.6 million at risk with RBC Barbados and $6.1 million at risk with RBC New York. Counterparty ratings are not published for RBC Barbados and RBS Capital Market LLC. |
7. Collateral Positions
The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements and for initial margin payments on centrally cleared Swaps. In addition, the Company receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements. The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements and Swap contracts, as applicable. In connection with these margining practices, either the Company or its counterparty may be required to pledge cash or securities as collateral. When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral or provide collateral to the Company in the form of cash or equivalent securities.
35
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements and derivative hedging instruments at September 30, 2018 and December 31, 2017:
September 30, 2018 | December 31, 2017 | |||||||||||||||
(In Thousands) | Assets Pledged | Collateral Held | Assets Pledged | Collateral Held | ||||||||||||
Derivative Hedging Instruments: | ||||||||||||||||
Agency MBS | $ | 2,877 | $ | — | $ | 21,756 | $ | — | ||||||||
Cash (1) | — | — | 6,405 | — | ||||||||||||
2,877 | — | 28,161 | — | |||||||||||||
Repurchase Agreement Borrowings: | ||||||||||||||||
Agency MBS | 2,792,396 | — | 2,705,754 | — | ||||||||||||
Legacy Non-Agency MBS (2) | 2,075,540 | — | 1,652,983 | — | ||||||||||||
RPL/NPL MBS | 1,161,568 | — | 726,540 | — | ||||||||||||
U.S. Treasury securities | — | — | 472,095 | — | ||||||||||||
CRT securities | 504,931 | — | 595,900 | — | ||||||||||||
MSR related assets | 565,272 | — | 482,158 | — | ||||||||||||
Residential whole loans (3) | 1,888,445 | — | 1,474,704 | — | ||||||||||||
Cash (1) | 6,489 | — | 6,902 | — | ||||||||||||
8,994,641 | — | 8,117,036 | — | |||||||||||||
Reverse Repurchase Agreements: | ||||||||||||||||
U.S. Treasury securities | — | — | — | 504,062 | ||||||||||||
— | — | — | 504,062 | |||||||||||||
Total | $ | 8,997,518 | $ | — | $ | 8,145,197 | $ | 504,062 | ||||||||
(1) Cash pledged as collateral is reported as Restricted cash on the Company’s consolidated balance sheets.
(2) In addition, at December 31, 2017 $688.1 million of Legacy Non-Agency MBS were pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.
(3) At September 30, 2018 includes Non-Agency MBS with an aggregate fair value of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation.
The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and derivative hedging instruments at September 30, 2018:
September 30, 2018 | ||||||||||||||||||||||||||||
Assets Pledged Under Repurchase Agreements | Assets Pledged Against Derivative Hedging Instruments | Total Fair Value of Assets Pledged and Accrued Interest | ||||||||||||||||||||||||||
(In Thousands) | Fair Value | Amortized Cost | Accrued Interest on Pledged Assets | Fair Value/ Carrying Value | Amortized Cost | Accrued Interest on Pledged Assets | ||||||||||||||||||||||
Agency MBS | $ | 2,792,396 | $ | 2,842,022 | $ | 8,527 | $ | 2,877 | $ | 3,036 | $ | 7 | $ | 2,803,807 | ||||||||||||||
Legacy Non-Agency MBS | 2,075,540 | 1,548,906 | 8,531 | — | — | — | 2,084,071 | |||||||||||||||||||||
RPL/NPL MBS | 1,161,568 | 1,162,829 | 984 | — | — | — | 1,162,552 | |||||||||||||||||||||
CRT securities | 504,931 | 472,217 | 436 | — | — | — | 505,367 | |||||||||||||||||||||
MSR related assets | 565,272 | 564,350 | 644 | — | — | — | 565,916 | |||||||||||||||||||||
Residential whole loans (1)(2) | 1,888,445 | 1,861,387 | 8,485 | — | — | — | 1,896,930 | |||||||||||||||||||||
Cash (3) | 6,489 | 6,489 | — | — | — | — | 6,489 | |||||||||||||||||||||
Total | $ | 8,994,641 | $ | 8,458,200 | $ | 27,607 | $ | 2,877 | $ | 3,036 | $ | 7 | $ | 9,025,132 | ||||||||||||||
(1) | Includes residential whole loans held at carrying value with an aggregate fair value of $1.2 billion and aggregate amortized cost of $1.1 billion and residential whole loans held at fair value with an aggregate fair value and amortized cost of $685.1 million. |
(2) | Includes Non-Agency MBS with an aggregate fair value and amortized cost of $27.0 million obtained in connection with the Company’s loan securitization transactions that are eliminated in consolidation. |
(3) | Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. |
36
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
8. Offsetting Assets and Liabilities
The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at September 30, 2018 and December 31, 2017:
Offsetting of Financial Assets and Derivative Assets
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Net Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | ||||||||||||||||||||
(In Thousands) | Financial Instruments | Cash Collateral Received | ||||||||||||||||||||||
September 30, 2018 | ||||||||||||||||||||||||
Swaps, at fair value | $ | 22,311 | $ | — | $ | 22,311 | $ | (22,311 | ) | $ | — | $ | — | |||||||||||
Total | $ | 22,311 | $ | — | $ | 22,311 | $ | (22,311 | ) | $ | — | $ | — | |||||||||||
December 31, 2017 | ||||||||||||||||||||||||
Swaps, at fair value | $ | 679 | $ | — | $ | 679 | $ | (679 | ) | $ | — | $ | — | |||||||||||
Total | $ | 679 | $ | — | $ | 679 | $ | (679 | ) | $ | — | $ | — | |||||||||||
Offsetting of Financial Liabilities and Derivative Liabilities
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | ||||||||||||||||||||
(In Thousands) | Financial Instruments (1) | Cash Collateral Pledged (1) | ||||||||||||||||||||||
September 30, 2018 | ||||||||||||||||||||||||
Swaps, at fair value (2) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||
Repurchase agreements (3)(4) | 7,278,289 | — | 7,278,289 | (7,271,800 | ) | (6,489 | ) | — | ||||||||||||||||
Total | $ | 7,278,289 | $ | — | $ | 7,278,289 | $ | (7,271,800 | ) | $ | (6,489 | ) | $ | — | ||||||||||
December 31, 2017 | ||||||||||||||||||||||||
Swaps, at fair value (2) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||
Repurchase agreements (3)(4) | 6,614,907 | — | 6,614,907 | (6,608,005 | ) | (6,902 | ) | — | ||||||||||||||||
Total | $ | 6,614,907 | $ | — | $ | 6,614,907 | $ | (6,608,005 | ) | $ | (6,902 | ) | $ | — | ||||||||||
(1) Amounts disclosed in the Financial Instruments column of the above table represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements. Amounts disclosed in the Cash Collateral Pledged column of the above table represent amounts pledged as collateral against repurchase agreements.
(2) The fair value of securities pledged against the Company’s Swaps was $2.9 million and $21.8 million at September 30, 2018 and December 31, 2017, respectively. Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap.
(3) The fair value of financial instruments pledged against the Company’s repurchase agreements was $9.0 billion and $8.1 billion at September 30, 2018 and December 31, 2017, respectively.
(4) Excludes $19,000 and $206,000 of unamortized debt issuance costs at September 30, 2018 and December 31, 2017, respectively.
Nature of Setoff Rights
In the Company’s consolidated balance sheets, all balances associated with repurchase agreements are presented on a gross basis. Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction.
37
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
9. Other Liabilities
The following table presents the components of the Company’s Other liabilities at September 30, 2018 and December 31, 2017:
(In Thousands) | September 30, 2018 | December 31, 2017 | ||||||
Securitized debt (1) | $ | 714,203 | $ | 363,944 | ||||
Obligation to return securities held as collateral, at fair value | — | 504,062 | ||||||
Senior Notes | 96,805 | 96,773 | ||||||
Dividends and dividend equivalents payable | 90,136 | 79,771 | ||||||
Accrued interest payable | 11,630 | 12,263 | ||||||
Payable for unsettled MBS and residential whole loans purchases | 10,888 | — | ||||||
Accrued expenses and other | 27,821 | 21,584 | ||||||
Total Other Liabilities | $ | 951,483 | $ | 1,078,397 | ||||
(1) | Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 10 and 15 for further discussion.) |
Senior Notes
On April 11, 2012, the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering. The total net proceeds to the Company from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount. The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042. The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31%. The Company may redeem the Senior Notes, in whole or in part, at any time on or after April 15, 2017, at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date.
The Senior Notes are the Company’s senior unsecured obligations and are subordinate to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness.
10. Commitments and Contingencies
(a) Lease Commitments
The Company pays monthly rent pursuant to two operating leases. The lease term for the Company’s headquarters in New York, New York extends through June 30, 2020. The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges. In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash. The letter of credit may be drawn upon by the landlord in the event that the Company defaults under certain terms of the lease. In addition, the Company has a lease through December 31, 2021 for its off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling $32,000 annually.
(b) Representations and Warranties in Connection with Loan Securitization Transactions
In connection with the loan securitization transactions entered into by the Company, the Company has the obligation under certain circumstances to repurchase assets previously transferred to securitization vehicles upon breach of certain representations and warranties. As of September 30, 2018, the Company had no reserve established for repurchases of loans and was not aware of any material unsettled repurchase claims that would require the establishment of such a reserve. (See Note 15)
38
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
(c) Corporate Loan
The Company has participated in a loan to provide financing to an entity that originates loans and owns MSRs. The loan is secured by certain MSRs, as well as certain other unencumbered assets owned by the borrower. Under the terms of the participation agreement, the Company has committed to provide financing of $100.0 million of which approximately $60.1 million was drawn at September 30, 2018. (See Note 3)
(d) Rehabilitation Loan Commitments
At September 30, 2018, the Company had unfunded commitments of $43.9 million in connection with its purchased Rehabilitation loans. (See Note 4)
(e) MBS Purchase Commitments
At September 30, 2018, the Company had a commitment to purchase a Non-Agency MBS at an estimated price of $2.3 million. The expected settlement amount is included in the Non-Agency MBS balances presented at fair value on the Company’s consolidated balance sheets, with a corresponding liability recorded in Other liabilities and included in Payable for unsettled MBS and residential whole loan purchases.
(f) Residential Whole Loan Purchase Commitments
At September 30, 2018, the Company has agreed, subject to the completion of due diligence and customary closing conditions, to purchase residential whole loans with an aggregate estimated purchase price of $8.6 million, of which $6.8 million is presented in other loans held at carrying value and $1.8 million in residential whole loans held at fair value with a corresponding liability recorded in Other liabilities and included in Payable for unsettled MBS and residential whole loan purchases.
11. Stockholders’ Equity
(a) Preferred Stock
On April 15, 2013, the Company completed the issuance of 8.0 million shares of its 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT) and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE American or NASDAQ, or any successor exchange.
The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive). Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment. In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.
39
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2018 through September 30, 2018:
Declaration Date | Record Date | Payment Date | Dividend Per Share | |||||
August 20, 2018 | September 7, 2018 | September 28, 2018 | $ | 0.46875 | ||||
May 17, 2018 | June 4, 2018 | June 29, 2018 | 0.46875 | |||||
February 20, 2018 | March 2, 2018 | March 30, 2018 | 0.46875 | |||||
(b) Dividends on Common Stock
The following table presents cash dividends declared by the Company on its common stock from January 1, 2018 through September 30, 2018:
Declaration Date (1) | Record Date | Payment Date | Dividend Per Share | ||||||
September 13, 2018 | October 1, 2018 | October 31, 2018 | $ | 0.20 | (1) | ||||
June 7, 2018 | June 29, 2018 | July 31, 2018 | 0.20 | ||||||
March 7, 2018 | March 29, 2018 | April 30, 2018 | 0.20 | ||||||
(1) At September 30, 2018, the Company had accrued dividends and dividend equivalents payable of $90.1 million related to the common stock dividend declared on September 13, 2018.
(c) Public Offering of Common Stock
The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the nine months ended September 30, 2018 and the year ended December 31, 2017.
Share Issue Date | Shares Issued | Gross Proceeds Per Share | Gross Proceeds | |||||||||
(In Thousands, Except Per Share Amounts) | ||||||||||||
August 7, 2018 | 50,875 | (1) | $ | 7.78 | $ | 395,807 | (1) | |||||
May 10, 2017 | 23,000 | 7.85 | 180,550 | (2) | ||||||||
(1) Includes approximately 875,000 shares issued on September 5, 2018 pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company incurred approximately $6.5 million of underwriting discounts and related expenses in connection with this equity offering.
(2) The Company incurred approximately $2.3 million of underwriting discounts and related expenses in connection with this equity offering.
(d) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)
On September 16, 2016, the Company filed a shelf registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP. Pursuant to Rule 462(e) of the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 15 million shares of common stock. The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments. At September 30, 2018, approximately 11.9 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.
During the three and nine months ended September 30, 2018, the Company issued 64,731 and 302,264 shares of common stock through the DRSPP, raising net proceeds of approximately $519,000 and $2.2 million, respectively. From the inception of
40
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
the DRSPP in September 2003 through September 30, 2018, the Company issued 33,978,241 shares pursuant to the DRSPP, raising net proceeds of $283.7 million.
(e) Stock Repurchase Program
As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock. The Board reaffirmed such authorization in May 2010. In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization. Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate, (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources. Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock. The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the nine months ended September 30, 2018. At September 30, 2018, 6,616,355 shares remained authorized for repurchase under the Repurchase Program.
(f) Accumulated Other Comprehensive Income/(Loss)
The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2018:
Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 | |||||||||||||||||||||||
(In Thousands) | Net Unrealized Gain/(Loss) on AFS Securities | Net (Loss)/Gain on Swaps | Total AOCI | Net Unrealized Gain/(Loss) on AFS Securities | Net (Loss)/Gain on Swaps | Total AOCI | ||||||||||||||||||
Balance at beginning of period | $ | 548,551 | $ | 16,160 | $ | 564,711 | $ | 620,648 | $ | (11,424 | ) | $ | 609,224 | |||||||||||
OCI before reclassifications | (34,278 | ) | 5,390 | (28,888 | ) | (90,250 | ) | 32,974 | (57,276 | ) | ||||||||||||||
Amounts reclassified from AOCI (1) | (9,455 | ) | — | (9,455 | ) | (25,580 | ) | — | (25,580 | ) | ||||||||||||||
Net OCI during the period (2) | (43,733 | ) | 5,390 | (38,343 | ) | (115,830 | ) | 32,974 | (82,856 | ) | ||||||||||||||
Balance at end of period | $ | 504,818 | $ | 21,550 | $ | 526,368 | $ | 504,818 | $ | 21,550 | $ | 526,368 | ||||||||||||
(1) See separate table below for details about these reclassifications.
(2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2017:
Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2017 | |||||||||||||||||||||||
(In Thousands) | Net Unrealized Gain/(Loss) on AFS Securities | Net (Loss)/Gain on Swaps | Total AOCI | Net Unrealized Gain/(Loss) on AFS Securities | Net (Loss)/Gain on Swaps | Total AOCI | ||||||||||||||||||
Balance at beginning of period | $ | 668,223 | $ | (35,841 | ) | $ | 632,382 | $ | 620,403 | $ | (46,721 | ) | $ | 573,682 | ||||||||||
OCI before reclassifications | 6,988 | 5,791 | 12,779 | 71,188 | 16,671 | 87,859 | ||||||||||||||||||
Amounts reclassified from AOCI (1) | (14,935 | ) | — | (14,935 | ) | (31,315 | ) | — | (31,315 | ) | ||||||||||||||
Net OCI during the period (2) | (7,947 | ) | 5,791 | (2,156 | ) | 39,873 | 16,671 | 56,544 | ||||||||||||||||
Balance at end of period | $ | 660,276 | $ | (30,050 | ) | $ | 630,226 | $ | 660,276 | $ | (30,050 | ) | $ | 630,226 | ||||||||||
(1) See separate table below for details about these reclassifications.
(2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
41
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2018:
Three Months Ended September 30, 2018 | Nine Months Ended September 30, 2018 | |||||||||
Details about AOCI Components | Amounts Reclassified from AOCI | Affected Line Item in the Statement Where Net Income is Presented | ||||||||
(In Thousands) | ||||||||||
AFS Securities: | ||||||||||
Realized gain on sale of securities | $ | (9,455 | ) | $ | (25,580 | ) | Net gain on sales of investment securities | |||
Total AFS Securities | $ | (9,455 | ) | $ | (25,580 | ) | ||||
Total reclassifications for period | $ | (9,455 | ) | $ | (25,580 | ) | ||||
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2017:
Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2017 | |||||||||
Details about AOCI Components | Amounts Reclassified from AOCI | Affected Line Item in the Statement Where Net Income is Presented | ||||||||
(In Thousands) | ||||||||||
AFS Securities: | ||||||||||
Realized gain on sale of securities | $ | (14,935 | ) | $ | (30,283 | ) | Net gain on sales of investment securities | |||
OTTI recognized in earnings | — | (1,032 | ) | Net impairment losses recognized in earnings | ||||||
Total AFS Securities | $ | (14,935 | ) | $ | (31,315 | ) | ||||
Total reclassifications for period | $ | (14,935 | ) | $ | (31,315 | ) | ||||
On securities for which OTTI had been recognized in prior periods, the Company did not have any unrealized losses recorded in AOCI at September 30, 2018 and December 31, 2017.
42
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
12. EPS Calculation
The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands, Except Per Share Amounts) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Numerator: | ||||||||||||||||
Net income | $ | 87,132 | $ | 63,805 | $ | 240,922 | $ | 221,799 | ||||||||
Dividends declared on preferred stock | (3,750 | ) | (3,750 | ) | (11,250 | ) | (11,250 | ) | ||||||||
Dividends, dividend equivalents and undistributed earnings allocated to participating securities | (472 | ) | (409 | ) | (1,393 | ) | (1,299 | ) | ||||||||
Net income to common stockholders - basic and diluted | $ | 82,910 | $ | 59,646 | $ | 228,279 | $ | 209,250 | ||||||||
Denominator: | ||||||||||||||||
Weighted average common shares for basic and diluted earnings per share (1) | 428,713 | 396,698 | 408,614 | 385,282 | ||||||||||||
Basic and diluted earnings per share | $ | 0.19 | $ | 0.15 | $ | 0.56 | $ | 0.54 | ||||||||
(1) | At September 30, 2018, the Company had approximately 2.2 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three and nine months ended September 30, 2018, as their inclusion would have been anti-dilutive. These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.72. These equity instruments may have a dilutive impact on future EPS. |
13. Equity Compensation, Employment Agreements and Other Benefit Plans
(a) Equity Compensation Plan
In accordance with the terms of the Company’s Equity Plan, which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.
Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit. At September 30, 2018, approximately 5.7 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan. A participant may generally not receive stock-based awards in excess of 1.5 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock. Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025.
Restricted Stock Units
Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date. Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of September 30, 2018 are designated to be settled in shares of the Company’s common stock. The Company did not grant any RSUs during the three months ended September 30, 2018 and 2017 and granted 843,802 and 898,945 during the nine months ended September 30, 2018 and 2017, respectively. There were 20,000 RSUs forfeited during the nine months ended September 30, 2018. There were no RSUs forfeited during the nine months ended September 30, 2017. All RSUs outstanding at September 30, 2018 may be entitled to receive dividend
43
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled. At September 30, 2018 and December 31, 2017, the Company had unrecognized compensation expense of $6.2 million and $4.1 million, respectively, related to RSUs. The unrecognized compensation expense at September 30, 2018 is expected to be recognized over a weighted average period of 1.8 years.
Restricted Stock
The Company did not award any shares of restricted common stock during the nine months ended September 30, 2018 and 2017. At September 30, 2018, the Company did not have any unvested shares of restricted common stock outstanding.
Dividend Equivalents
A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.
Expense Recognized for Equity-Based Compensation Instruments
The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
RSUs | $ | 1,082 | $ | 1,836 | $ | 3,891 | $ | 5,194 | ||||||||
Restricted shares of common stock | — | 74 | — | 175 | ||||||||||||
Total | $ | 1,082 | $ | 1,910 | $ | 3,891 | $ | 5,369 | ||||||||
(b) Employment Agreements
At September 30, 2018, the Company had employment agreements with four of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.
(c) Deferred Compensation Plans
The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation. The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.
Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company. Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock. Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time. The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded. Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.
44
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date. The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Non-employee directors | $ | (22 | ) | $ | 125 | $ | — | $ | 339 | |||||||
Total | $ | (22 | ) | $ | 125 | $ | — | $ | 339 | |||||||
The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2018 and December 31, 2017 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2018 and December 31, 2017:
September 30, 2018 | December 31, 2017 | |||||||||||||||
(In Thousands) | Undistributed Income Deferred (1) | Liability Under Deferred Plans | Undistributed Income Deferred (1) | Liability Under Deferred Plans | ||||||||||||
Non-employee directors | $ | 2,100 | $ | 2,420 | $ | 1,688 | $ | 2,056 | ||||||||
Total | $ | 2,100 | $ | 2,420 | $ | 1,688 | $ | 2,056 | ||||||||
(1) Represents the cumulative amounts that were deferred by participants through September 30, 2018 and December 31, 2017, which had not been distributed through such respective date.
(d) Savings Plan
The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code. Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law. Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan. The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code. The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%. For the three months ended September 30, 2018 and 2017, the Company recognized expenses for matching contributions of $89,000 and $87,500, respectively, and $282,000 and $262,500 for the nine months ended September 30, 2018 and 2017, respectively.
14. Fair Value of Financial Instruments
A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of valuation hierarchy are defined as follows:
Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.
45
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral
The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity. Securities obtained as collateral are classified as Level 1 in the fair value hierarchy.
MBS and CRT Securities
The Company determines the fair value of its Agency MBS based upon prices obtained from third-party pricing services, which are indicative of market activity, and repurchase agreement counterparties.
For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs. The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds. Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace.
In determining the fair value of the Company’s Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions. For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered. The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.
The Company’s Legacy Non-Agency MBS, RPL/NPL MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters. Accordingly, these securities are classified as Level 2 in the fair value hierarchy.
Term Notes Backed by MSR Related Collateral
The Company’s valuation process for term notes backed by MSR related collateral considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. At September 30, 2018, the indicative implied yields used in the valuation of these securities ranged from 4.9% to 6.2%. The weighted average indicative yield to maturity was 5.62%. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fair value of the related underlying MSR collateral and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient. As this process includes significant unobservable inputs, these securities are classified as Level 3 in the fair value hierarchy.
46
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Residential Whole Loans, at Fair Value
The Company determines the fair value of its residential whole loans held at fair value after considering valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans. The valuation approach applied generally depends on whether the loan is considered performing or non-performing at the date the valuation is performed. For performing loans, estimates of fair value are derived using a discounted cash flow approach, where estimates of cash flows are determined from the scheduled payments, adjusted using forecasted prepayment, default and loss given default rates. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, expected costs and home price appreciation. Estimated cash flows for both performing and non-performing loans are discounted at yields considered appropriate to arrive at a reasonable exit price for the asset. Indications of loan value such as actual trades, bids, offers and generic market color may be used in determining the appropriate discount yield. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.
Swaps
All of the Company’s Swaps are cleared by a central clearing house. Valuations provided by the clearing house are used for purposes of determining the fair value of the Company’s Swaps. Such valuations obtained are tested with internally developed models that apply readily observable market parameters. As the Company’s Swaps are subject to the clearing house’s margin requirements, no credit valuation adjustment was considered necessary in determining the fair value of such instruments. Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. Swaps are classified as Level 2 in the fair value hierarchy.
Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations. The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve. The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced. The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.
47
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2018 and December 31, 2017, on the consolidated balance sheets by the valuation hierarchy, as previously described:
Fair Value at September 30, 2018
(In Thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Assets: | ||||||||||||||||
Agency MBS | $ | — | $ | 2,905,490 | $ | — | $ | 2,905,490 | ||||||||
Non-Agency MBS | — | 3,334,610 | — | 3,334,610 | ||||||||||||
CRT securities | — | 538,945 | — | 538,945 | ||||||||||||
Term notes backed by MSR related collateral | — | — | 505,195 | 505,195 | ||||||||||||
Residential whole loans, at fair value | — | — | 1,449,365 | 1,449,365 | ||||||||||||
Securities obtained and pledged as collateral | — | — | — | — | ||||||||||||
Swaps | — | 22,311 | — | 22,311 | ||||||||||||
Total assets carried at fair value | $ | — | $ | 6,801,356 | $ | 1,954,560 | $ | 8,755,916 | ||||||||
Liabilities: | ||||||||||||||||
Obligation to return securities obtained as collateral | $ | — | $ | — | $ | — | $ | — | ||||||||
Total liabilities carried at fair value | $ | — | $ | — | $ | — | $ | — | ||||||||
Fair Value at December 31, 2017
(In Thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Assets: | ||||||||||||||||
Agency MBS | $ | — | $ | 2,824,681 | $ | — | $ | 2,824,681 | ||||||||
Non-Agency MBS | — | 3,533,966 | — | 3,533,966 | ||||||||||||
CRT securities | — | 664,403 | — | 664,403 | ||||||||||||
Term notes backed by MSR related collateral | — | — | 381,804 | 381,804 | ||||||||||||
Residential whole loans, at fair value | — | — | 1,325,115 | 1,325,115 | ||||||||||||
Securities obtained and pledged as collateral | 504,062 | — | — | 504,062 | ||||||||||||
Swaps | — | 679 | — | 679 | ||||||||||||
Total assets carried at fair value | $ | 504,062 | $ | 7,023,729 | $ | 1,706,919 | $ | 9,234,710 | ||||||||
Liabilities: | ||||||||||||||||
Obligation to return securities obtained as collateral | $ | 504,062 | $ | — | $ | — | $ | 504,062 | ||||||||
Total liabilities carried at fair value | $ | 504,062 | $ | — | $ | — | $ | 504,062 | ||||||||
48
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis
The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:
Residential Whole Loans, at Fair Value (1) | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||||
Balance at beginning of period | $ | 1,468,540 | $ | 744,072 | $ | 1,325,115 | $ | 814,682 | ||||||||
Purchases and capitalized advances (2) | 76,566 | 284,930 | 393,867 | 295,094 | ||||||||||||
Changes in fair value recorded in Net gain on residential whole loans held at fair value | 8,442 | 5,289 | 26,788 | 12,499 | ||||||||||||
Collection of principal, net of liquidation gains/losses | (54,331 | ) | (17,670 | ) | (155,199 | ) | (53,366 | ) | ||||||||
Repurchases | (561 | ) | (257 | ) | (1,623 | ) | (1,013 | ) | ||||||||
Transfer to REO | (51,089 | ) | (33,214 | ) | (141,381 | ) | (84,746 | ) | ||||||||
Balance at end of period | $ | 1,447,567 | $ | 983,150 | $ | 1,447,567 | $ | 983,150 | ||||||||
(1) | Excludes approximately $1.8 million and $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018 and 2017, respectively. |
(2) | Included in the activity presented for the three and nine months ended September 30, 2018 and 2017 are approximately $34.4 million and$92.7 million of loans the Company committed to purchase during the three months ended June 30, 2018 and year ended December 31, 2017, but for which the closing of the purchase transaction occurred during the three and nine months ended September 30, 2018 and 2017, respectively. |
The following table presents additional information for the three and nine months ended September 30, 2018 and 2017 about the Company’s investments in term notes backed by MSR related collateral held at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:
Term Notes Backed by MSR Related Collateral | ||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
(In Thousands) | 2018 | 2017 | 2018 | 2017 (1) | ||||||||||||
Balance at beginning of period | $ | 381,390 | $ | 273,961 | $ | 381,804 | $ | — | ||||||||
Purchases | 290,042 | 161,000 | 439,392 | 311,000 | ||||||||||||
Collection of principal | (166,120 | ) | (123,961 | ) | (316,120 | ) | (140,980 | ) | ||||||||
Changes in unrealized gain/losses | (117 | ) | 563 | 119 | 563 | |||||||||||
Transfers from Level 2 to Level 3 (1) | — | — | — | 140,980 | ||||||||||||
Balance at end of period | $ | 505,195 | $ | 311,563 | $ | 505,195 | $ | 311,563 | ||||||||
(1) | Investments in term notes backed by MSR related collateral were transferred from Level 2 to Level 3 during the nine months ended September 30, 2017 as there had been very limited secondary market trading in these securities since issuance. Transfers between levels are deemed to take place on the first day of the reporting period in which the transfer has taken place. |
The Company did not transfer any assets or liabilities from one level to another during the three and nine months ended September 30, 2018 and the three months ended September 30, 2017.
49
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Fair Value Methodology for Level 3 Financial Instruments
Residential Whole Loans, at Fair Value
The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2018 and December 31, 2017:
September 30, 2018 | ||||||||||||||
(Dollars in Thousands) | Fair Value (1) | Valuation Technique | Unobservable Input | Weighted Average (2) | Range | |||||||||
Residential whole loans, at fair value | $ | 693,874 | Discounted cash flow | Discount rate | 5.3 | % | 4.5-8.0% | |||||||
Prepayment rate | 3.8 | % | 0.0-13.5% | |||||||||||
Default rate | 2.7 | % | 0.0-31.0% | |||||||||||
Loss severity | 13.0 | % | 0.0-100.0% | |||||||||||
$ | 683,566 | Liquidation model | Discount rate | 8.2 | % | 6.1-50.0% | ||||||||
Annual change in home prices | 3.3 | % | (1.0)-11.8% | |||||||||||
Liquidation timeline (in years) | 1.8 | 0.1-4.5 | ||||||||||||
Current value of underlying properties (3) | $ | 767 | $2-$7,950 | |||||||||||
Total | $ | 1,377,440 | ||||||||||||
December 31, 2017 | ||||||||||||||
(Dollars in Thousands) | Fair Value (1) | Valuation Technique | Unobservable Input | Weighted Average (2) | Range | |||||||||
Residential whole loans, at fair value | $ | 358,871 | Discounted cash flow | Discount rate | 5.5 | % | 4.5-13.0% | |||||||
Prepayment rate | 4.1 | % | 1.15-15.1% | |||||||||||
Default rate | 2.9 | % | 0.0-6.5% | |||||||||||
Loss severity | 13.8 | % | 0.0-100.0% | |||||||||||
$ | 592,940 | Liquidation model | Discount rate | 8.0 | % | 6.1-50.0% | ||||||||
Annual change in home prices | 2.5 | % | (8.0)-8.8% | |||||||||||
Liquidation timeline (in years) | 1.6 | 0.1-4.5 | ||||||||||||
Current value of underlying properties (3) | $ | 772 | $0-$9,900 | |||||||||||
Total | $ | 951,811 | ||||||||||||
(1) Excludes approximately $70.1 million and $373.3 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2018 and December 31, 2017, respectively.
(2) Amounts are weighted based on the fair value of the underlying loan.
(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately$378,000 and $336,000 as of September 30, 2018 and December 31, 2017, respectively.
50
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2018 and December 31, 2017:
September 30, 2018 | December 31, 2017 | |||||||||||||||
Carrying Value | Estimated Fair Value | Carrying Value | Estimated Fair Value | |||||||||||||
(In Thousands) | ||||||||||||||||
Financial Assets: | ||||||||||||||||
Agency MBS | $ | 2,905,490 | $ | 2,905,490 | $ | 2,824,681 | $ | 2,824,681 | ||||||||
Non-Agency MBS | 3,334,610 | 3,334,610 | 3,533,966 | 3,533,966 | ||||||||||||
CRT securities | 538,945 | 538,945 | 664,403 | 664,403 | ||||||||||||
MSR related assets | 565,272 | 565,272 | 492,080 | 493,026 | ||||||||||||
Residential whole loans, at carrying value | 2,471,567 | 2,549,927 | 908,516 | 988,688 | ||||||||||||
Residential whole loans, at fair value | 1,449,365 | 1,449,365 | 1,325,115 | 1,325,115 | ||||||||||||
Securities obtained and pledged as collateral | — | — | 504,062 | 504,062 | ||||||||||||
Cash and cash equivalents | 104,186 | 104,186 | 449,757 | 449,757 | ||||||||||||
Restricted cash | 6,489 | 6,489 | 13,307 | 13,307 | ||||||||||||
Swaps | 22,311 | 22,311 | 679 | 679 | ||||||||||||
Financial Liabilities (1): | ||||||||||||||||
Repurchase agreements | 7,278,270 | 7,289,006 | 6,614,701 | 6,623,255 | ||||||||||||
Securitized debt | 714,203 | 713,783 | 363,944 | 366,109 | ||||||||||||
Obligation to return securities obtained as collateral | — | — | 504,062 | 504,062 | ||||||||||||
Senior Notes | 96,805 | 100,791 | 96,773 | 103,729 | ||||||||||||
(1) Carrying value of securitized debt, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.
In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis discussed on pages 45-50, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table that are not reported at fair value on a recurring basis:
Residential Whole Loans, at Carrying Value: The Company generally determines the fair value of its residential whole loans held at carrying value using the same approach applied for residential whole loans held at fair value. Given the short duration of the Company’s Rehabilitation loans, these investments are determined to have a carrying value which approximates fair value. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy.
Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts. At September 30, 2018 and December 31, 2017, the Company’s money market funds were invested in securities issued by the U.S. Government or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above. Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value.
Corporate Loans: The Company determines the fair value of its Corporate loans after considering recent past and expected future loan performance, recent financial performance of the borrower and estimates of the current value of the underlying collateral, which includes certain MSRs and other assets of the borrower that are pledged to secure the borrowing. The Company’s investment in Corporate loans are classified as Level 3 in the fair value hierarchy.
Repurchase Agreements: The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity. Such interest rates are estimated based on LIBOR rates observed in the market. The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy.
51
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Securitized Debt: In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy.
Senior Notes: The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date. The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy.
The Company holds REO at the lower of the current carrying amount or fair value less estimated selling costs. At September 30, 2018 and December 31, 2017, the Company’s REO had an aggregate carrying value of $223.1 million and $152.4 million, and an aggregate estimated fair value of $246.0 million and $175.8 million, respectively. The Company classifies fair value measurements of REO as Level 3 in the fair value hierarchy.
15. Use of Special Purpose Entities and Variable Interest Entities
A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it. SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets. The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying financial assets on improved terms. Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments. Investors in an SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement.
The Company has entered into several financing transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate these transactions. See Note 2(r) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with financing transactions.
The Company has engaged in loan securitizations and in prior years, MBS resecuritization transactions, primarily for the purpose of obtaining improved overall financing terms as well as non-recourse financing on a portion of its residential whole loan and Non-Agency MBS portfolios. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying assets transferred to the VIEs.
Loan Securitization Transactions
In July 2018, as part of a loan securitization transaction, the Company sold residential whole loans with an aggregate unpaid principal balance of $347.7 million to an entity that the Company consolidates as a VIE. In connection with the transaction, third-party investors purchased $236.0 million face amount of senior bonds (“Senior Bonds”) with a coupon rate of 4.164%. As a result of this transaction, the Company acquired $101.7 million face amount of non-rated certificates issued by the securitization vehicle, and received $236.0 million in cash, excluding expenses, accrued interest, and underwriting fees.
In May 2018, as part of a loan securitization transaction, the Company sold residential whole loans with an aggregate unpaid principal balance of $319.1 million to an entity that the Company consolidates as a VIE. In connection with the transaction, third-party investors purchased $184.0 million face amount of Senior Bonds with a coupon rate of 3.875%. As a result of this transaction, the Company acquired $46.4 million face amount of non-rated certificates issued by the securitization vehicle, and received $184.0 million in cash, excluding expenses, accrued interest, and underwriting fees.
52
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
The following table summarizes the key details of the loan securitization transactions the Company has been involved in to date:
(Dollars in Thousands) | September 30, 2018 | December 31, 2017 | |||||||
Aggregate unpaid principal balance of residential whole loans sold | $ | 1,290,029 | $ | 620,924 | |||||
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors | $ | 802,817 | $ | 382,847 | |||||
Outstanding amount of Senior Bonds | $ | 714,203 | (1) | $ | 363,944 | (1) | |||
Weighted average fixed rate for Senior Bonds issued | 3.65 | % | (2) | 3.14 | % | (2) | |||
Face amount of Senior Support Certificates received by the Company (3) | $ | 275,174 | $ | 127,001 | |||||
Cash received | $ | 802,815 | $ | 382,845 | |||||
(1) | Net of $4.1 million and $2.3 million of deferred financing costs at September 30, 2018 and December 31, 2017, respectively. |
(2) | At September 30, 2018 and December 31, 2017, $604.7 million and $233.7 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by 300 basis points at 36 months from issuance if the bond is not redeemed before such date. |
(3) | Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions. |
As of September 30, 2018 and December 31, 2017, as a result of the transactions described above, securitized loans with a carrying value of approximately $215.1 million and $183.2 million are included in “Residential whole loans, at carrying value,” securitized loans with a fair value of approximately $723.8 million and $289.3 million are included in “Residential whole loans, at fair value,” and REO with a carrying value approximately $61.0 million and $5.5 million are included in “Other assets” on the Company’s consolidated balance sheets, respectively. As of September 30, 2018 and December 31, 2017, the aggregate carrying value of Senior Bonds issued by consolidated VIEs was $714.2 million and $363.9 million, respectively. These Senior Bonds are disclosed as “Securitized debt” and are included in Other liabilities on the Company’s consolidated balance sheets. The holders of the securitized debt have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties with respect to the residential whole loans sold to the VIE. In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.
The Company concluded that the entities created to facilitate the loan securitization transactions are VIEs. The Company then completed an analysis of whether each VIE created to facilitate the securitization transactions should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE. In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:
• | whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE; and |
• | whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE. |
Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate the loan securitization transactions.
53
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2018
Residential Whole Loans and REO (including Residential Whole Loans and REO transferred to consolidated VIEs)
Included on the Company’s consolidated balance sheets as of September 30, 2018 and December 31, 2017 are a total of $3.9 billion and $2.2 billion of residential whole loans, of which approximately $2.5 billion and $908.5 million are reported at carrying value and $1.4 billion and $1.3 billion are reported at fair value, respectively. In addition, at September 30, 2018 and December 31, 2017, the Company had REO with an aggregate carrying value of $223.1 million and $152.4 million, and an aggregate estimated fair value of $246.0 million and $175.8 million, respectively. The inclusion of these assets arises from the Company’s interests in certain trusts established to acquire the loans and entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated. During the three and nine months ended September 30, 2018, the Company recognized interest income from residential whole loans reported at carrying value of approximately $29.5 million and $61.8 million, respectively. During the three and nine months ended September 30, 2017, the Company recognized interest income from residential whole loans reported at carrying value of approximately $9.0 million and $26.2 million, respectively. These amounts are included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains on residential whole loans held at fair value during the three and nine months ended September 30, 2018 of approximately $34.9 million and $105.9 million, respectively. During the three and nine months ended September 30, 2017, the Company recognized net gains on residential whole loans held at fair value $18.7 million and $48.7 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4)
54
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q, we refer to MFA Financial, Inc. and its subsidiaries as “the Company,” “MFA,” “we,” “us,” or “our,” unless we specifically state otherwise or the context otherwise indicates.
The following discussion should be read in conjunction with our financial statements and accompanying notes included in Item 1 of this Quarterly Report on Form 10-Q as well as our Annual Report on Form 10-K for the year ended December 31, 2017.
Forward Looking Statements
When used in this Quarterly Report on Form 10-Q, in future filings with the SEC or in press releases or other written or oral communications, statements which are not historical in nature, including those containing words such as “will,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “could,” “would,” “may” the negative of these words or similar expressions, are intended to identify “forward-looking statements” within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act and, as such, may involve known and unknown risks, uncertainties and assumptions.
These forward-looking statements include information about possible or assumed future results with respect to our business, financial condition, liquidity, results of operations, plans and objectives. Statements regarding the following subjects, among others, may be forward-looking: changes in interest rates and the market (i.e., fair) value of our MBS, residential whole loans, CRT securities and other assets; changes in the prepayment rates on residential mortgage assets, an increase of which could result in a reduction of the yield on certain investments in our portfolio and an increase of which could require us to reinvest the proceeds received by us as a result of such prepayments in investments with lower coupons; credit risks underlying our assets, including changes in the default rates and management’s assumptions regarding default rates on the mortgage loans securing our Non-Agency MBS and relating to our residential whole loan portfolio; our ability to borrow to finance our assets and the terms, including the cost, maturity and other terms, of any such borrowings; implementation of or changes in government regulations or programs affecting our business; our estimates regarding taxable income the actual amount of which is dependent on a number of factors, including, but not limited to, changes in the amount of interest income and financing costs, the method elected by us to accrete the market discount on Non-Agency MBS and residential whole loans and the extent of prepayments, realized losses and changes in the composition of our Agency MBS, Non-Agency MBS and residential whole loan portfolios that may occur during the applicable tax period, including gain or loss on any MBS disposals and whole loan modifications, foreclosures and liquidations; the timing and amount of distributions to stockholders, which are declared and paid at the discretion of our Board and will depend on, among other things, our taxable income, our financial results and overall financial condition and liquidity, maintenance of our REIT qualification and such other factors as the Board deems relevant; our ability to maintain our qualification as a REIT for federal income tax purposes; our ability to maintain our exemption from registration under the Investment Company Act of 1940, as amended (or the Investment Company Act), including statements regarding the concept release issued by the SEC relating to interpretive issues under the Investment Company Act with respect to the status under the Investment Company Act of certain companies that are engaged in the business of acquiring mortgages and mortgage-related interests; our ability to continue growing our residential whole loan portfolio, which is dependent on, among other things, the supply of loans offered for sale in the market; expected returns on our investments in nonperforming residential whole loans (or NPLs), which are affected by, among other things, the length of time required to foreclose upon, sell, liquidate or otherwise reach a resolution of the property underlying the NPL, home price values, amounts advanced to carry the asset (e.g., taxes, insurance, maintenance expenses, etc. on the underlying property) and the amount ultimately realized upon resolution of the asset; targeted or expected returns on our investments in recently-originated loans, the performance of which is, similar to our other mortgage loan investments, subject to, among other things, prepayment risk, credit risk and financing cost associated with such investments; risks associated with our investments in MSR related assets, including servicing, regulatory and economic risks, and risks associated with investing in real estate assets, including changes in business conditions and the general economy. These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that we file with the SEC, could cause our actual results to differ materially from those projected in any forward-looking statements we make. All forward-looking statements are based on beliefs, assumptions and expectations of our future performance, taking into account all information currently available. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
55
Business/General
We are a REIT primarily engaged in the business of investing, on a leveraged basis, in residential mortgage assets, including Agency MBS, Non-Agency MBS, residential whole loans, CRT securities and MSR related assets. Our principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. We selectively invest in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.
At September 30, 2018, we had total assets of approximately $11.8 billion, of which $6.2 billion, or 53.0%, represented our MBS portfolio. At such date, our MBS portfolio was comprised of $2.9 billion of Agency MBS and $3.3 billion of Non-Agency MBS, which includes $2.2 billion of Legacy Non-Agency MBS and $1.2 billion of RPL/NPL MBS that are primarily structured with a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. These RPL/NPL MBS are primarily backed by securitized re-performing and non-performing loans. In addition, at September 30, 2018, we had approximately $3.9 billion in residential whole loans acquired through interests in certain trusts established to acquire the loans, which represented approximately 33% of our total assets. During the third quarter of 2018 we continued to experience growth in our residential whole loan portfolio, which has been our fasting growing asset class over the last several quarters. In particular during the third quarter, our growth in this asset class was primarily through purchases or commitments to purchase newly or previously originated performing loans. Such loans, which as of September 30, 2018 comprise approximately 40% of our residential whole loans, include : (i) loans to finance (or refinance) one-to-four family residential properties and are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (or Non-QM loans), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (or Rehabilitation loans or Fix and Flip loans), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (or Single-family rental loans), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (or Seasoned performing loans). Our remaining investment-related assets were primarily comprised of MSR related assets, CRT securities, cash and cash equivalents (including restricted cash), REO and MBS and loan-related receivables.
The results of our business operations are affected by a number of factors, many of which are beyond our control, and primarily depend on, among other things, the level of our net interest income, the market value of our assets, which is driven by numerous factors, including the supply and demand for residential mortgage assets in the marketplace, the terms and availability of adequate financing, general economic and real estate conditions (both on a national and local level), the impact of government actions in the real estate and mortgage sector, and the credit performance of our credit sensitive residential mortgage assets. In recent periods, the impact on our results from changes in market values of certain financial instruments for which changes in fair value are recorded in net income each period, such as certain residential whole loans, Agency MBS, CRT securities and Swaps not designated as hedges, has increased. Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS, the behavior of which involves various risks and uncertainties. Interest rates and conditional prepayment rates (or CPRs) (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance), vary according to the type of investment, conditions in the financial markets, competition and other factors, none of which can be predicted with any certainty.
With respect to our business operations, increases in interest rates, in general, may over time cause: (i) the interest expense associated with our borrowings to increase; (ii) the value of our residential mortgage assets and, correspondingly, our stockholders’ equity to decline; (iii) coupons on our adjustable rate assets to reset, on a delayed basis, to higher interest rates; (iv) prepayments on our assets to decline, thereby slowing the amortization of purchase premiums and the accretion of our purchase discounts; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to increase. Conversely, decreases in interest rates, in general, may over time cause: (i) the interest expense associated with our borrowings to decrease; (ii) the value of our residential mortgage assets and, correspondingly, our stockholders’ equity to increase; (iii) coupons on our adjustable rate assets to reset, on a delayed basis, to lower interest rates; (iv) prepayments on assets to increase, thereby accelerating the amortization of purchase premiums and the accretion of our purchase discounts; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to decrease. In addition, our borrowing costs and credit lines are further affected by the type of collateral we pledge and general conditions in the credit market.
Our investments in residential mortgage assets expose us to credit risk, generally meaning that we are subject to credit losses due to the risk of delinquency, default and foreclosure on the underlying real estate collateral. We believe the discounted purchase prices paid on certain of these investments mitigate our risk of loss in the event that, as we expect on most such investments, we receive less than 100% of the par value of these investments. Our investment process for credit sensitive assets focuses primarily on quantifying and pricing credit risk.
56
Premiums arise when we acquire an MBS or loan at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value) or when we acquire residential whole loans at a price in excess of their aggregate principal balance. Conversely, discounts arise when we acquire an MBS or loan at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance. Premiums paid are amortized against interest income and accretable purchase discounts on these investments are accreted to interest income. Purchase premiums, which are primarily carried on our Agency MBS, certain CRT securities and Non-QM loans, are amortized against interest income over the life of the investment using the effective yield method, adjusted for actual prepayment activity. An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the interest income earned on these assets.
CPR levels are impacted by, among other things, conditions in the housing market, new regulations, government and private sector initiatives, interest rates, availability of credit to home borrowers, underwriting standards and the economy in general. In particular, CPR reflects the conditional repayment rate (or CRR), which measures voluntary prepayments of mortgages collateralizing a particular MBS, and the conditional default rate (or CDR), which measures involuntary prepayments resulting from defaults. CPRs on Agency MBS and Legacy Non-Agency MBS may differ significantly. For the three months ended September 30, 2018, our Agency MBS portfolio experienced a weighted average CPR of 16.8%, and our Legacy Non-Agency MBS portfolio experienced a weighted average CPR of 16.8%. Over the last consecutive eight quarters, ending with September 30, 2018, the monthly weighted average CPR on our Agency and Legacy Non-Agency MBS portfolios ranged from a high of 18.4% experienced during the month ended July 31, 2017 to a low of 13.5%, experienced during the month ended March 31, 2018, with an average CPR over such quarters of 16.2%.
Our method of accounting for Non-Agency MBS purchased at significant discounts to par value requires us to make assumptions with respect to each security. These assumptions include, but are not limited to, future interest rates, voluntary prepayment rates, default rates, mortgage modifications and loss severities. As part of our Non-Agency MBS surveillance process, we track and compare each security’s actual performance over time to the performance expected at the time of purchase or, if we have modified our original purchase assumptions, to our revised performance expectations. To the extent that actual performance or our expectation of future performance of our Non-Agency MBS deviates materially from our expected performance parameters, we may revise our performance expectations, such that the amount of purchase discount designated as credit discount may be increased or decreased over time. Nevertheless, credit losses greater than those anticipated or in excess of the recorded purchase discount could occur, which could materially adversely impact our operating results.
It is our business strategy to hold our residential mortgage assets as long-term investments. On at least a quarterly basis, excluding investments for which the fair value option has been elected or for which specialized loan accounting is otherwise applied, we assess our ability and intent to continue to hold each asset and, as part of this process, we monitor our MBS, CRT securities and MSR related assets that are designated as AFS for OTTI. A change in our ability and/or intent to continue to hold any of these securities that are in an unrealized loss position, or a deterioration in the underlying characteristics of these securities, could result in our recognizing future impairment charges or a loss upon the sale of any such security. At September 30, 2018, we had net unrealized gains on our Non-Agency MBS of $548.8 million, comprised of gross unrealized gains of $550.9 million and gross unrealized losses of $2.1 million, and net unrealized losses of $50.4 million on our Agency MBS, comprised of gross unrealized losses of $66.1 million and gross unrealized gains of $15.7 million. At September 30, 2018, we did not intend to sell any securities in our portfolio that are designated as AFS and that were in an unrealized loss position, and we believe it is more likely than not that we will not be required to sell those securities before recovery of their amortized cost basis, which may be at their maturity.
We rely primarily on borrowings under repurchase agreements to finance our residential mortgage assets. Our residential mortgage investments have longer-term contractual maturities than our borrowings under repurchase agreements. Even though the majority of our investments have interest rates that adjust over time based on short-term changes in corresponding interest rate indices (typically following an initial fixed-rate period for our Hybrids), the interest rates we pay on our borrowings will typically change at a faster pace than the interest rates we earn on our investments. In order to reduce this interest rate risk exposure, we may enter into derivative instruments, which at September 30, 2018 were comprised of Swaps.
The majority of our Swap derivative instruments are designated as cash-flow hedges against a portion of our current and forecasted LIBOR-based repurchase agreements. While these Swaps do not extend the maturities of the associated repurchase agreement being hedged; they do, however, lock in a fixed rate of interest over their term for the notional amount of the Swap corresponding to the hedged item.
57
Recent Market Conditions and Our Strategy
At September 30, 2018, our residential mortgage asset portfolio, which includes MBS, residential whole loans and REO, CRT securities and MSR related assets was approximately $11.5 billion compared to $10.2 billion at June 30, 2018. For the remainder of 2018 we expect to continue to seek investment opportunities primarily focused on residential whole loans, as well as RPL/NPL MBS and MSR related assets as market opportunities arise.
The following table presents the activity for our residential mortgage asset portfolio for the three months ended September 30, 2018:
(In Millions) | June 30, 2018 | Runoff (1) | Acquisitions | Other (2) | September 30, 2018 | Change | ||||||||||||||||||
Residential whole loans and REO | $ | 3,601 | $ | (188 | ) | $ | 707 | $ | 24 | $ | 4,144 | $ | 543 | |||||||||||
RPL/NPL MBS | 909 | (192 | ) | 446 | (1 | ) | 1,162 | 253 | ||||||||||||||||
MSR related assets | 381 | (166 | ) | 350 | — | 565 | 184 | |||||||||||||||||
CRT securities | 571 | (3 | ) | 84 | (113 | ) | 539 | (32 | ) | |||||||||||||||
Legacy Non-Agency MBS | 2,335 | (145 | ) | 2 | (19 | ) | 2,173 | (162 | ) | |||||||||||||||
Agency MBS | 2,363 | (192 | ) | 758 | (24 | ) | 2,905 | 542 | ||||||||||||||||
Totals | $ | 10,160 | $ | (886 | ) | $ | 2,347 | $ | (133 | ) | $ | 11,488 | $ | 1,328 | ||||||||||
(1) | Primarily includes principal repayments, cash collections on purchased credit impaired loans and sales of REO. |
(2) | Primarily includes sales, changes in fair value, net premium amortization/discount accretion and adjustments to record lower of cost or estimated fair value adjustments on REO. During the three months ended September 30, 2018, we sold certain CRT securities for $118.9 million, realizing gains of $13.0 million and sold certain Non-Agency MBS for $24.3 million, realizing gains of $3.4 million. |
At September 30, 2018, our total recorded investment in residential whole loans and REO was $4.1 billion, or 36.1% of our residential mortgage asset portfolio. Of this amount, (i) $2.5 billion is presented as Residential whole loans, at carrying value (of which $825.6 million were purchased credit impaired loans and $1.6 billion were other loans held at carrying value), and (ii) $1.4 billion as Residential whole loans, at fair value, in our consolidated balance sheets. For the three months ended September 30, 2018, we recognized approximately $29.5 million of income on residential whole loans held at carrying value in Interest Income on our consolidated statements of operations, representing an effective yield of 5.89% (excluding servicing costs). In addition, we recorded a net gain on residential whole loans held at fair value of $34.9 million in Other Income, net in our consolidated statements of operations for the three months ended September 30, 2018. At September 30, 2018 and June 30, 2018, we had REO with an aggregate carrying value of $223.1 million and $192.2 million, respectively, which is included in Other assets on our consolidated balance sheets.
At the end of the third quarter of 2018, the average coupon on mortgages underlying our Agency MBS was higher compared to the end of the third quarter of 2017, due to upward resets on securities within the portfolio, purchases of higher yielding Agency MBS and the impact of the removal from the portfolio of Agency MBS sold during 2018. As a result, the coupon yield on our Agency MBS portfolio increased to 3.32% for the three months ended September 30, 2018, from 2.98% for the three months ended September 30, 2017, and the net Agency MBS yield increased to 2.21% for the three months ended September 30, 2018 from 1.97% for the three months ended September 30, 2017. The net yield for our Legacy Non-Agency MBS portfolio was 10.76% for the three months ended September 30, 2018 compared to 8.93% for the three months ended September 30, 2017. The increase in the net yield on our Legacy Non-Agency MBS portfolio reflects the improved performance of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases and changes in interest rates since the third quarter of the prior year, higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount as well as the impact of the cash proceeds received during 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. The net yield for our RPL/NPL MBS portfolio was 5.01% for the three months ended September 30, 2018 compared to 4.43% for the three months ended September 30, 2017. The increase in the net yield reflects an increase in the average coupon yield to 4.56% for the three months ended September 30, 2018 from 4.24% for the three months ended September 30, 2017 and higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount.
We believe that our $531.8 million Credit Reserve and OTTI appropriately factors in remaining uncertainties regarding underlying mortgage performance and the potential impact on future cash flows for our existing Legacy Non-Agency MBS portfolio. In addition, while the majority of our Legacy Non-Agency MBS will not return their full face value due to loan defaults, we believe that they will deliver attractive loss adjusted yields due to our discounted amortized cost of 69% of face value at September 30, 2018. Home price appreciation and underlying mortgage loan amortization have decreased the LTV for many of
58
the mortgages underlying our Legacy Non-Agency portfolio. Home price appreciation during the past few years has generally been driven by a combination of limited housing supply due partly to low levels of new home construction, low mortgage rates and demographic-driven U.S. household formation. Lower LTVs lessen the likelihood of defaults and simultaneously decrease loss severities. Further, during 2017 and the nine months ended September 30, 2018, we have also observed faster voluntary prepayment (i.e., prepayment of loans in full with no loss) speeds than originally projected. The yields on our Legacy Non-Agency MBS that were purchased at a discount are generally positively impacted if prepayment rates on these securities exceed our prepayment assumptions. Based on these current conditions, we have reduced estimated future losses within our Legacy Non-Agency portfolio. As a result, during the three months ended September 30, 2018, $10.2 million was transferred from Credit Reserve to accretable discount. This increase in accretable discount is expected to increase the interest income realized over the remaining life of our Legacy Non-Agency MBS. We believe that the majority of the impact on interest income from the reduction in Credit Reserve will occur over the next ten years.
Our book value per common share was $7.46 as of September 30, 2018, a decline from book value per common share of $7.54 as of June 30, 2018. This decrease was primarily due to lower unrealized gains on Legacy Non-Agency MBS and higher unrealized losses on Agency MBS, which were partially offset by an increase in the fair value of Swaps.
During the three months ended September 30, 2018, we issued approximately 50.9 million shares of common stock in a public offering, generating net proceeds of approximately $389.4 million. While the majority of proceeds raised have been deployed by the end of the quarter primarily through purchases of additional mortgage related assets, we expect to continue to focus on optimizing our capital structure through the use of leverage as we pursue additional investment opportunities going forward.
Repurchase agreement funding for our residential mortgage investments continued to be available to us from multiple counterparties during the third quarter of 2018. Typically, repurchase agreement funding involving credit-sensitive investments is available at terms requiring higher collateralization and higher interest rates than for repurchase agreement funding involving Agency MBS. At September 30, 2018, our debt consisted of borrowings under repurchase agreements with 28 counterparties, securitized debt, Senior Notes outstanding and payable for unsettled purchases, resulting in a debt-to-equity multiple of 2.3 times. (See table on page 76 under Results of Operations that presents our quarterly leverage multiples since September 30, 2017.)
In July 2018, as part of a loan securitization transaction, we sold residential whole loans with an aggregate unpaid principal balance of $347.7 million to an entity that we consolidate as a VIE. In connection with the transaction, third-party investors purchased $236.0 million face amount of senior bonds with a coupon rate of 4.1637%. As a result of this transaction, we acquired $101.7 million face amount of non-rated certificates issued by the securitization vehicle, and received $236.0 million in cash, excluding expenses, accrued interest, and underwriting fees.
At September 30, 2018, we have access to various sources of liquidity which we estimate to be in excess of $412.1 million. This amount includes (i) $104.2 million of cash and cash equivalents; (ii) $188.2 million in estimated financing available from unpledged Agency MBS and from other Agency MBS collateral that is currently pledged in excess of contractual requirements; and (iii) $119.7 million in estimated financing available from unpledged Non-Agency MBS and from other Non-Agency MBS and CRT collateral that is currently pledged in excess of contractual requirements. Our sources of liquidity do not include restricted cash. In addition, we have $1.1 billion of unencumbered residential whole loans. We are evaluating potential opportunities to finance these assets including loan securitization. With access to multiple sources of liquidity and potential financing opportunities for unencumbered residential whole loans, we believe that we are positioned to continue to take advantage of investment opportunities within the residential mortgage marketplace.
59
Information About Our Assets
The table below presents certain information about our asset allocation at September 30, 2018:
ASSET ALLOCATION
Agency MBS | Legacy Non-Agency MBS | RPL/NPL MBS (1) | Credit Risk Transfer Securities | MSR Related Assets | Residential Whole Loans, at Carrying Value (2) | Residential Whole Loans, at Fair Value | Other, net (3) | Total | ||||||||||||||||||||||||||||
(Dollars in Millions) | ||||||||||||||||||||||||||||||||||||
Fair Value/Carrying Value | $ | 2,905 | $ | 2,173 | $ | 1,162 | $ | 539 | $ | 565 | $ | 2,472 | $ | 1,449 | $ | 387 | $ | 11,652 | ||||||||||||||||||
Less Payable for Unsettled Purchases | — | (2 | ) | — | — | — | (7 | ) | (2 | ) | — | (11 | ) | |||||||||||||||||||||||
Less Repurchase Agreements | (2,584 | ) | (1,592 | ) | (913 | ) | (405 | ) | (436 | ) | (893 | ) | (455 | ) | — | (7,278 | ) | |||||||||||||||||||
Less Securitized Debt | — | — | — | — | — | (173 | ) | (541 | ) | — | (714 | ) | ||||||||||||||||||||||||
Less Senior Notes | — | — | — | — | — | — | — | (97 | ) | (97 | ) | |||||||||||||||||||||||||
Net Equity Allocated | $ | 321 | $ | 579 | $ | 249 | $ | 134 | $ | 129 | $ | 1,399 | $ | 451 | $ | 290 | $ | 3,552 | ||||||||||||||||||
Debt/Net Equity Ratio (4) | 8.0 | x | 2.8 | x | 3.7 | x | 3.0 | x | 3.4 | x | 0.8 | x | 2.2 | x | 2.3 | x | ||||||||||||||||||||
(1) | RPL/NPL MBS are backed primarily by securitized re-performing and non-performing loans. The securities are primarily structured such that the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. Included with the balance of Non-Agency MBS reported on our consolidated balance sheets. |
(2) | Includes $825.6 million of purchased credit impaired loans, $989.8 million of Non-QM loans, $329.3 million of Rehabilitation loans, $79.7 million of Single-family rental loans and $247.1 million of Seasoned performing loans. At September 30, 2018, the total fair value of these loans is estimated to be approximately $2.5 billion. |
(3) | Includes cash and cash equivalents and restricted cash, other assets and other liabilities. |
(4) | Represents the sum of borrowings under repurchase agreements, securitized debt and payable for unsettled purchases as a multiple of net equity allocated. The numerator of our Total Debt/Net Equity Ratio also includes Senior Notes. |
60
Agency MBS
The following table presents certain information regarding the composition of our Agency MBS portfolio as of September 30, 2018 and December 31, 2017:
September 30, 2018
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Coupon (2) | 3 Month Average CPR | ||||||||||||||||
15-Year Fixed Rate: | |||||||||||||||||||||||
Low Loan Balance (3) | $ | 732,119 | 104.4 | % | 98.9 | % | $ | 724,409 | 77 | 2.98 | % | 11.5 | % | ||||||||||
Generic | 141,324 | 104.4 | 100.4 | 141,937 | 85 | 3.51 | 11.8 | ||||||||||||||||
Total 15-Year Fixed Rate | $ | 873,443 | 104.4 | % | 99.2 | % | $ | 866,346 | 78 | 3.06 | % | 11.5 | % | ||||||||||
30-Year Fixed Rate: | |||||||||||||||||||||||
Generic | $ | 723,041 | 104.0 | % | 103.3 | % | $ | 746,658 | 3 | 4.50 | % | 8.7 | % | ||||||||||
Total 30-Year Fixed Rate | $ | 723,041 | 104.0 | % | 103.3 | % | $ | 746,658 | 3 | 4.50 | % | 8.7 | % | ||||||||||
Hybrid | $ | 1,183,989 | 103.5 | % | 103.6 | % | $ | 1,226,396 | 104 | 3.70 | % | 22.0 | % | ||||||||||
CMO/Other | $ | 63,835 | 102.5 | % | 102.8 | % | $ | 65,652 | 207 | 3.84 | % | 13.7 | % | ||||||||||
Total Portfolio | $ | 2,844,308 | 103.9 | % | 102.1 | % | $ | 2,905,052 | 73 | 3.71 | % | 16.8 | % | ||||||||||
December 31, 2017
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Coupon (2) | 3 Month Average CPR | ||||||||||||||||
15-Year Fixed Rate: | |||||||||||||||||||||||
Low Loan Balance (3) | $ | 948,225 | 104.3 | % | 101.7 | % | $ | 964,373 | 67 | 2.95 | % | 10.3 | % | ||||||||||
Generic | 172,862 | 104.4 | 103.1 | 178,210 | 76 | 3.51 | 9.3 | ||||||||||||||||
Total 15-Year Fixed Rate | $ | 1,121,087 | 104.3 | % | 101.9 | % | $ | 1,142,583 | 68 | 3.04 | % | 10.2 | % | ||||||||||
Hybrid | $ | 1,540,431 | 103.5 | % | 103.9 | % | $ | 1,601,107 | 96 | 3.27 | % | 17.1 | % | ||||||||||
CMO/Other | $ | 76,944 | 102.5 | % | 102.8 | % | $ | 79,100 | 198 | 3.22 | % | 9.9 | % | ||||||||||
Total Portfolio | $ | 2,738,462 | 103.8 | % | 103.1 | % | $ | 2,822,790 | 88 | 3.17 | % | 14.1 | % | ||||||||||
(1) | Does not include principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively. |
(2) | Weighted average is based on MBS current face at September 30, 2018 and December 31, 2017, respectively. |
(3) | Low loan balance represents MBS collateralized by mortgages with an original loan balance of less than or equal to $175,000. |
61
The following table presents certain information regarding our fixed-rate Agency MBS as of September 30, 2018 and December 31, 2017:
September 30, 2018
Coupon | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Loan Rate | Low Loan Balance and/or HARP (3) | 3 Month Average CPR | |||||||||||||||||
(Dollars in Thousands) | |||||||||||||||||||||||||
15-Year Fixed Rate: | |||||||||||||||||||||||||
2.5% | $ | 425,636 | 104.1 | % | 97.5 | % | $ | 414,790 | 70 | 3.02 | % | 100 | % | 9.9 | % | ||||||||||
3.0% | 195,769 | 105.9 | 99.2 | 194,183 | 74 | 3.49 | 100 | 12.7 | |||||||||||||||||
3.5% | 4,080 | 103.5 | 100.7 | 4,106 | 95 | 4.17 | 100 | 14.0 | |||||||||||||||||
4.0% | 213,626 | 103.5 | 102.1 | 218,066 | 94 | 4.40 | 81 | 13.8 | |||||||||||||||||
4.5% | 34,332 | 105.3 | 102.5 | 35,201 | 98 | 4.88 | 34 | 9.9 | |||||||||||||||||
Total 15-Year Fixed Rate | $ | 873,443 | 104.4 | % | 99.2 | % | $ | 866,346 | 78 | 3.54 | % | 93 | % | 11.5 | % | ||||||||||
30-Year Fixed Rate: | |||||||||||||||||||||||||
4.5% | $ | 723,041 | 104.0 | % | 103.3 | % | $ | 746,658 | 3 | 5.17 | % | — | % | 8.7 | % | ||||||||||
Total 30-Year Fixed Rate | $ | 723,041 | 104.0 | % | 103.3 | % | $ | 746,658 | 3 | 5.17 | % | — | % | 8.7 | % | ||||||||||
Total Fixed Rate Portfolio | $ | 1,596,484 | 104.2 | % | 101.0 | % | $ | 1,613,004 | 44 | 4.28 | % | 51 | % | 11.0 | % | ||||||||||
December 31, 2017
Coupon | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Loan Rate | Low Loan Balance and/or HARP (3) | 3 Month Average CPR | |||||||||||||||||
(Dollars in Thousands) | |||||||||||||||||||||||||
15-Year Fixed Rate: | |||||||||||||||||||||||||
2.5% | $ | 579,002 | 104.0 | % | 100.5 | % | $ | 581,867 | 60 | 3.04 | % | 100 | % | 9.3 | % | ||||||||||
3.0% | 231,325 | 105.9 | 102.2 | 236,316 | 66 | 3.49 | 100 | 9.5 | |||||||||||||||||
3.5% | 5,403 | 103.5 | 103.4 | 5,586 | 86 | 4.18 | 100 | 23.0 | |||||||||||||||||
4.0% | 263,447 | 103.5 | 104.3 | 274,783 | 85 | 4.40 | 80 | 12.4 | |||||||||||||||||
4.5% | 41,910 | 105.2 | 105.1 | 44,031 | 89 | 4.88 | 34 | 10.2 | |||||||||||||||||
Total 15-Year Fixed Rate | $ | 1,121,087 | 104.3 | % | 101.9 | % | $ | 1,142,583 | 68 | 3.52 | % | 93 | % | 10.2 | % | ||||||||||
(1) | Does not include principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively. |
(2) | Weighted average is based on MBS current face at September 30, 2018 and December 31, 2017, respectively. |
(3) | Low Loan Balance represents MBS collateralized by mortgages with an original loan balance less than or equal to $175,000. Home Affordable Refinance Program (or HARP) MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination. |
62
The following table presents certain information regarding our Hybrid Agency MBS as of September 30, 2018 and December 31, 2017:
September 30, 2018
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Coupon (2) | Weighted Average Loan Age (Months) (2) | Weighted Average Months to Reset (3) | Interest Only (4) | 3 Month Average CPR | ||||||||||||||||||
Hybrid | |||||||||||||||||||||||||||
Agency 3/1 | $ | 71,402 | 102.6 | % | 105.0 | % | $ | 74,952 | 3.99 | % | 148 | 5 | — | % | 15.2 | % | |||||||||||
Agency 5/1 | $ | 506,821 | 103.3 | % | 104.5 | % | $ | 529,421 | 4.07 | % | 115 | 6 | 15 | % | 23.4 | % | |||||||||||
Agency 7/1 | 436,654 | 103.7 | 103.5 | 452,069 | 3.42 | 93 | 8 | 20 | 25.0 | ||||||||||||||||||
Agency 10/1 | 169,112 | 104.3 | 100.5 | 169,954 | 3.18 | 84 | 38 | 59 | 12.3 | ||||||||||||||||||
Total Hybrids | $ | 1,183,989 | 103.5 | % | 103.6 | % | $ | 1,226,396 | 3.70 | % | 104 | 11 | 22 | % | 22.0 | % | |||||||||||
December 31, 2017
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Coupon (2) | Weighted Average Loan Age (Months) (2) | Weighted Average Months to Reset (3) | Interest Only (4) | 3 Month Average CPR | ||||||||||||||||||
Hybrid | |||||||||||||||||||||||||||
Agency 3/1 | $ | 92,790 | 102.5 | % | 104.9 | % | $ | 97,314 | 3.44 | % | 138 | 6 | 8 | % | 16.8 | % | |||||||||||
Agency 5/1 | $ | 661,581 | 103.3 | % | 104.5 | % | $ | 691,660 | 3.45 | % | 107 | 5 | 23 | % | 17.5 | % | |||||||||||
Agency 7/1 | 589,843 | 103.6 | 103.6 | 611,207 | 3.06 | 84 | 11 | 28 | 18.4 | ||||||||||||||||||
Agency 10/1 | 196,217 | 104.2 | 102.4 | 200,926 | 3.16 | 75 | 46 | 57 | 12.0 | ||||||||||||||||||
Total Hybrids | $ | 1,540,431 | 103.5 | % | 103.9 | % | $ | 1,601,107 | 3.27 | % | 96 | 13 | 28 | % | 17.1 | % | |||||||||||
(1) | Does not include principal payments receivable of $438,000 and $1.9 million at September 30, 2018 and December 31, 2017, respectively. |
(2) | Weighted average is based on MBS current face at September 30, 2018 and December 31, 2017, respectively. |
(3) | Weighted average months to reset is the number of months remaining before the coupon interest rate resets. At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic or lifetime caps. The months to reset do not reflect scheduled amortization or prepayments. |
(4) | Interest only represents MBS backed by mortgages currently in their interest-only period. Percentage is based on MBS current face at September 30, 2018 and December 31, 2017, respectively. |
63
Non-Agency MBS
The following table presents information with respect to our Non-Agency MBS at September 30, 2018 and December 31, 2017:
(In Thousands) | September 30, 2018 | December 31, 2017 | |||||||
Non-Agency MBS | |||||||||
Face/Par | $ | 3,509,289 | $ | 3,718,743 | |||||
Fair Value | 3,334,610 | 3,533,966 | |||||||
Amortized Cost | 2,785,828 | 2,910,241 | |||||||
Purchase Discount Designated as Credit Reserve and OTTI | (531,757 | ) | (1) | (593,227 | ) | (2) | |||
Purchase Discount Designated as Accretable | (191,745 | ) | (215,325 | ) | |||||
Purchase Premiums | 41 | 50 | |||||||
(1) | Includes discount designated as Credit Reserve of $519.6 million and OTTI of $12.2 million. |
(2) | Includes discount designated as Credit Reserve of $579.0 million and OTTI of $14.2 million. |
Purchase Discounts on Non-Agency MBS
The following table presents the changes in the components of purchase discount on Non-Agency MBS with respect to purchase discount designated as Credit Reserve and OTTI, and accretable purchase discount, for the three and nine months ended September 30, 2018 and 2017:
Three Months Ended September 30, 2018 | Three Months Ended September 30, 2017 | |||||||||||||||
(In Thousands) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | ||||||||||||
Balance at beginning of period | $ | (553,596 | ) | $ | (202,248 | ) | $ | (626,498 | ) | $ | (257,967 | ) | ||||
Impact of RMBS Issuer Settlement (2) | — | (2,734 | ) | — | — | |||||||||||
Accretion of discount | — | 20,115 | — | 18,621 | ||||||||||||
Realized credit losses | 12,042 | — | 13,982 | — | ||||||||||||
Purchases | (1,975 | ) | 1,368 | — | (1,929 | ) | ||||||||||
Sales | 1,552 | 1,974 | 4,620 | 11,244 | ||||||||||||
Transfers/release of credit reserve | 10,220 | (10,220 | ) | 14,762 | (14,762 | ) | ||||||||||
Balance at end of period | $ | (531,757 | ) | $ | (191,745 | ) | $ | (593,134 | ) | $ | (244,793 | ) | ||||
Nine Months Ended September 30, 2018 | Nine Months Ended September 30, 2017 | |||||||||||||||
(In Thousands) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | ||||||||||||
Balance at beginning of period | $ | (593,227 | ) | $ | (215,325 | ) | $ | (694,241 | ) | $ | (278,191 | ) | ||||
Impact of RMBS Issuer Settlement (2)(3) | — | (14,822 | ) | — | — | |||||||||||
Accretion of discount | — | 54,860 | — | 60,461 | ||||||||||||
Realized credit losses | 31,443 | — | 39,445 | — | ||||||||||||
Purchases | (2,510 | ) | 1,856 | (484 | ) | (3,449 | ) | |||||||||
Sales | 7,144 | 7,079 | 29,398 | 10,166 | ||||||||||||
Net impairment losses recognized in earnings | — | — | (1,032 | ) | — | |||||||||||
Transfers/release of credit reserve | 25,393 | (25,393 | ) | 33,780 | (33,780 | ) | ||||||||||
Balance at end of period | $ | (531,757 | ) | $ | (191,745 | ) | $ | (593,134 | ) | $ | (244,793 | ) | ||||
(1) | Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security. |
(2) | Includes the impact of approximately $2.7 million of cash proceeds (a one-time payment) received by the Company during the three and nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by Lehman Brothers Holdings Inc. |
(3) | Includes the impact of approximately $12.1 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. |
64
The following table presents information with respect to the yield components of our Non-Agency MBS for the three months ended September 30, 2018 and 2017:
Three Months Ended September 30, 2018 | Three Months Ended September 30, 2017 | |||||||||||
Legacy Non-Agency MBS | RPL/NPL MBS | Legacy Non-Agency MBS | RPL/NPL MBS | |||||||||
Non-Agency MBS | ||||||||||||
Coupon Yield (1) | 6.32 | % | 4.56 | % | 5.63 | % | 4.24 | % | ||||
Effective Yield Adjustment (2) | 4.44 | 0.45 | 3.30 | 0.19 | ||||||||
Net Yield | 10.76 | % | 5.01 | % | 8.93 | % | 4.43 | % | ||||
(1) | Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate. |
(2) | The effective yield adjustment is the difference between the net yield, calculated utilizing management’s estimates of timing and amount of future cash flows for Legacy Non-Agency MBS and RPL/NPL MBS, less the current coupon yield. |
Actual maturities of MBS are generally shorter than stated contractual maturities because actual maturities of MBS are affected by the contractual lives of the underlying mortgage loans, periodic payments of principal and prepayments of principal. The following table presents certain information regarding the amortized costs, weighted average yields and contractual maturities of our MBS at September 30, 2018 and does not reflect the effect of prepayments or scheduled principal amortization on our MBS:
Within One Year | One to Five Years | Five to Ten Years | Over Ten Years | Total MBS | |||||||||||||||||||||||||||||||||||
(Dollars in Thousands) | Amortized Cost | Weighted Average Yield | Amortized Cost | Weighted Average Yield | Amortized Cost | Weighted Average Yield | Amortized Cost | Weighted Average Yield | Total Amortized Cost | Total Fair Value | Weighted Average Yield | ||||||||||||||||||||||||||||
Agency MBS: | |||||||||||||||||||||||||||||||||||||||
Fannie Mae | $ | — | — | % | $ | 43 | 1.95 | % | $ | 530,680 | 1.97 | % | $ | 1,391,577 | 2.20 | % | $ | 1,922,300 | $ | 1,896,739 | 2.13 | % | |||||||||||||||||
Freddie Mac | — | — | — | — | 382,608 | 1.79 | 645,845 | 4.29 | 1,028,453 | 1,003,583 | 3.36 | ||||||||||||||||||||||||||||
Ginnie Mae | — | — | — | — | 89 | 3.31 | 5,031 | 2.99 | 5,120 | 5,168 | 3.00 | ||||||||||||||||||||||||||||
Total Agency MBS | $ | — | — | % | $ | 43 | 1.95 | % | $ | 913,377 | 1.90 | % | $ | 2,042,453 | 2.86 | % | $ | 2,955,873 | $ | 2,905,490 | 2.56 | % | |||||||||||||||||
Non-Agency MBS | $ | — | — | % | $ | 312,399 | 4.25 | % | $ | 2,554 | 4.50 | % | $ | 2,470,875 | 8.54 | % | $ | 2,785,828 | $ | 3,334,610 | 8.05 | % | |||||||||||||||||
Total MBS | $ | — | — | % | $ | 312,442 | 4.25 | % | $ | 915,931 | 1.91 | % | $ | 4,513,328 | 5.97 | % | $ | 5,741,701 | $ | 6,240,100 | 5.23 | % | |||||||||||||||||
CRT Securities
At September 30, 2018, our total investment in CRT securities was $538.9 million, with a net unrealized gain of $34.2 million, a weighted average yield of 5.75% and a weighted average time to maturity of 10.6 years. At December 31, 2017, our total investment in CRT securities was $664.4 million, with a net unrealized gain of $56.3 million, a weighted average yield of 6.02% and weighted average time to maturity of 9.2 years.
65
Residential Whole Loans
The following table presents the contractual maturities of our residential whole loans held by consolidated trusts and certain entities established in connection with our loan securitization transactions at September 30, 2018 and does not reflect estimates of prepayments or scheduled amortization. For purchased credit impaired loans held at carrying value, amounts presented are estimated based on the underlying loan contractual amounts.
(In Thousands) | Purchased Credit Impaired Loans, at Carrying Value | Other Loans, at Carrying Value (1) | Residential Whole Loans, at Fair Value (1) | |||||||||
Amount due: | ||||||||||||
Within one year | $ | 604 | $ | 270,163 | $ | 8,769 | ||||||
After one year: | ||||||||||||
Over one to five years | 4,421 | 61,462 | 9,848 | |||||||||
Over five years | 820,589 | 1,307,555 | 1,428,950 | |||||||||
Total due after one year | $ | 825,010 | $ | 1,369,017 | $ | 1,438,798 | ||||||
Total residential whole loans | $ | 825,614 | $ | 1,639,180 | $ | 1,447,567 | ||||||
(1) | Excludes approximately $6.8 million of other loans held at carrying value and $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018. |
The following table presents, at September 30, 2018, the dollar amount of certain of our residential whole loans contractually maturing after one year, and indicates whether the loans have fixed interest rates or adjustable interest rates:
(In Thousands) | Other Loans, at Carrying Value (1)(2) | Residential Whole Loans, at Fair Value (1)(2) | ||||||
Interest rates: | ||||||||
Fixed | $ | 301,687 | $ | 819,414 | ||||
Adjustable | 1,067,330 | 619,384 | ||||||
Total | $ | 1,369,017 | $ | 1,438,798 | ||||
(1) | Includes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of September 30, 2018. |
(2) | Excludes approximately $6.8 million of other loans held at carrying value and $1.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2018. |
Information is not presented for purchased credit impaired loans held at carrying value as income is recognized based on pools of assets with similar risk characteristics using an estimated yield based on cash flows expected to be collected over the lives of the loans in such pools rather than on the contractual coupons of the underlying loans.
66
Exposure to Financial Counterparties
We finance a significant portion of our residential mortgage assets with repurchase agreements. In connection with these financing arrangements, we pledge our assets as collateral to secure the borrowing. The amount of collateral pledged will typically exceed the amount of the financing with the extent of over-collateralization ranging from 3% to 5% of the amount borrowed for Agency MBS collateral, up to 30% for Non-Agency MBS and MSR related asset collateral, and up to 33% for residential whole loan collateral. Consequently, while repurchase agreement financing results in our recording a liability to the counterparty in our consolidated balance sheets, we are exposed to the counterparty, if during the term of the repurchase agreement financing, a lender should default on its obligation and we are not able to recover our pledged assets. The amount of this exposure is the difference between the amount loaned to us plus interest due to the counterparty and the fair value of the collateral pledged by us to the lender including accrued interest receivable on such collateral.
The table below summarizes our exposure to our counterparties at September 30, 2018, by country:
Country | Number of Counterparties | Repurchase Agreement Financing | Exposure (1) | Exposure as a Percentage of MFA Total Assets | |||||||||
(Dollars in Thousands) | |||||||||||||
European Countries: (2) | |||||||||||||
United Kingdom | 2 | $ | 753,870 | $ | 352,240 | 2.99 | % | ||||||
Switzerland | 3 | 696,878 | 140,747 | 1.19 | |||||||||
France | 2 | 559,749 | 132,315 | 1.12 | |||||||||
Holland | 1 | 92,679 | 5,957 | 0.05 | |||||||||
Total European | 8 | 2,103,176 | 631,259 | 5.35 | % | ||||||||
Other Countries: | |||||||||||||
United States | 13 | $ | 3,492,950 | $ | 792,178 | 6.72 | % | ||||||
Canada (4) | 2 | 884,458 | 243,731 | 2.07 | |||||||||
Japan (5) | 3 | 364,436 | 26,377 | 0.22 | |||||||||
South Korea | 1 | 320,016 | 26,237 | 0.22 | |||||||||
China (5) | 1 | 113,253 | 11,784 | 0.10 | |||||||||
Total Other | 20 | 5,175,113 | 1,100,307 | 9.33 | % | ||||||||
Total | 28 | $ | 7,278,289 | $ | 1,731,566 | 14.68 | % | ||||||
(1) | Represents for each counterparty the amount of cash and/or securities pledged as collateral less the aggregate of repurchase agreement financing and net interest receivable/payable on all such instruments. |
(2) | Includes European-based counterparties as well as U.S.-domiciled subsidiaries of the European parent entity. |
(3) | Includes London branch of one counterparty and Cayman Islands branch of the other counterparty. |
(4) | Includes Canada-based counterparties as well as U.S.-domiciled subsidiaries of Canadian parent entities. In the case of one counterparty, also includes exposure of $237.6 million to a Barbados-based affiliate of the Canadian parent entity. |
(5) | Exposure is to U.S.-domiciled subsidiary of the Japanese or Chinese parent entity, as the case may be. |
At September 30, 2018, we did not use credit default swaps or other forms of credit protection to hedge the exposures summarized in the table above.
Uncertainty in the global financial market and weak economic conditions in Europe, including as a result of the United Kingdom’s recent vote to leave the European Union (commonly known as “Brexit”), could potentially impact our major European financial counterparties, with the possibility that this would also impact the operations of their U.S. domiciled subsidiaries. This could adversely affect our financing and operations as well as those of the entire mortgage sector in general. Management monitors our exposure to our repurchase agreement counterparties on a regular basis, using various methods, including review of recent rating agency actions or other developments and by monitoring the amount of cash and securities collateral pledged and the associated loan amount under repurchase agreements with our counterparties. We intend to make reverse margin calls on our counterparties to recover excess collateral as permitted by the agreements governing our financing arrangements, or take other necessary actions to reduce the amount of our exposure to a counterparty when such actions are considered necessary.
67
Tax Considerations
Current period estimated taxable income
We estimate that for the nine months ended September 30, 2018, our taxable income was approximately $257.7 million. Based on dividends paid or declared during the nine months ended September 30, 2018, we have undistributed taxable income of approximately $47.8 million, or $0.11 per share. We have until the filing of our 2018 tax return (due not later than October 15, 2019) to declare the distribution of any 2018 REIT taxable income not previously distributed.
Key differences between GAAP net income and REIT Taxable Income for Non-Agency MBS and Residential Whole Loans
Our total Non-Agency MBS portfolio for tax differs from our portfolio reported for GAAP primarily due to the fact that for tax purposes: (i) certain of the MBS contributed to the VIEs used to facilitate MBS resecuritization transactions were deemed to be sold; and (ii) the tax basis of underlying MBS considered to be reacquired in connection with the unwind of such transactions becomes the fair value of such securities at the time of the unwind. For GAAP reporting purposes the underlying MBS that were included in these MBS resecuritization transactions were not considered to be sold. Similarly, for tax purposes the residential whole loans contributed to the VIE used to facilitate our second quarter 2017 loan securitization transaction were deemed to be sold for tax purposes, but not for GAAP reporting purposes. In addition, for our Non-Agency MBS and residential whole loan tax portfolios, potential timing differences arise with respect to the accretion of market discount into income and recognition of realized losses for tax purposes as compared to GAAP. Consequently, our REIT taxable income calculated in a given period may differ significantly from our GAAP net income.
The determination of taxable income attributable to Non-Agency MBS and residential whole loans is dependent on a number of factors, including principal payments, defaults, loss mitigation efforts and loss severities. In estimating taxable income for Non-Agency MBS and residential whole loans during the year, management considers estimates of the amount of discount expected to be accreted. Such estimates require significant judgment and actual results may differ from these estimates. Moreover, the deductibility of realized losses from Non-Agency MBS and residential whole loans and their effect on market discount accretion are analyzed on an asset-by-asset basis and, while they will result in a reduction of taxable income, this reduction tends to occur gradually and primarily for Non-Agency MBS in periods after the realized losses are reported. In addition, for MBS resecuritization transactions that were treated as a sale of the underlying MBS for tax purposes, taxable gain or loss, if any, resulting from the unwind of such transactions is not recognized in GAAP net income.
Securitization transactions result in differences between GAAP net income and REIT Taxable Income
For tax purposes, depending on the transaction structure, a securitization and/or resecuritization transaction may be treated either as a sale or a financing of the underlying collateral. Income recognized from securitization and resecuritization transactions will differ for tax and GAAP purposes. For tax purposes, we own and may in the future acquire interests in securitization and/or resecuritization trusts, in which several of the classes of securities are or will be issued with original issue discount (or OID). As the holder of the retained interests in the trust, we generally will be required to include OID in our current gross interest income over the term of the applicable securities as the OID accrues. The rate at which the OID is recognized into taxable income is calculated using a constant rate of yield to maturity, with realized losses impacting the amount of OID recognized in REIT taxable income once they are actually incurred. Under the Tax Cuts and Jobs Act (or TCJA), the timing of REIT taxable income may be affected by when we include such income for financial accounting purposes. For tax purposes, REIT taxable income may be recognized in excess of economic income (i.e., OID) or in advance of the corresponding cash flow from these assets, thereby affecting our dividend distribution requirement to stockholders. In addition, for securitization and/or resecuritization transactions that were treated as a sale of the underlying collateral for tax purposes, the unwind of any such transaction will likely result in a taxable gain or loss that is likely not recognized in GAAP net income since securitization and resecuritization transactions are typically accounted for as financing transactions for GAAP purposes. The tax basis of underlying residential whole loans or MBS re-acquired in connection with the unwind of such transactions becomes the fair market value of such assets at the time of the unwind.
Regulatory Developments
The U.S. Congress, Board of Governors of the Federal Reserve System, U.S. Treasury, Federal Deposit Insurance Corporation, SEC and other governmental and regulatory bodies have taken and continue to consider additional actions in response to the 2007-2008 financial crisis. In particular, the Dodd-Frank Wall Street Reform and Consumer Protection Act (or the Dodd-Frank Act) created a new regulator, an independent bureau housed within the Federal Reserve System, and known as the Consumer Financial Protection Bureau (or the CFPB). The CFPB has broad authority over a wide range of consumer financial products and
68
services, including mortgage lending and servicing. One portion of the Dodd-Frank Act, the Mortgage Reform and Anti-Predatory Lending Act (or Mortgage Reform Act), contains underwriting and servicing standards for the mortgage industry, restrictions on compensation for mortgage loan originators, and various other requirements related to mortgage origination. In addition, the Dodd-Frank Act grants enforcement authority and broad discretionary regulatory authority to the CFPB to prohibit or condition terms, acts or practices relating to residential mortgage loans that the CFPB finds abusive, unfair, deceptive or predatory, as well as to take other actions that the CFPB finds are necessary or proper to ensure responsible affordable mortgage credit remains available to consumers. The Dodd-Frank Act also affects the securitization of mortgages (and other assets) with requirements for risk retention by securitizers and requirements for regulating rating agencies.
The Dodd-Frank Act requires that numerous regulations be issued, many of which (including those mentioned above regarding servicing, underwriting and mortgage loan originator compensation) have only recently been implemented and operationalized. As a result, we are unable to fully predict at this time how the Dodd-Frank Act, as well as other laws or regulations that may be adopted in the future, will affect our business, results of operations and financial condition, or the environment for repurchase financing and other forms of borrowing, the investing environment for Agency MBS, Non-Agency MBS and/or residential mortgage loans, the securitization industry, Swaps and other derivatives. However, at a minimum, we believe that the Dodd-Frank Act and the regulations promulgated thereunder are likely to continue to increase the economic and compliance costs for participants in the mortgage and securitization industries, including us.
In addition to the regulatory actions being implemented under the Dodd-Frank Act, on August 31, 2011, the SEC issued a concept release under which it is reviewing interpretive issues related to Section 3(c)(5)(C) of the Investment Company Act. Section 3(c)(5)(C) excludes from the definition of “investment company” entities that are primarily engaged in, among other things, “purchasing or otherwise acquiring mortgages and other liens on and interests in real estate.” Many companies that engage in the business of acquiring mortgages and mortgage-related instruments seek to rely on existing interpretations of the SEC Staff with respect to Section 3(c)(5)(C) so as not to be deemed an investment company for the purpose of regulation under the Investment Company Act. In connection with the concept release, the SEC requested comments on, among other things, whether it should reconsider its existing interpretation of Section 3(c)(5)(C). To date the SEC has not taken or otherwise announced any further action in connection with the concept release.
The FHFA and both houses of Congress have discussed and considered separate measures intended to restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac. Congress may continue to consider legislation that would significantly reform the country’s mortgage finance system, including, among other things, eliminating Freddie Mac and Fannie Mae and replacing them with a single new MBS insurance agency. Many details remain unsettled, including the scope and costs of the agencies’ guarantee and their affordable housing mission, some of which could be addressed even in the absence of large-scale reform. While the likelihood of enactment of major mortgage finance system reform in the short term remains uncertain, it is possible that the adoption of any such reforms could adversely affect the types of assets we can buy, the costs of these assets and our business operations. As the FHFA and both houses of Congress continue to consider various measures intended to dramatically restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac, we expect debate and discussion on the topic to continue throughout 2018. In June 2018, the Trump Administration proposed a plan that would end the conservatorship of Fannie Mae and Freddie Mac and privatize the GSEs. However, we cannot be certain if any housing and/or mortgage-related legislation will emerge from committee, or be approved by Congress, and if so, what the effect would be on our business.
69
Results of Operations
Quarter Ended September 30, 2018 Compared to the Quarter Ended September 30, 2017
General
For the third quarter of 2018, we had net income available to our common stock and participating securities of $83.4 million, or $0.19 per basic and diluted common share, compared to net income available to common stock and participating securities of $60.1 million, or $0.15 per basic and diluted common share, for the third quarter of 2017. The increase in net income available to common stock and participating securities and the increase of this item on a per share basis primarily reflects higher net gains on our residential whole loans held at fair value and higher net interest income driven by increased investment in residential whole loans held at carrying value. In addition, operating and other expenses were higher in the prior year period primarily due to non-recurring expenses in relation to our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer.
Net Interest Income
Net interest income represents the difference between income on interest-earning assets and expense on interest-bearing liabilities. Net interest income depends primarily upon the volume of interest-earning assets and interest-bearing liabilities and the corresponding interest rates earned or paid. Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS. Interest rates and CPRs (which measure the amount of unscheduled principal prepayment on a bond as a percentage of the bond balance) vary according to the type of investment, conditions in the financial markets, and other factors, none of which can be predicted with any certainty.
The changes in average interest-earning assets and average interest-bearing liabilities and their related yields and costs are discussed in greater detail below under “Interest Income” and “Interest Expense.”
For the third quarter of 2018, our net interest spread and margin were 2.41% and 2.82%, respectively, compared to a net interest spread and margin of 2.02% and 2.54%, respectively, for the third quarter of 2017. Our net interest income increased by $2.7 million, or 4.8%, to $58.6 million for the third quarter of 2018, from $55.9 million for the third quarter of 2017. Current quarter net interest income on residential whole loans held at carrying value increased by approximately $16.0 million compared to the third quarter of 2017, primarily due increased investment in these assets. This increase was partially offset by a decrease of approximately $3.8 million in net interest income from Agency MBS and Non-Agency MBS compared to the third quarter of 2017, primarily due to lower average amounts invested in these securities and higher Agency MBS funding costs, partially offset by higher yields earned on Legacy Non-Agency MBS. In addition, net interest income also includes $10.6 million of interest expense associated with residential whole loans held at fair value, reflecting a $6.0 million increase in borrowing costs related to these investments compared to the third quarter of 2017. Coupon interest income received from residential whole loans held at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.
70
Analysis of Net Interest Income
The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the three months ended September 30, 2018 and 2017. Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown. The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.
Three Months Ended September 30, | ||||||||||||||||||||||
2018 | 2017 | |||||||||||||||||||||
(Dollars in Thousands) | Average Balance | Interest | Average Yield/Cost | Average Balance | Interest | Average Yield/Cost | ||||||||||||||||
Assets: | ||||||||||||||||||||||
Interest-earning assets: | ||||||||||||||||||||||
Agency MBS (1) | $ | 2,595,896 | $ | 14,332 | 2.21 | % | $ | 3,154,112 | $ | 15,533 | 1.97 | % | ||||||||||
Legacy Non-Agency MBS (1) | 1,709,704 | 46,010 | 10.76 | 2,182,148 | 48,693 | 8.93 | ||||||||||||||||
RPL/NPL MBS (1) | 1,010,910 | 12,657 | 5.01 | 1,315,737 | 14,559 | 4.43 | ||||||||||||||||
Total MBS | 5,316,510 | 72,999 | 5.49 | 6,651,997 | 78,785 | 4.74 | ||||||||||||||||
CRT securities (1) | 500,649 | 7,748 | 6.19 | 604,322 | 8,676 | 5.74 | ||||||||||||||||
MSR related assets (1) | 482,100 | 6,407 | 5.32 | 454,354 | 7,194 | 6.33 | ||||||||||||||||
Residential whole loans, at carrying value (2) | 2,003,913 | 29,524 | 5.89 | 609,538 | 9,026 | 5.92 | ||||||||||||||||
Cash and cash equivalents (3) | 181,242 | 754 | 1.66 | 657,331 | 1,452 | 0.88 | ||||||||||||||||
Total interest-earning assets | 8,484,414 | 117,432 | 5.54 | 8,977,542 | 105,133 | 4.68 | ||||||||||||||||
Total non-interest-earning assets (2) | 2,841,079 | 2,487,953 | ||||||||||||||||||||
Total assets | $ | 11,325,493 | $ | 11,465,495 | ||||||||||||||||||
Liabilities and stockholders’ equity: | ||||||||||||||||||||||
Interest-bearing liabilities: | ||||||||||||||||||||||
Total repurchase agreements (4) | $ | 6,594,050 | $ | 50,881 | 3.02 | % | $ | 7,022,913 | $ | 46,303 | 2.58 | % | ||||||||||
Securitized debt | 665,572 | 5,986 | 3.52 | 139,276 | 962 | 2.70 | ||||||||||||||||
Senior Notes | 96,797 | 2,011 | 8.31 | 96,756 | 2,010 | 8.31 | ||||||||||||||||
Total interest-bearing liabilities | 7,356,419 | 58,878 | 3.13 | 7,258,945 | 49,275 | 2.66 | ||||||||||||||||
Total non-interest-bearing liabilities | 554,082 | 927,877 | ||||||||||||||||||||
Total liabilities | 7,910,501 | 8,186,822 | ||||||||||||||||||||
Stockholders’ equity | 3,414,992 | 3,278,673 | ||||||||||||||||||||
Total liabilities and stockholders’ equity | $ | 11,325,493 | $ | 11,465,495 | ||||||||||||||||||
Net interest income/net interest rate spread (5) | $ | 58,554 | 2.41 | % | $ | 55,858 | 2.02 | % | ||||||||||||||
Net interest-earning assets/net interest margin (6) | $ | 1,127,995 | 2.82 | % | $ | 1,718,597 | 2.54 | % | ||||||||||||||
Ratio of interest-earning assets to interest-bearing liabilities | 1.15 | x | 1.24 | x | ||||||||||||||||||
(1) | Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities. For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date. |
(2) | Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets. |
(3) | Includes average interest-earning cash, cash equivalents and restricted cash. |
(4) | Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration. |
(5) | Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds. |
(6) | Net interest margin reflects annualized net interest income divided by average interest-earning assets. |
71
Rate/Volume Analysis
The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated. Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change. The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.
Three Months Ended September 30, 2018 | ||||||||||||
Compared to | ||||||||||||
Three Months Ended September 30, 2017 | ||||||||||||
Increase/(Decrease) due to | Total Net Change in Interest Income/Expense | |||||||||||
(In Thousands) | Volume | Rate | ||||||||||
Interest-earning assets: | ||||||||||||
Agency MBS | $ | (2,954 | ) | $ | 1,753 | $ | (1,201 | ) | ||||
Legacy Non-Agency MBS | (11,644 | ) | 8,961 | (2,683 | ) | |||||||
RPL/NPL MBS | (3,659 | ) | 1,757 | (1,902 | ) | |||||||
CRT securities | (1,568 | ) | 640 | (928 | ) | |||||||
MSR related assets | 420 | (1,207 | ) | (787 | ) | |||||||
Residential whole loans, at carrying value (1) | 20,544 | (46 | ) | 20,498 | ||||||||
Cash and cash equivalents | (1,470 | ) | 772 | (698 | ) | |||||||
Total net change in income from interest-earning assets | $ | (331 | ) | $ | 12,630 | $ | 12,299 | |||||
Interest-bearing liabilities: | ||||||||||||
Agency repurchase agreements | $ | (2,500 | ) | $ | 2,979 | $ | 479 | |||||
Legacy Non-Agency repurchase agreements | (2,233 | ) | 158 | (2,075 | ) | |||||||
RPL/NPL MBS repurchase agreements | (1,300 | ) | 907 | (393 | ) | |||||||
CRT securities repurchase agreements | (24 | ) | 625 | 601 | ||||||||
MSR related assets repurchase agreements | 616 | (40 | ) | 576 | ||||||||
Residential whole loans at carrying value repurchase agreements | 3,908 | 159 | 4,067 | |||||||||
Residential whole loans at fair value repurchase agreements | 535 | 788 | 1,323 | |||||||||
Securitized debt | 4,652 | 372 | 5,024 | |||||||||
Senior Notes | 1 | — | 1 | |||||||||
Total net change in expense of interest-bearing liabilities | $ | 3,655 | $ | 5,948 | $ | 9,603 | ||||||
Net change in net interest income | $ | (3,986 | ) | $ | 6,682 | $ | 2,696 | |||||
(1) | Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets. |
72
The following table presents certain quarterly information regarding our net interest spread and net interest margin for the quarterly periods presented:
Total Interest-Earning Assets and Interest- Bearing Liabilities | ||||||
Net Interest Spread (1) | Net Interest Margin (2) | |||||
Quarter Ended | ||||||
September 30, 2018 | 2.41 | % | 2.82 | % | ||
June 30, 2018 | 2.30 | 2.66 | ||||
March 31, 2018 | 2.25 | 2.64 | ||||
December 31, 2017 | 2.08 | 2.54 | ||||
September 30, 2017 | 2.02 | 2.54 | ||||
(1) | Reflects the difference between the yield on average interest-earning assets and average cost of funds. |
(2) | Reflects annualized net interest income divided by average interest-earning assets. |
The following table presents the components of the net interest spread earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS for the quarterly periods presented:
Agency MBS | Legacy Non-Agency MBS | RPL/NPL MBS | Total MBS | |||||||||||||||||||||||||||||||||
Quarter Ended | Net Yield (1) | Cost of Funding (2) | Net Interest Rate Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Rate Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Rate Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Rate Spread (3) | ||||||||||||||||||||||||
September 30, 2018 | 2.21 | % | 2.22 | % | (0.01 | )% | 10.76 | % | 3.29 | % | 7.47 | % | 5.01 | % | 3.10 | % | 1.91 | % | 5.49 | % | 2.73 | % | 2.76 | % | ||||||||||||
June 30, 2018 | 2.03 | 2.04 | (0.01 | ) | 9.89 | 3.30 | 6.59 | 4.52 | 3.19 | 1.33 | 5.16 | 2.64 | 2.52 | |||||||||||||||||||||||
March 31, 2018 | 2.21 | 1.91 | 0.30 | 9.44 | 3.29 | 6.15 | 4.36 | 2.94 | 1.42 | 5.06 | 2.53 | 2.53 | ||||||||||||||||||||||||
December 31, 2017 | 2.08 | 1.79 | 0.29 | 9.12 | 3.29 | 5.83 | 4.27 | 2.72 | 1.55 | 4.85 | 2.44 | 2.41 | ||||||||||||||||||||||||
September 30, 2017 | 1.97 | 1.75 | 0.22 | 8.93 | 3.26 | 5.67 | 4.43 | 2.69 | 1.74 | 4.74 | 2.41 | 2.33 | ||||||||||||||||||||||||
(1) | Reflects annualized interest income on MBS divided by average amortized cost of MBS. |
(2) | Reflects annualized interest expense divided by average balance of repurchase agreements, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration and securitized debt. Agency MBS cost of funding includes 6, 9, 26, 43 and 44 basis points and Legacy Non-Agency MBS cost of funding includes 5, 8, 30, 45 and 45 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended September 30, 2018, June 30, 2018, March 31, 2018, December 31, 2017 and September 30, 2017, respectively. |
(3) | Reflects the difference between the net yield on average MBS and average cost of funds on MBS. |
Interest Income
Interest income on our Agency MBS for the third quarter of 2018 decreased by $1.2 million, or 7.7%, to $14.3 million from $15.5 million for the third quarter of 2017. This decrease primarily reflects a $558.2 million decrease in the average amortized cost of our Agency MBS portfolio to $2.6 billion for the third quarter of 2018 from $3.2 billion for the third quarter of 2017 partially offset by an increase in the net yield on our Agency MBS to 2.21% for the third quarter of 2018 from 1.97% for the third quarter of 2017. At the end of the third quarter of 2018, the average coupon on mortgages underlying our Agency MBS was higher compared to the end of the third quarter of 2017, due to upward resets on securities within the portfolio, purchases of higher yielding Agency MBS and the impact of the removal from the portfolio of Agency MBS sold during 2018. In addition, for the third quarter of 2018, our Agency MBS portfolio experienced a 16.8% CPR and we recognized $7.2 million of net premium amortization compared to a CPR of 16.2% and $7.9 million of net premium amortization for the third quarter of 2017. At September 30, 2018, we had net purchase premiums on our Agency MBS of $111.1 million, or 3.9% of current par value, compared to net purchase premiums of $104.0 million, or 3.8% of par value, at December 31, 2017.
Interest income on our Non-Agency MBS decreased $4.6 million, or 7.2%, for the third quarter of 2018 to $58.7 million compared to $63.3 million for the third quarter of 2017. This decrease is primarily due to the decrease in the average amortized cost of our Non-Agency MBS portfolio of $777.3 million, or 22.2%, to $2.7 billion for the third quarter of 2018 from $3.5 billion for the third quarter of 2017. This decrease more than offset the impact of the higher yields generated on our Legacy Non-Agency
73
MBS portfolio, which were 10.76% for the third quarter of 2018 compared to 8.93% for the third quarter of 2017. The increase in the net yield on our Legacy Non-Agency MBS portfolio reflects the improved performance of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases and changes in interest rates since the third quarter of the prior year, higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount as well as the impact of the cash proceeds received during the second quarter of 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. Our RPL/NPL MBS portfolio yielded 5.01% for the third quarter of 2018 compared to 4.43% for the third quarter of 2017. The increase in the net yield primarily reflects an increase in the average coupon yield to 4.56% for the third quarter of 2018 from 4.24% for the third quarter of 2017 and higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount.
During the third quarter of 2018, we recognized net purchase discount accretion of $20.1 million on our Non-Agency MBS, compared to $18.6 million for the third quarter of 2017. At September 30, 2018, we had net purchase discounts of $722.8 million, including Credit Reserve and previously recognized OTTI of $531.8 million, on our Legacy Non-Agency MBS, or 30.8% of par value. During the third quarter of 2018 we reallocated $10.2 million of purchase discount designated as Credit Reserve to accretable purchase discount.
The following table presents the coupon yield and net yields earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS and weighted average CPRs experienced for such MBS for the quarterly periods presented:
Agency MBS | Legacy Non-Agency MBS | RPL/NPL MBS | |||||||||||||||||||||||||
Quarter Ended | Coupon Yield (1) | Net Yield (2) | 3 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 3 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 3 Month Average Bond CPR (4) | ||||||||||||||||||
September 30, 2018 | 3.32 | % | 2.21 | % | 16.8 | % | 6.32 | % | 10.76 | % | 16.8 | % | 4.56 | % | 5.01 | % | 19.6 | % | |||||||||
June 30, 2018 | 3.09 | 2.03 | 16.2 | 6.09 | 9.89 | 15.8 | 4.49 | 4.52 | 20.4 | ||||||||||||||||||
March 31, 2018 | 3.02 | 2.21 | 12.7 | 5.91 | 9.44 | 14.9 | 4.35 | 4.36 | 14.0 | ||||||||||||||||||
December 31, 2017 | 3.00 | 2.08 | 14.1 | 5.82 | 9.12 | 16.3 | 4.24 | 4.27 | 20.1 | ||||||||||||||||||
September 30, 2017 | 2.98 | 1.97 | 16.2 | 5.63 | 8.93 | 18.7 | 4.24 | 4.43 | 26.2 | ||||||||||||||||||
(1) | Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate. |
(2) | Reflects annualized interest income on MBS divided by average amortized cost of MBS. |
(3) | 3 month average CPR weighted by positions as of the beginning of each month in the quarter. |
(4) | All principal payments are considered to be prepayments for CPR purposes. |
Interest income on our residential whole loans held at carrying value increased by $20.5 million, or 227.1%, for the third quarter of 2018, to $29.5 million compared to $9.0 million for the third quarter of 2017. This increase primarily reflects a $1.4 billion increase in the average balance of this portfolio to $2.0 billion for the third quarter of 2018 from $609.5 million for the third quarter of 2017 partially offset by a slight decrease in the yield (net of servicing costs) to 5.89% for the third quarter of 2018 from 5.92% for the third quarter of 2017.
Interest Expense
Our interest expense for the third quarter of 2018 increased by $9.6 million to $58.9 million from $49.3 million for the third quarter of 2017. This increase primarily reflects an increase in financing rates on our repurchase agreement financings, and an increase in our average borrowings and securitized debt to finance residential whole loans and MSR related assets, which was partially offset by a decrease in our average repurchase agreement borrowings to finance our MBS portfolio. The effective interest rate paid on our borrowings increased to 3.13% for the quarter ended September 30, 2018 from 2.66% for the quarter ended September 30, 2017.
At September 30, 2018, we had repurchase agreement borrowings of $7.3 billion, of which $2.1 billion was hedged for accounting purposes with Swaps. Payments made and/or received on our Swaps designated as hedges for accounting purposes are a component of our borrowing costs and accounted for interest expense of $547,000, or 3 basis points, for the third quarter of 2018, as compared to interest expense of $5.3 million, or 29 basis points, for the third quarter of 2017. The weighted average fixed-pay rate on our Swaps designated as hedges increased to 2.19% for the quarter ended September 30, 2018 from 2.04% for
74
the quarter ended and September 30, 2017. The weighted average variable interest rate received on our Swaps designated as hedges increased to 2.09% for the quarter ended September 30, 2018 from 1.23% for the quarter ended September 30, 2017.
We expect that our interest expense and funding costs for the remainder of 2018 will be impacted by market interest rates, the amount of our borrowings and incremental hedging activity, existing and future interest rates on our hedging instruments and the extent to which we execute additional longer-term structured financing transactions. As a result of these variables, our borrowing costs cannot be predicted with any certainty. (See Notes 5(c), 6 and 14 to the accompanying consolidated financial statements, included under Item 1 of this Quarterly Report on Form 10-Q.)
Other Income, net
For the third quarter of 2018, Other Income, net increased by $19.3 million, or 66.2%, to $48.4 million compared to $29.1 million for the third quarter of 2017. The components of Other Income, net for the third quarter of 2018 and 2017 are summarized in the table below:
Quarter Ended September 30, | ||||||||
(In Thousands) | 2018 | 2017 | ||||||
Net gains on residential whole loans held at fair value | $ | 34,942 | $ | 18,679 | ||||
Liquidation gains on purchased credit impaired loans and other loan related income | 3,172 | 2,958 | ||||||
Net loss on REO properties | (2,125 | ) | (2,324 | ) | ||||
Realized gains on MBS and CRT securities sold | 16,415 | 14,934 | ||||||
Net unrealized loss on MBS and CRT securities held at fair value | (8,545 | ) | (5,220 | ) | ||||
Net gain on Swaps not designated as hedges for accounting purposes | 4,002 | — | ||||||
OTTI and other | 498 | 70 | ||||||
Total Other Income, net | $ | 48,359 | $ | 29,097 | ||||
Operating and Other Expense
For the third quarter of 2018, we had compensation and benefits and other general and administrative expenses of $11.0 million, or 1.29% of average equity, compared to $15.0 million, or 1.83% of average equity, for the third quarter of 2017. Compensation and benefits expense decreased by approximately $4.0 million to $6.9 million for the third quarter of 2018, compared to $10.9 million for the third quarter of 2017, primarily due to the impact of non-recurring expenses recorded in the prior year quarter in relation to the our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer. Our other general and administrative expenses increased by $74,000 to $4.2 million for the quarter ended September 30, 2018 compared to $4.1 million for the quarter ended September 30, 2017.
Operating and Other Expense for the third quarter of 2018 also includes $8.8 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses increased compared to the prior year period by approximately $2.6 million, or 41.8%, primarily due to higher non-recoverable advances on REO and higher loan and REO servicing fees, partially offset by lower loan acquisition related expenses.
75
Selected Financial Ratios
The following table presents information regarding certain of our financial ratios at or for the dates presented:
At or for the Quarter Ended | Return on Average Total Assets (1) | Return on Average Total Stockholders’ Equity (2) | Total Average Stockholders’ Equity to Total Average Assets (3) | Dividend Payout Ratio (4) | Leverage Multiple (5) | Book Value per Share of Common Stock (6) | |||||||||||
September 30, 2018 | 2.94 | % | 10.21 | % | 30.15 | % | 1.05 | 2.3 | $ | 7.46 | |||||||
June 30, 2018 | 2.58 | 8.74 | 31.19 | 1.18 | 2.3 | 7.54 | |||||||||||
March 31, 2018 | 2.93 | 10.27 | 29.91 | 1.00 | 2.2 | 7.62 | |||||||||||
December 31, 2017 | 3.47 | 12.29 | 29.33 | 0.83 | 2.3 | 7.70 | |||||||||||
September 30, 2017 | 2.10 | 7.78 | 28.60 | 1.33 | 2.4 | 7.70 | |||||||||||
(1) | Reflects annualized net income available to common stock and participating securities divided by average total assets. |
(2) | Reflects annualized net income divided by average total stockholders’ equity. |
(3) | Reflects total average stockholders’ equity divided by total average assets. |
(4) | Reflects dividends declared per share of common stock divided by earnings per share. |
(5) | Represents the sum of borrowings under repurchase agreements, securitized debt, payable for unsettled purchases, obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity. |
(6) | Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding. |
Nine Month Period Ended September 30, 2018 Compared to the Nine Month Period Ended September 30, 2017
General
For the nine months ended September 30, 2018, we had net income available to common stock and participating securities of $229.7 million, or $0.56 per basic and diluted common share, compared to net income available to common stock and participating securities of $210.5 million, or $0.54 per basic and diluted common share, for the nine months ended September 30, 2017. The increase in net income available to common stock and participating securities, and the increase of this item on a per share basis primarily reflects higher net gains on our residential whole loans held at fair value, a decrease in net interest income and lower net Other income, primarily driven by unrealized losses on MBS and CRT securities accounted for at fair value, compared to unrealized gains on CRT securities in the prior year period. In addition, operating and other expenses were higher for the nine month period ended September 30, 2018, primarily due to higher costs in connection with growing and servicing our residential whole loan portfolio, partially offset by lower compensation related expenses, as the prior year period included the impact of non-recurring expenses in relation to our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer.
Net Interest Income
For the nine months ended September 30, 2018, our net interest spread and margin were 2.32% and 2.71%, respectively, compared to a net interest spread and margin of 2.15% and 2.59%, respectively, for the nine months ended September 30, 2017. Our net interest income decreased by $22.2 million, or 12.1%, to $161.7 million for the nine months ended September 30, 2018, from $183.9 million for the nine months ended September 30, 2017. For the nine months ended September 30, 2018, net interest income from Agency MBS and Non-Agency MBS declined compared to the nine months ended September 30, 2017, by approximately $33.1 million, primarily due to lower average amounts invested in these securities and higher funding costs, partially offset by higher yields earned on these securities. These decreases were partially offset by higher net interest income on residential whole loans held at carrying value, MSR related assets and CRT securities of approximately $27.8 million compared to the nine months ended September 30, 2017, primarily due to higher average balances invested in these assets. In addition, net interest income for the nine months ended September 30, 2018 also includes $29.6 million of interest expense associated with residential whole loans held at fair value, reflecting a $16.4 million increase in borrowing costs related to these investments compared to the nine months ended September 30, 2017. Coupon interest income received from residential whole loans held at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.
76
Analysis of Net Interest Income
The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the nine months ended September 30, 2018 and 2017. Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown. The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.
Nine Months Ended September 30, | ||||||||||||||||||||||
2018 | 2017 | |||||||||||||||||||||
Average Balance | Interest | Average Yield/Cost | Average Balance | Interest | Average Yield/Cost | |||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||
Assets: | ||||||||||||||||||||||
Interest-earning assets: | ||||||||||||||||||||||
Agency MBS (1) | $ | 2,654,925 | $ | 42,795 | 2.15 | % | $ | 3,383,373 | $ | 50,014 | 1.97 | % | ||||||||||
Legacy Non-Agency MBS (1) | 1,831,292 | 137,439 | 10.01 | 2,350,975 | 156,829 | 8.89 | ||||||||||||||||
RPL/NPL MBS (1) | 929,835 | 32,373 | 4.64 | 1,813,557 | 55,899 | 4.11 | ||||||||||||||||
Total MBS | 5,416,052 | 212,607 | 5.23 | 7,547,905 | 262,742 | 4.64 | ||||||||||||||||
CRT securities (1) | 556,258 | 25,939 | 6.22 | 520,585 | 22,898 | 5.86 | ||||||||||||||||
MSR related assets (1) | 440,979 | 20,249 | 6.12 | 376,811 | 17,833 | 6.31 | ||||||||||||||||
Residential whole loans, at carrying value (2) | 1,410,100 | 61,788 | 5.84 | 587,511 | 26,219 | 5.95 | ||||||||||||||||
Cash and cash equivalents (3) | 230,945 | 2,348 | 1.36 | 531,722 | 2,854 | 0.72 | ||||||||||||||||
Total interest-earning assets | 8,054,334 | 322,931 | 5.35 | 9,564,534 | 332,546 | 4.64 | ||||||||||||||||
Total non-interest-earning assets (2) | 2,785,653 | 2,207,939 | ||||||||||||||||||||
Total assets | $ | 10,839,987 | $ | 11,772,473 | ||||||||||||||||||
Liabilities and stockholders’ equity: | ||||||||||||||||||||||
Interest-bearing liabilities: | ||||||||||||||||||||||
Total repurchase agreements and other advances (4) | 6,434,725 | 142,832 | 2.93 | 7,704,662 | 141,444 | 2.42 | ||||||||||||||||
Securitized debt | 486,352 | 12,378 | 3.36 | 57,073 | 1,173 | 2.71 | ||||||||||||||||
Senior Notes | 96,787 | 6,032 | 8.31 | 96,746 | 6,029 | 8.31 | ||||||||||||||||
Total interest-bearing liabilities | 7,017,864 | 161,242 | 3.03 | 7,858,481 | 148,646 | 2.49 | ||||||||||||||||
Total non-interest-bearing liabilities | 526,766 | 734,181 | ||||||||||||||||||||
Total liabilities | 7,544,630 | 8,592,662 | ||||||||||||||||||||
Stockholders’ equity | 3,295,357 | 3,179,811 | ||||||||||||||||||||
Total liabilities and stockholders’ equity | $ | 10,839,987 | $ | 11,772,473 | ||||||||||||||||||
Net interest income/ net interest rate spread (5) | $ | 161,689 | 2.32 | % | $ | 183,900 | 2.15 | % | ||||||||||||||
Net interest-earning assets/ net interest margin (6) | $ | 1,036,470 | 2.71 | % | $ | 1,706,053 | 2.59 | % | ||||||||||||||
Ratio of interest-earning assets to interest-bearing liabilities | 1.15 | x | 1.22 | x | ||||||||||||||||||
(1) | Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities. For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date. |
(2) | Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets. |
(3) | Includes average interest-earning cash, cash equivalents and restricted cash. |
(4) | Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration. |
(5) | Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds. |
(6) | Net interest margin reflects annualized net interest income divided by average interest-earning assets. |
77
Rate/Volume Analysis
The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated. Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change. The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.
Nine Months Ended September 30, 2018 | ||||||||||||
Compared to | ||||||||||||
Nine Months Ended September 30, 2017 | ||||||||||||
Increase/(Decrease) due to | Total Net Change in Interest Income/Expense | |||||||||||
(In Thousands) | Volume | Rate | ||||||||||
Interest-earning assets: | ||||||||||||
Agency MBS | $ | (11,467 | ) | $ | 4,248 | $ | (7,219 | ) | ||||
Legacy Non-Agency MBS | (37,470 | ) | 18,080 | (19,390 | ) | |||||||
RPL/NPL MBS | (30,006 | ) | 6,480 | (23,526 | ) | |||||||
CRT securities | 1,619 | 1,422 | 3,041 | |||||||||
MSR related assets | 2,960 | (544 | ) | 2,416 | ||||||||
Residential whole loans, at carrying value (1) | 36,053 | (484 | ) | 35,569 | ||||||||
Cash and cash equivalents | (2,174 | ) | 1,668 | (506 | ) | |||||||
Total net change in income from interest-earning assets | $ | (40,485 | ) | $ | 30,870 | $ | (9,615 | ) | ||||
Interest-bearing liabilities: | ||||||||||||
Agency repurchase agreements and other advances | $ | (9,170 | ) | $ | 9,049 | $ | (121 | ) | ||||
Legacy Non-Agency repurchase agreements | (7,401 | ) | 1,501 | (5,900 | ) | |||||||
RPL/NPL MBS repurchase agreements | (16,657 | ) | 5,610 | (11,047 | ) | |||||||
CRT securities repurchase agreements | 1,226 | 1,666 | 2,892 | |||||||||
MSR related assets repurchase agreements | 1,768 | 141 | 1,909 | |||||||||
Residential whole loan at carrying value repurchase agreements | 4,304 | 1,409 | 5,713 | |||||||||
Residential whole loan at fair value repurchase agreements | 5,470 | 2,472 | 7,942 | |||||||||
Securitized debt | 10,861 | 344 | 11,205 | |||||||||
Senior Notes | 3 | — | 3 | |||||||||
Total net change in expense of interest-bearing liabilities | $ | (9,596 | ) | $ | 22,192 | $ | 12,596 | |||||
Net change in net interest income | $ | (30,889 | ) | $ | 8,678 | $ | (22,211 | ) | ||||
(1) | Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets. |
The following table presents the components of the net interest spread earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS for the periods presented:
Agency MBS | Legacy Non-Agency MBS | RPL/NPL MBS | Total MBS | |||||||||||||||||||||||||||||||||
Nine Months Ended | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | ||||||||||||||||||||||||
September 30, 2018 | 2.15 | % | 2.05 | % | 0.10 | % | 10.01 | % | 3.29 | % | 6.72 | % | 4.64 | % | 3.08 | % | 1.56 | % | 5.23 | % | 2.63 | % | 2.60 | % | ||||||||||||
September 30, 2017 | 1.97 | % | 1.60 | % | 0.37 | % | 8.89 | % | 3.19 | % | 5.70 | % | 4.11 | % | 2.43 | % | 1.68 | % | 4.64 | % | 2.27 | % | 2.37 | % | ||||||||||||
(1) Reflects annualized interest income on MBS divided by average amortized cost of MBS.
(2) Reflects annualized interest expense divided by average balance of repurchase agreements and other advances, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration, and securitized debt. Agency MBS cost of funding includes 14 and 51 basis points and Legacy Non-Agency MBS cost of funding includes 14 and 54 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the nine months ended September 30, 2018 and 2017, respectively.
(3) Reflects the difference between the net yield on average MBS and average cost of funds on MBS.
78
Interest Income
Interest income on our Agency MBS for the nine months ended September 30, 2018 decreased by $7.2 million, or 14.4%, to $42.8 million from $50.0 million for the nine months ended September 30, 2017. This change primarily reflects a $728.4 million decrease in the average amortized cost of our Agency MBS portfolio to $2.7 billion for the nine months ended September 30, 2018 from $3.4 billion for the nine months ended September 30, 2017 partially offset by an increase in the net yield on our Agency MBS to 2.15% for the nine months ended September 30, 2018 from 1.97% for the nine months ended September 30, 2017. At the end of the third quarter of 2018, the average coupon on mortgages underlying our Agency MBS was higher compared to the end of the third quarter of 2017. In addition, during the nine months ended September 30, 2018, our Agency MBS portfolio experienced a 13.5% CPR and we recognized $19.8 million of net premium amortization compared to a CPR of 14.4% and $24.6 million of net premium amortization for the nine months ended September 30, 2017. At September 30, 2018, we had net purchase premiums on our Agency MBS of $111.1 million, or 3.9% of current par value, compared to net purchase premiums of $104.0 million, or 3.8% of par value at December 31, 2017.
Interest income on our Non-Agency MBS decreased by $42.9 million, or 20.2%, for the nine months ended September 30, 2018 to $169.8 million compared to $212.7 million for the nine months ended September 30, 2017. This decrease is primarily due to the decrease in the average amortized cost of our Non-Agency MBS portfolio of $1.4 billion or 33.7%, to $2.8 billion from $4.2 billion for the nine months ended September 30, 2017. This decrease more than offset the impact of the higher yields generated on our Legacy Non-Agency MBS portfolio, which were 10.01% for the nine months ended September 30, 2018 compared to 8.89% for the nine months ended September 30, 2017. The increase in the net yield on our Legacy Non-Agency MBS portfolio reflects the improved performance of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases and changes in interest rates since the third quarter of the prior year, higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount as well as the impact of the cash proceeds received during the nine months ended September 30, 2018 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities. Our RPL/NPL MBS portfolio yielded 4.64% for the nine months ended September 30, 2018 compared to 4.11% for the nine months ended September 30, 2017. The increase in the net yield primarily reflects an increase in the average coupon yield to 4.47% for the nine months ended September 30, 2018 from 4.01% for the nine months ended September 30, 2017.
During the nine months ended September 30, 2018, we recognized net purchase discount accretion of $54.9 million on our Non-Agency MBS, compared to $60.5 million for the nine months ended September 30, 2017. At September 30, 2018, we had net purchase discounts of $722.8 million, including Credit Reserve and previously recognized OTTI of $531.8 million, on our Legacy Non-Agency MBS, or 30.8% of par value. During the nine months ended September 30, 2018 we reallocated $25.4 million of purchase discount designated as Credit Reserve to accretable purchase discount.
The following table presents the coupon yield and net yields earned on our Agency MBS, Legacy Non-Agency MBS and RPL/NPL MBS and weighted average CPRs experienced for such MBS for the periods presented:
Agency MBS | Legacy Non-Agency MBS | RPL/NPL MBS | |||||||||||||||||||||||||
Nine Months Ended | Coupon Yield (1) | Net Yield (2) | 9 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 9 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 9 Month Average Bond CPR (4) | ||||||||||||||||||
September 30, 2018 | 3.14 | % | 2.15 | % | 13.5 | % | 6.10 | % | 10.01 | % | 14.3 | % | 4.47 | % | 4.64 | % | 18.0 | % | |||||||||
September 30, 2017 | 2.94 | 1.97 | 14.4 | 5.55 | 8.89 | 16.3 | 4.01 | 4.11 | 32.2 | ||||||||||||||||||
(1) | Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate. |
(2) | Reflects annualized interest income on MBS divided by average amortized cost of MBS. |
(3) | 9 month average CPR weighted by positions as of the beginning of each month in the quarter. |
(4) | All principal payments are considered to be prepayments for CPR purposes. |
Interest income on our residential whole loans held at carrying value increased by $35.6 million, or 135.7%, for the nine months ended September 30, 2018 to $61.8 million compared to $26.2 million for the nine months ended September 30, 2017. This increase primarily reflects a $822.6 million increase in the average balance of this portfolio to $1.4 billion for the nine months ended September 30, 2018 from $587.5 million for the nine months ended September 30, 2017 partially offset by a decrease in the yield (net of servicing costs) to 5.84% for the nine months ended September 30, 2018 from 5.95% for the nine months ended September 30, 2017.
79
Interest Expense
Our interest expense for the nine months ended September 30, 2018 increased by $12.6 million, or 8.5%, to $161.2 million, from $148.6 million for the nine months ended September 30, 2017. This increase primarily reflects an increase in financing rates on our repurchase agreement financings, an increase in our average borrowings and securitized debt to finance residential whole loans, MSR related assets and CRT securities, which was partially offset by a decrease in our average repurchase agreement borrowings and other advances to finance our MBS portfolio. The effective interest rate paid on our borrowings increased to 3.03% for the nine months ended September 30, 2018, from 2.49% for the nine months ended September 30, 2017.
Payments made and/or received on our Swaps designated as hedges for accounting purposes are a component of our borrowing costs and accounted for interest expense of $4.2 million, or 8 basis points, for the nine months ended September 30, 2018, compared to interest expense of $19.6 million, or 33 basis points, for the nine months ended September 30, 2017. The weighted average fixed-pay rate on our Swaps designated as hedges increased to 2.09% for the nine months ended September 30, 2018 from 1.96% for the nine months ended September 30, 2017. The weighted average variable interest rate received on our Swaps designated as hedges increased to 1.86% for the nine months ended September 30, 2018 from 1.00% for the nine months ended September 30, 2017.
Other Income, net
For the nine months ended September 30, 2018, Other Income, net increased by $44.0 million, or 47.3%, to $137.0 million compared to $93.0 million for the nine months ended September 30, 2017. The components of Other Income, net for the nine months ended September 30, 2018 and 2017 are summarized in the table below:
Nine Months Ended September 30, | ||||||||
(In Thousands) | 2018 | 2017 | ||||||
Net gains on residential whole loans held at fair value | $ | 105,883 | $ | 48,660 | ||||
Liquidation gains on purchased credit impaired loans and other loan related income | 10,018 | 4,835 | ||||||
Net loss on REO properties | (4,899 | ) | (4,463 | ) | ||||
Realized gains on MBS and CRT securities sold | 32,661 | 30,530 | ||||||
Net unrealized (loss)/gain on MBS and CRT securities held at fair value | (11,776 | ) | 14,173 | |||||
Net gain on Swaps not designated as hedges for accounting purposes | 4,355 | — | ||||||
OTTI and other | 783 | (733 | ) | |||||
Total Other Income, net: | $ | 137,025 | $ | 93,002 | ||||
Operating and Other Expense
During the nine months ended September 30, 2018, we had compensation and benefits and other general and administrative expenses of $34.2 million, or 1.38% of average equity, compared to $40.3 million, or 1.69% of average equity, for the nine months ended September 30, 2017. Compensation and benefits expense decreased $5.6 million to $20.7 million for the nine months ended September 30, 2018, compared to $26.3 million for the nine months ended September 30, 2017, which includes the impact of non-recurring expenses recorded in the third quarter of 2017 in relation to the our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer. Our other general and administrative expenses decreased by $491,000 to $13.6 million for the nine months ended September 30, 2018 compared to $14.1 million for the nine months ended September 30, 2017, primarily due to higher costs in the prior period associated with loan securitization transactions and lower costs associated with deferred compensation to Directors in the current year period, partially offset by an increase in professional services related costs in the current year period.
Operating and Other Expense during the nine months ended September 30, 2018 also includes $23.6 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses increased compared to the prior year period by approximately $8.8 million, or 59.4%, primarily due to increased loan servicing and related fees, increases in non-recoverable advances on REO. In addition, the prior period included the impact of a reversal of allowance for loan losses recorded against purchased credit impact residential whole loans, while the current year period included a small increase in the allowance for loan losses.
80
Selected Financial Ratios
The following table presents information regarding certain of our financial ratios at or for the dates presented:
At or for the Nine Months Ended | Return on Average Total Assets (1) | Return on Average Total Stockholders’ Equity (2) | Total Average Stockholders’ Equity to Total Average Assets (3) | Dividend Payout Ratio (4) | Leverage Multiple (5) | Book Value per Share of Common Stock (6) | ||||||||||||
September 30, 2018 | 2.82 | % | 9.75 | % | 30.40 | % | 1.07 | 2.3 | $ | 7.46 | ||||||||
September 30, 2017 | 2.38 | 9.30 | 27.01 | 1.11 | 2.4 | 7.70 | ||||||||||||
(1) | Reflects annualized net income available to common stock and participating securities divided by average total assets. |
(2) | Reflects annualized net income divided by average total stockholders’ equity. |
(3) | Reflects total average stockholders’ equity divided by total average assets. |
(4) | Reflects dividends declared per share of common stock divided by earnings per share. |
(5) | Represents the sum of borrowings under repurchase agreements, securitized debt, payable for unsettled purchases, obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity. |
(6) | Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding. |
Recent Accounting Standards to Be Adopted in Future Periods
Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement
In August 2018, the FASB issued ASU 2018-13, Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurements (or ASU 2018-13). The amendments in ASU 2018-13 eliminate, add and modify certain disclosure requirements for fair value measurements as part of the FASB’s disclosure framework project, which aims to improve the effectiveness of disclosures in the notes to financial statements by focusing on requirements that are the most important to the users. The guidance in this ASU is effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, but entities are permitted to early adopt either the entire standard or only the provisions that eliminate or modify the requirements. The guidance on changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 measurements, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. We do not expect that adoption of ASU 2018-13 will have a significant impact on our financial position or financial statement disclosures.
Compensation - Stock Compensation - Improvements to Nonemployee Share-Based Payment Accounting
In June 2018, the FASB issued ASU 2018-07, Improvements to Nonemployee Share-Based Payment Accounting (or ASU 2018-07). The amendments in this ASU simplify the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The amendments in ASU 2018-07 do not change existing guidance on accounting for share-based payment transactions for employees. ASU 2018-07 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, but no earlier than an entity’s adoption of FASB Accounting Standards Codification Topic 606, Revenue from Contracts with Customers. An entity should apply the amendments of this ASU to all new awards granted after the date of adoption. In addition, entities will apply the new guidance to equity-classified nonemployee awards for which a measurement date has not been established and liability-classified nonemployee awards that have not been settled as of date of adoption by recognizing a cumulative-effect adjustment to retained earnings as of the beginning of the annual period of adoption. We are currently evaluating the effect that ASU 2018-07 will have on our consolidated financial statements and related disclosures, but do not anticipate that adoption of the new standard would have a significant impact.
Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities
In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities (or ASU 2017-12). The amendments in this ASU expand an entity’s ability to hedge non-financial and financial risk components and reduce complexity in fair value hedges of interest rate risk. The new guidance eliminates the requirement to separately measure and report hedge ineffectiveness and requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. ASU 2017-12 also simplifies certain documentation and assessment requirements and modifies the accounting for components excluded from the assessment of hedge effectiveness. ASU 2017-12 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early application is permitted in any interim period or fiscal year before the effective date. An entity should apply the amendments of this ASU to
81
cash flow and net investment hedge relationships that exist on the date of adoption using a modified retrospective approach. The presentation and disclosure requirements of ASU 2017-12 should be applied prospectively. In addition, certain transition elections may be made by an entity upon adoption to allow for existing hedging relationships to transition to the newly allowable alternatives within this ASU. We are currently evaluating the effect that ASU 2017-12 will have on our consolidated financial statements and related disclosures, but do not anticipate that adoption of the new standard would have a significant impact.
Receivables - Nonrefundable Fees and Other Costs
In March 2017, the FASB issued ASU 2017-08, Premium Amortization on Purchased Callable Debt Securities (or ASU 2017-08). The amendments in this ASU shorten the amortization period for certain purchased callable debt securities held at a premium to the earliest call date. ASU 2017-08 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early application is permitted in any interim period or fiscal year before the effective date. An entity should apply the amendments of this ASU on the date of adoption using a modified retrospective approach through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently evaluating the effect that ASU 2017-08 will have on our consolidated financial statements and expect to complete our evaluation in the fourth fiscal quarter of 2018.
Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments
In June 2016, the FASB issued ASU 2016-13, Measurements of Credit Losses on Financial Instruments (or ASU 2016-13). The amendments in ASU 2016-13 require entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Entities will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 also requires enhanced financial statement disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. ASU 2016-13 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for all entities for annual periods beginning after December 15, 2018, and interim periods therein. The amendments in this ASU are required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the first reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. We will continue to monitor and evaluate the potential effects that ASU 2016-13 will have on our consolidated financial statements and related disclosures.
Under ASU 2016-13, credit losses for available-for-sale debt securities should be measured in a manner similar to current GAAP. However, the amendments in this ASU require that credit losses be recorded through an allowance for credit losses, which will allow subsequent reversals in credit loss estimates to be recognized in current income. In addition, the allowance on available-for-sale debt securities will be limited to the extent that the fair value is less than the amortized cost. Based on our initial evaluation of the amendments in this ASU, we anticipate being required to make changes to the way we account for credit impairment losses on our available-for-sale debt securities. Under our current accounting, credit impairment losses are generally required to be recorded as OTTI, which directly reduce the carrying amount of impaired securities, and are recorded in earnings and are not reversed if expected cash flows subsequently recover. Under the new guidance, credit impairments on such securities will be recorded as an allowance for credit losses that are also recorded in earnings, but the allowance can be reversed through earnings in a subsequent period if expected cash flows subsequently recover.
In addition, we expect that the new guidance will also result in changes to the accounting and presentation of our residential whole loans held at carrying value. We currently anticipate that, upon adoption, the guidance will result in an increase in the gross carrying amount of our purchased credit impaired loans held at carrying value by the amount of the allowance for loan losses calculated under the new guidance. Thereafter, changes in the expected cash flows of such assets are expected to result in the recognition (or reversal) of an allowance for loan losses that will impact earnings. In addition, we expect that the guidance will result in an increase in the allowance for credit losses for our Other Loans at Carrying Value, with a resulting negative adjustment to retained earnings.
Leases
In February 2016, the FASB issued ASU 2016-02, Leases (or ASU 2016-02). The amendments in this ASU establish a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the
82
financial statements, with certain practical expedients available. Our significant lease contracts are discussed in Note 10(a) of the accompanying consolidated financial statements. While we continue to evaluate the potential impact that adoption of ASU 2016-02 will have on our financial reporting, given the relatively limited nature and extent of lease financing transactions that we have entered into, we do not expect that the adoption of ASU 2016-02 will have a significant impact on our financial position or financial statement disclosures.
Liquidity and Capital Resources
General
Our principal sources of cash generally consist of borrowings under repurchase agreements and other collateralized financings, payments of principal and interest we receive on our investment portfolio, cash generated from our operating results and, to the extent such transactions are entered into, proceeds from capital market and structured financing transactions. Our most significant uses of cash are generally to pay principal and interest on our financing transactions, to purchase residential mortgage assets, to make dividend payments on our capital stock, to fund our operations and to make other investments that we consider appropriate.
We seek to employ a diverse capital raising strategy under which we may issue capital stock and other types of securities. To the extent we raise additional funds through capital market transactions, we currently anticipate using the net proceeds from such transactions to acquire additional residential mortgage-related assets, consistent with our investment policy, and for working capital, which may include, among other things, the repayment of our financing transactions. There can be no assurance, however, that we will be able to access the capital markets at any particular time or on any particular terms. We have available for issuance an unlimited amount (subject to the terms and limitations of our charter) of common stock, preferred stock, depositary shares representing preferred stock, warrants, debt securities, rights and/or units pursuant to our automatic shelf registration statement and, at September 30, 2018, we had approximately 11.9 million shares of common stock available for issuance pursuant to our DRSPP shelf registration statement. During the nine months ended September 30, 2018, we issued 302,264 shares of common stock through our DRSPP, raising net proceeds of approximately $2.2 million. During the three months ended September 30, 2018, we issued approximately 50.9 million shares of common stock in a public offering, generating net proceeds of approximately $389.4 million.
Our borrowings under repurchase agreements are uncommitted and renewable at the discretion of our lenders and, as such, our lenders could determine to reduce or terminate our access to future borrowings at virtually any time. The terms of the repurchase transaction borrowings under our master repurchase agreements, as such terms relate to repayment, margin requirements and the segregation of all securities that are the subject of repurchase transactions, generally conform to the terms contained in the standard master repurchase agreement published by the Securities Industry and Financial Markets Association (or SIFMA) or the global master repurchase agreement published by SIFMA and the International Capital Market Association. In addition, each lender typically requires that we include supplemental terms and conditions to the standard master repurchase agreement. Typical supplemental terms and conditions, which differ by lender, may include changes to the margin maintenance requirements, required haircuts (as defined below), purchase price maintenance requirements, requirements that all controversies related to the repurchase agreement be litigated in a particular jurisdiction and cross default and setoff provisions.
With respect to margin maintenance requirements for repurchase agreements secured by harder to value assets, such as Non-Agency MBS, residential whole loans and MSR related assets, margin calls are typically determined by our counterparties based on their assessment of changes in the fair value of the underlying collateral and in accordance with the agreed upon haircuts specified in the transaction confirmation with the counterparty. We address margin call requests in accordance with the required terms specified in the applicable repurchase agreement and such requests are typically satisfied by posting additional cash or collateral on the same business day. We review margin calls made by counterparties and assess them for reasonableness by comparing the counterparty valuation against our valuation determination. When we believe that a margin call is unnecessary because our assessment of collateral value differs from the counterparty valuation, we typically hold discussions with the counterparty and are able to resolve the matter. In the unlikely event that resolution cannot be reached, we will look to resolve the dispute based on the remedies available to us under the terms of the repurchase agreement, which in some instances may include the engagement of a third-party to review collateral valuations. For other agreements that do not include such provisions, we could resolve the matter by substituting collateral as permitted in accordance with the agreement or otherwise request the counterparty to return the collateral in exchange for cash to unwind the financing.
83
The following table presents information regarding the margin requirements, or the percentage amount by which the collateral value is contractually required to exceed the loan amount (this difference is referred to as the “haircut”), on our repurchase agreements at September 30, 2018 and December 31, 2017:
At September 30, 2018 | Weighted Average Haircut | Low | High | ||||||
Repurchase agreement borrowings secured by: | |||||||||
Agency MBS | 4.48 | % | 3.00 | % | 5.00 | % | |||
Legacy Non-Agency MBS | 21.70 | 15.00 | 30.00 | ||||||
RPL/NPL MBS | 21.22 | 15.00 | 30.00 | ||||||
CRT securities | 19.73 | 16.67 | 25.00 | ||||||
MSR related assets | 22.56 | 20.00 | 30.00 | ||||||
Residential whole loans | 21.93 | 8.00 | 33.00 | ||||||
At December 31, 2017 | Weighted Average Haircut | Low | High | ||||||
Repurchase agreement borrowings secured by: | |||||||||
Agency MBS | 4.65 | % | 3.00 | % | 8.00 | % | |||
Legacy Non-Agency MBS | 21.87 | 15.00 | 35.00 | ||||||
RPL/NPL MBS | 22.05 | 20.00 | 27.50 | ||||||
U.S. Treasury securities | 1.47 | 1.00 | 2.00 | ||||||
CRT securities | 22.16 | 15.00 | 25.00 | ||||||
MSR related assets | 33.19 | 30.00 | 50.00 | ||||||
Residential whole loans | 26.10 | 20.00 | 35.00 | ||||||
During the first nine months of 2018, the weighted average haircut requirements for the respective underlying collateral types for our repurchase agreements have remained fairly consistent compared to the end of 2017. Weighted average haircuts have decreased on MSR related assets, CRT securities and residential whole loans.
Repurchase agreement funding for our residential mortgage investments has been available to us at generally attractive market terms from multiple counterparties. Typically, due to the risks inherent in credit sensitive residential mortgage investments, repurchase agreement funding involving such investments is available at terms requiring higher collateralization and higher interest rates than repurchase agreement funding secured by Agency MBS and U.S. Treasury securities. Therefore, we generally expect to be able to finance our acquisitions of Agency MBS on more favorable terms than financing for credit sensitive investments.
We maintain cash and cash equivalents, unpledged Agency and Non-Agency MBS and collateral in excess of margin requirements held by our counterparties (or collectively, “cash and other unpledged collateral”) to meet routine margin calls and protect against unforeseen reductions in our borrowing capabilities. Our ability to meet future margin calls will be impacted by our ability to use cash or obtain financing from unpledged collateral, which can vary based on the market value of such collateral, our cash position and margin requirements. Our cash position fluctuates based on the timing of our operating, investing and financing activities and is managed based on our anticipated cash needs. (See our Consolidated Statements of Cash Flows, included under Item 1 of this Quarterly Report on Form 10-Q and “Interest Rate Risk” included under Item 3 of this Quarterly Report on Form 10-Q.)
At September 30, 2018, we had a total of $9.0 billion of MBS, CRT securities, residential whole loans and MSR related assets and $6.5 million of restricted cash pledged against our repurchase agreements. At September 30, 2018, we have access to various sources of liquidity which we estimate exceeds $412.1 million. This includes (i) $104.2 million of cash and cash equivalents; (ii) $188.2 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that is currently pledged in excess of contractual requirements; and (iii) $119.7 million in estimated financing available from unpledged Non-Agency MBS and from other Non-Agency MBS and CRT collateral that is currently pledged in excess of contractual requirements. Our sources of liquidity do not include restricted cash. In addition, we have $1.1 billion of unencumbered residential whole loans. We are evaluating potential opportunities to finance these assets, including loan securitization.
84
The table below presents certain information about our borrowings under repurchase agreements and securitized debt:
Repurchase Agreements | Securitized Debt | |||||||||||||||||||||||
Quarter Ended (1) | Quarterly Average Balance | End of Period Balance | Maximum Balance at Any Month-End | Quarterly Average Balance | End of Period Balance | Maximum Balance at Any Month-End | ||||||||||||||||||
(In Thousands) | ||||||||||||||||||||||||
September 30, 2018 | $ | 6,594,050 | $ | 7,278,270 | $ | 7,278,270 | $ | 665,572 | $ | 714,203 | $ | 744,521 | ||||||||||||
June 30, 2018 | 6,189,916 | 5,892,228 | 6,319,178 | 432,283 | 518,655 | 523,490 | ||||||||||||||||||
March 31, 2018 | 6,519,390 | 6,558,860 | 6,558,860 | 357,819 | 351,278 | 361,002 | ||||||||||||||||||
December 31, 2017 | 6,661,020 | 6,614,701 | 6,760,360 | 212,445 | 363,944 | 363,944 | ||||||||||||||||||
September 30, 2017 | 7,022,913 | 6,871,443 | 7,023,702 | 139,276 | 137,327 | 141,088 | ||||||||||||||||||
(1) | The information presented in the table above excludes Senior Notes issued in April 2012. The outstanding balance of Senior Notes has been unchanged at $100.0 million since issuance. |
Cash Flows and Liquidity for the Nine Months Ended September 30, 2018
Our cash, cash equivalents and restricted cash decreased by $352.4 million during the nine months ended September 30, 2018, reflecting: $1.6 billion used in our investing activities; $1.2 billion provided by our financing activities; and $90.3 million provided by our operating activities.
At both September 30, 2018 and December 31, 2017, our debt-to-equity multiple was 2.3 times. At September 30, 2018, we had borrowings under repurchase agreements of $7.3 billion with 28 counterparties, of which $2.6 billion were secured by Agency MBS, $1.6 billion were secured by Legacy Non-Agency MBS, $913.2 million were secured by RPL/NPL MBS, $405.2 million were secured by CRT securities, $435.8 million were secured by MSR related assets and $1.3 billion were secured by residential whole loans. We continue to have available capacity under our repurchase agreement credit lines. In addition, at September 30, 2018, we had securitized debt of $714.2 million in connection with our loan securitization transactions. At December 31, 2017, we had borrowings under repurchase agreements of $6.6 billion with 31 counterparties, of which $2.5 billion were secured by Agency MBS, $1.3 billion were secured by Legacy Non-Agency MBS, $567.1 million were secured by RPL/NPL MBS, $470.3 million were secured by U.S. Treasuries, $459.1 million were secured by CRT securities, $317.3 million were secured by MSR related assets and $1.0 billion were secured by residential whole loans. In addition, at December 31, 2017, we had securitized debt of $363.9 million in connection with our loan securitization transactions.
During the nine months ended September 30, 2018, $1.6 billion was provided by our investing activities. We paid $2.2 billion for purchases of residential whole loans and capitalized advances, and purchased $512.5 million of MSR related assets, $647.3 million of Non-Agency MBS, $795.9 million of Agency MBS, and $104.6 million of CRT securities funded with cash and repurchase agreement borrowings. In addition, during the nine months ended September 30, 2018, we received cash of $1.8 billion from prepayments and scheduled amortization on our MBS, CRT securities and MSR related assets, of which $547.6 million was attributable to Agency MBS, $797.4 million was from Non-Agency MBS, $11.8 million was from CRT securities and $440.3 million was attributable to MSR related assets, and we sold certain of our investment securities for $341.6 million, realizing net gains of $32.7 million. While we generally intend to hold our MBS and CRT securities as long-term investments, we may sell certain of our securities in order to manage our interest rate risk and liquidity needs, meet other operating objectives and adapt to market conditions. During the nine months ended September 30, 2018 we received $345.9 million of principal payments on residential whole loans and $93.6 million of proceeds on sales of REO.
In connection with our repurchase agreement borrowings and Swaps, we routinely receive margin calls/reverse margin calls from our counterparties and make margin calls to our counterparties. Margin calls and reverse margin calls, which requirements vary over time, may occur daily between us and any of our counterparties when the value of collateral pledged changes from the amount contractually required. The value of securities pledged as collateral fluctuates reflecting changes in: (i) the face (or par) value of our MBS; (ii) market interest rates and/or other market conditions; and (iii) the market value of our Swaps. Margin calls/reverse margin calls are satisfied when we pledge/receive additional collateral in the form of additional securities and/or cash.
85
The table below summarizes our margin activity with respect to our repurchase agreement financings for the quarterly periods presented:
Collateral Pledged to Meet Margin Calls | Cash and Securities Received for Reverse Margin Calls | Net Assets Received/(Pledged) for Margin Activity | ||||||||||||||||||
For the Quarter Ended (1) | Fair Value of Securities Pledged | Cash Pledged | Aggregate Assets Pledged For Margin Calls | |||||||||||||||||
(In Thousands) | ||||||||||||||||||||
September 30, 2018 | $ | 61,492 | $ | 3,005 | $ | 64,497 | $ | 8,294 | $ | (56,203 | ) | |||||||||
June 30, 2018 | 44,278 | — | 44,278 | 20,001 | (24,277 | ) | ||||||||||||||
March 31, 2018 | 40,831 | — | 40,831 | 18,835 | (21,996 | ) | ||||||||||||||
December 31, 2017 | 87,960 | — | 87,960 | 80,105 | (7,855 | ) | ||||||||||||||
September 30, 2017 | 83,513 | — | 83,513 | 53,499 | (30,014 | ) | ||||||||||||||
(1) Excludes variation margin payments on the Company’s cleared Swaps which are treated as a legal settlement of the exposure under the Swap contract.
We are subject to various financial covenants under our repurchase agreements and derivative contracts, which include minimum net worth and/or profitability requirements, maximum debt-to-equity ratios and minimum market capitalization requirements. We have maintained compliance with all of our financial covenants through September 30, 2018.
During the nine months ended September 30, 2018, we paid $239.6 million for cash dividends on our common stock and dividend equivalents and paid cash dividends of $11.3 million on our preferred stock. On September 13, 2018, we declared our third quarter 2018 dividend on our common stock of $0.20 per share; on October 31, 2018, we paid this dividend, which totaled approximately $90.1 million, including dividend equivalents of approximately $241,000.
We believe that we have adequate financial resources to meet our current obligations, including margin calls, as they come due, to fund dividends we declare and to actively pursue our investment strategies. However, should the value of our MBS suddenly decrease, significant margin calls on our repurchase agreement borrowings could result and our liquidity position could be materially and adversely affected. Further, should market liquidity tighten, our repurchase agreement counterparties may increase our margin requirements on new financings, reducing our ability to use leverage. Access to financing may also be negatively impacted by the ongoing volatility in the world financial markets, potentially adversely impacting our current or potential lenders’ ability or willingness to provide us with financing. In addition, there is no assurance that favorable market conditions will continue to permit us to consummate additional securitization transactions if we determine to seek that form of financing.
Off-Balance Sheet Arrangements
We have not participated in transactions that create relationships with unconsolidated entities or financial partnerships which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Inflation
Substantially all of our assets and liabilities are financial in nature. As a result, changes in interest rates and other factors impact our performance far more than does inflation. Our results of operations and reported assets, liabilities and equity are measured with reference to historical cost or fair value without considering inflation.
86
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We seek to manage our risks related to interest rates, liquidity, prepayment speeds, market value and the credit quality of our assets while, at the same time, seeking to provide an opportunity to stockholders to realize attractive total returns through ownership of our capital stock. While we do not seek to avoid risk, we seek, consistent with our investment policies, to: assume risk that can be quantified based on management’s judgment and experience and actively manage such risk; earn sufficient returns to justify the taking of such risks; and maintain capital levels consistent with the risks that we undertake.
Interest Rate Risk
We generally acquire interest-rate sensitive assets and fund them with interest-rate sensitive liabilities, a portion of which are hedged with Swaps. We are exposed to interest rate risk on our residential mortgage assets, as well as on our liabilities. Changes in interest rates can affect our net interest income and the fair value of our assets and liabilities.
We finance the majority of our investments in residential mortgage assets with short-term repurchase agreements. In general, when interest rates change, the borrowing costs of our repurchase agreements (net of the impact of Swaps) change more quickly than the yield on our assets. In a rising interest rate environment, the borrowing costs of our repurchase agreements may increase faster than the interest income on our assets, thereby reducing our net income. In order to mitigate compression in net income based on such interest rate movements, we use Swaps to lock in a portion of the net interest spread between assets and liabilities.
When interest rates change, the fair value of our residential mortgage assets could change at a different rate than the fair value of our liabilities. We measure the sensitivity of our portfolio to changes in interest rates by estimating the duration of our assets and liabilities. Duration is the approximate percentage change in fair value for a 100 basis point parallel shift in the yield curve. In general, our assets have higher duration than our liabilities and in order to reduce this exposure we use Swaps to reduce the gap in duration between our assets and liabilities.
In calculating the duration of our Agency MBS we take into account the characteristics of the underlying mortgage loans including whether the underlying loans are fixed rate, adjustable or hybrid; coupon, expected prepayment rates and lifetime and periodic caps. We use third-party financial models, combined with management’s assumptions and observed empirical data when estimating the duration of our Agency MBS.
In analyzing the interest rate sensitivity of our Legacy Non-Agency MBS we take into account the characteristics of the underlying mortgage loans, including credit quality and whether the underlying loans are fixed-rate, adjustable or hybrid. We estimate the duration of our Legacy Non-Agency MBS using management’s assumptions.
The majority of our RPL/NPL MBS deal structures contain a contractual coupon step-up feature where the coupon increases from 300 - 400 basis points at 36 - 48 months from issuance or sooner. Therefore, we believe their fair value exhibits little sensitivity to changes in interest rates. We estimate the duration of these securities using management’s assumptions.
The fair value of our re-performing residential whole loans is dependent on the value of the underlying real estate collateral, past and expected delinquency status of the borrower as well as the level of interest rates. Because the borrower is not delinquent on their mortgage payments but is less likely to prepay the loan due to weak credit history and/or high LTV, we believe our re-performing residential whole loans exhibit positive duration. We estimate the duration of our re-performing residential whole loans using management’s assumptions.
The fair value of our Non-QM loans and Single family rental loans are dependent on the value of the underlying real estate collateral, as well as the level of interest rates. Because these loans are primarily newly or recently originated performing loans, we believe these investments exhibit positive duration. Given the short duration of the Company’s Rehabilitation loans, we believe the fair value of these loans exhibits little sensitivity to changes in interest rates. We estimate the duration of these other loans held at carrying value using management’s assumptions.
The fair value of our non-performing residential whole loans is primarily dependent on the value of the underlying real estate collateral and the time required for collateral liquidation. Since neither the value of the collateral nor the liquidation timeline is generally sensitive to interest rates, we believe their fair value exhibits little sensitivity to interest rates. We estimate the duration of our non-performing residential whole loans using management’s assumptions.
We use Swaps as part of our overall interest rate risk management strategy. Such derivative financial instruments are intended to act as a hedge against future interest rate increases on our repurchase agreement financings, which rates are typically highly
87
correlated with LIBOR. While our derivatives do not extend the maturities of our borrowings under repurchase agreements, they do, in effect, lock in a fixed rate of interest over their term for a corresponding amount of our repurchase agreement financings that are hedged.
At September 30, 2018, MFA’s $5.1 billion of Agency MBS and Legacy Non-Agency MBS were backed by Hybrid, adjustable and fixed-rate mortgages. Additional information about these MBS, including average months to reset and three-month average CPR, is presented below:
Agency MBS | Legacy Non-Agency MBS (1) | Total (1) | ||||||||||||||||||||||||||||
Time to Reset | Fair Value (2) | Average Months to Reset (3) | 3 Month Average CPR (4) | Fair Value | Average Months to Reset (3) | 3 Month Average CPR (4) | Fair Value (2) | Average Months to Reset (3) | 3 Month Average CPR (4) | |||||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||||||
< 2 years (5) | $ | 1,150,471 | 6 | 22.7 | % | $ | 1,417,756 | 4 | 18.6 | % | $ | 2,568,227 | 5 | 20.3 | % | |||||||||||||||
2-5 years | 131,924 | 44 | 12.6 | — | — | — | 131,924 | 44 | 12.6 | |||||||||||||||||||||
> 5 years | 9,653 | 82 | 10.7 | — | — | — | 9,653 | 82 | 10.7 | |||||||||||||||||||||
ARM-MBS Total | $ | 1,292,048 | 11 | 21.6 | % | $ | 1,417,756 | 4 | 18.6 | % | $ | 2,709,804 | 7 | 19.9 | % | |||||||||||||||
15-year fixed (6) | $ | 866,346 | 11.5 | % | $ | 1,915 | 17.6 | % | $ | 868,261 | 11.5 | % | ||||||||||||||||||
30-year fixed (6) | 746,658 | 8.7 | 719,047 | 13.4 | 1,465,705 | 12.5 | ||||||||||||||||||||||||
40-year fixed (6) | — | — | 34,324 | 16.7 | 34,324 | 16.7 | ||||||||||||||||||||||||
Fixed-Rate Total | $ | 1,613,004 | 11.0 | % | $ | 755,286 | 13.6 | % | $ | 2,368,290 | 12.2 | % | ||||||||||||||||||
MBS Total | $ | 2,905,052 | 16.8 | % | $ | 2,173,042 | 16.8 | % | $ | 5,078,094 | 16.8 | % | ||||||||||||||||||
(1) | Excludes $1.2 billion of RPL/NPL MBS. Refer to table below for further information. |
(2) | Does not include principal payments receivable of $438,000. |
(3) | Months to reset is the number of months remaining before the coupon interest rate resets. At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic and/or lifetime caps. The months to reset do not reflect scheduled amortization or prepayments. |
(4) | 3 month average CPR weighted by positions as of the beginning of each month in the quarter. |
(5) | Includes floating-rate MBS that may be collateralized by fixed-rate mortgages. |
(6) | Information presented based on data available at time of loan origination. |
The following table presents certain information about our RPL/NPL MBS portfolio at September 30, 2018:
(Dollars in Thousands) | Fair Value | Net Coupon | Months to Step-Up (1) | 3 Month Average Bond CPR (2) | |||||||||
Re-Performing loans | $ | 97,871 | 4.36 | % | 31 | 11.4 | % | ||||||
Non-Performing loans | 1,063,697 | 4.66 | 24 | 19.9 | |||||||||
Total RPL/NPL MBS | $ | 1,161,568 | 4.63 | % | 24 | 19.6 | % | ||||||
(1) | Months to step-up is the weighted average number of months remaining before the coupon interest rate increases pursuant to the first coupon reset. We anticipate that the securities will be redeemed prior to the step-up date. |
(2) | All principal payments are considered to be prepayments for CPR purposes. |
At September 30, 2018, our CRT securities and MSR related assets had a fair value of $538.9 million and $565.3 million, respectively, and their coupons reset monthly based on one-month LIBOR.
88
Shock Table
The information presented in the following “Shock Table” projects the potential impact of sudden parallel changes in interest rates on our net interest income and portfolio value, including the impact of Swaps, over the next 12 months based on the assets in our investment portfolio at September 30, 2018. All changes in income and value are measured as the percentage change from the projected net interest income and portfolio value under the base interest rate scenario at September 30, 2018.
Change in Interest Rates | Estimated Value of Assets (1) | Estimated Value of Swaps | Estimated Value of Financial Instruments | Change in Estimated Value | Percentage Change in Net Interest Income | Percentage Change in Portfolio Value | ||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||
+100 Basis Point Increase | $ | 11,486,783 | $ | 69,382 | $ | 11,556,165 | $ | (146,619 | ) | (2.98 | )% | (1.25 | )% | |||||||||
+ 50 Basis Point Increase | $ | 11,582,562 | $ | 47,581 | $ | 11,630,143 | $ | (72,641 | ) | (1.19 | )% | (0.62 | )% | |||||||||
Actual at September 30, 2018 | $ | 11,677,003 | $ | 25,781 | $ | 11,702,784 | $ | — | — | — | ||||||||||||
- 50 Basis Point Decrease | $ | 11,770,104 | $ | 3,980 | $ | 11,774,084 | $ | 71,300 | (0.05 | )% | 0.61 | % | ||||||||||
-100 Basis Point Decrease | $ | 11,861,867 | $ | (17,820 | ) | $ | 11,844,047 | $ | 141,263 | (0.20 | )% | 1.21 | % | |||||||||
(1) | Such assets include MBS and CRT securities, residential whole loans and REO, MSR related assets, cash and cash equivalents and restricted cash. |
Certain assumptions have been made in connection with the calculation of the information set forth in the Shock Table and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes. The base interest rate scenario assumes interest rates at September 30, 2018. The analysis presented utilizes assumptions and estimates based on management’s judgment and experience. Furthermore, while we generally expect to retain the majority of our assets and the associated interest rate risk to maturity, future purchases and sales of assets could materially change our interest rate risk profile. It should be specifically noted that the information set forth in the above table and all related disclosure constitute forward-looking statements within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act. Actual results could differ significantly from those estimated in the Shock Table above.
The Shock Table quantifies the potential changes in net interest income and portfolio value, which includes the value of our Swaps (which are carried at fair value), should interest rates immediately change (i.e., are shocked). The Shock Table presents the estimated impact of interest rates instantaneously rising 50 and 100 basis points, and falling 50 and 100 basis points. The cash flows associated with our portfolio of MBS for each rate shock are calculated based on assumptions, including, but not limited to, prepayment speeds, yield on replacement assets, the slope of the yield curve and composition of our portfolio. Assumptions made with respect to the interest rate sensitive liabilities include anticipated interest rates, collateral requirements as a percent of repurchase agreement financings, and the amounts and terms of borrowing. At September 30, 2018, we applied a floor of 0% for all anticipated interest rates included in our assumptions. Due to this floor, it is anticipated that any hypothetical interest rate shock decrease would have a limited positive impact on our funding costs; however, because prepayments speeds are unaffected by this floor, it is expected that any increase in our prepayment speeds (occurring as a result of any interest rate shock decrease or otherwise) could result in an acceleration of premium amortization on our Agency MBS and discount accretion on our Non-Agency MBS and in the reinvestment of principal repayments in lower yielding assets. As a result, because the presence of this floor limits the positive impact of interest rate decrease on our funding costs, hypothetical interest rate shock decreases could cause a decline in the fair value of our financial instruments and our net interest income.
At September 30, 2018, the impact on portfolio value was approximated using estimated effective duration (i.e., the price sensitivity to changes in interest rates), including the effect of Swaps, of 1.14 which is the weighted average of 2.28 for our Agency MBS, 0.92 for our Non-Agency investments, 2.24 for our Residential whole loans, (2.40) for our Swaps, and 0.17 for our Other assets and cash and cash equivalents. Estimated convexity (i.e., the approximate change in duration relative to the change in interest rates) of the portfolio was (0.18), which is the weighted average of (0.74) for our Agency MBS, zero for our Swaps, zero for our Non-Agency MBS, zero for our Residential whole loans and zero for our Other assets and cash and cash equivalents. The impact on our net interest income is driven mainly by the difference between portfolio yield and cost of funding of our repurchase agreements, which includes the cost and/or benefit from Swaps. Our asset/liability structure is generally such that an increase in interest rates would be expected to result in a decrease in net interest income, as our borrowings are generally shorter in term than our interest-earning assets. When interest rates are shocked, prepayment assumptions are adjusted based on management’s expectations along with the results from the prepayment model.
89
Credit Risk
Although we do not believe that we are exposed to credit risk in our Agency MBS portfolio, we are exposed to credit risk through our credit-sensitive residential mortgage investments, in particular Legacy Non-Agency MBS and residential whole loans and to a lesser extent our investments in RPL/NPL MBS, CRT securities and MSR related assets. Our exposure to credit risk from our credit sensitive investments is discussed in more detail below:
Legacy Non-Agency MBS
Our investment process for Legacy Non-Agency MBS involves analysis focused primarily on quantifying and pricing credit risk. When we purchase Legacy Non-Agency MBS, we assign certain assumptions to each of the MBS, including but not limited to, future interest rates, voluntary prepayment rates, mortgage modifications, default rates and loss severities, and generally allocate a portion of the purchase discount as a Credit Reserve which provides credit protection for such securities. As part of our surveillance process, we review our Legacy Non-Agency MBS by tracking their actual performance compared to the securities’ expected performance at purchase or, if we have modified our original purchase assumptions, compared to our revised performance expectations. To the extent that actual performance of a Legacy Non-Agency MBS is less favorable than its expected performance, we may revise our performance expectations. As a result, we could reduce the accretable discount on the security and/or recognize an other-than-temporary impairment through earnings, either of which could have a material adverse impact on our operating results.
In evaluating our asset/liability management and Legacy Non-Agency MBS credit performance, we consider the credit characteristics of the mortgage loans underlying our Legacy Non-Agency MBS. The following table presents certain information about our Legacy Non-Agency MBS portfolio at September 30, 2018. Information presented with respect to the weighted average Fair Isaac Corporation (or FICO) scores and other information aggregated based on information reported at the time of mortgage origination are historical and, as such, do not reflect the impact of the general changes in home prices or changes in borrowers’ credit scores or the current use of the mortgaged properties.
90
The information in the table below is presented as of September 30, 2018:
Securities with Average Loan FICO of 715 or Higher (1) | Securities with Average Loan FICO Below 715 (1) | |||||||||||||||||||||||||||
Year of Securitization (2) | 2007 | 2006 | 2005 and Prior | 2007 | 2006 | 2005 and Prior | Total | |||||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||||
Number of securities | 84 | 59 | 71 | 32 | 57 | 63 | 366 | |||||||||||||||||||||
MBS current face (3) | $ | 660,718 | $ | 376,587 | $ | 375,917 | $ | 149,747 | $ | 390,180 | $ | 389,760 | $ | 2,342,909 | ||||||||||||||
Total purchase discounts, net (3) | $ | (205,614 | ) | $ | (114,752 | ) | $ | (80,410 | ) | $ | (50,452 | ) | $ | (154,324 | ) | $ | (117,207 | ) | $ | (722,759 | ) | |||||||
Purchase discount designated as Credit Reserve and OTTI (3)(4) | $ | (143,372 | ) | $ | (58,869 | ) | $ | (45,135 | ) | $ | (41,112 | ) | $ | (149,794 | ) | $ | (93,476 | ) | $ | (531,758 | ) | |||||||
Purchase discount designated as Credit Reserve and OTTI as percentage of current face | 21.7 | % | 15.6 | % | 12.0 | % | 27.5 | % | 38.4 | % | 24.0 | % | 22.7 | % | ||||||||||||||
MBS amortized cost (3) | $ | 455,104 | $ | 261,835 | $ | 295,507 | $ | 99,295 | $ | 235,856 | $ | 272,553 | $ | 1,620,150 | ||||||||||||||
MBS fair value (3) | $ | 613,637 | $ | 353,729 | $ | 362,391 | $ | 137,360 | $ | 338,212 | $ | 364,882 | $ | 2,170,211 | ||||||||||||||
Weighted average fair value to current face | 92.9 | % | 93.9 | % | 96.4 | % | 91.7 | % | 86.7 | % | 93.6 | % | 92.6 | % | ||||||||||||||
Weighted average coupon (5) | 4.47 | % | 3.87 | % | 4.34 | % | 5.16 | % | 5.14 | % | 4.93 | % | 4.59 | % | ||||||||||||||
Weighted average loan age (months) (5)(6) | 137 | 146 | 161 | 142 | 148 | 160 | 148 | |||||||||||||||||||||
Weighted average current loan size (5)(6) | $ | 487 | $ | 482 | $ | 283 | $ | 326 | $ | 248 | $ | 242 | $ | 362 | ||||||||||||||
Percentage amortizing (7) | 100 | % | 99 | % | 100 | % | 99 | % | 99 | % | 100 | % | 100 | % | ||||||||||||||
Weighted average FICO score at origination (5)(8) | 729 | 728 | 726 | 705 | 702 | 703 | 718 | |||||||||||||||||||||
Owner-occupied loans | 91.1 | % | 91.5 | % | 86.7 | % | 85.4 | % | 86.8 | % | 85.0 | % | 88.4 | % | ||||||||||||||
Rate-term refinancings | 31.1 | % | 22.4 | % | 14.2 | % | 22.8 | % | 15.6 | % | 14.4 | % | 21.1 | % | ||||||||||||||
Cash-out refinancings | 35.0 | % | 36.2 | % | 27.1 | % | 44.0 | % | 45.9 | % | 40.4 | % | 37.2 | % | ||||||||||||||
3 Month CPR (6) | 17.5 | % | 19.5 | % | 22.2 | % | 14.1 | % | 13.6 | % | 14.4 | % | 17.2 | % | ||||||||||||||
3 Month CRR (6)(9) | 14.4 | % | 15.7 | % | 19.4 | % | 10.4 | % | 9.5 | % | 12.4 | % | 14.0 | % | ||||||||||||||
3 Month CDR (6)(9) | 3.6 | % | 4.5 | % | 3.7 | % | 4.3 | % | 4.7 | % | 2.4 | % | 3.8 | % | ||||||||||||||
3 Month loss severity | 71.1 | % | 55.4 | % | 35.8 | % | 78.6 | % | 68.3 | % | 58.3 | % | 61.3 | % | ||||||||||||||
60+ days delinquent (8) | 11.6 | % | 10.3 | % | 8.7 | % | 14.0 | % | 12.4 | % | 11.4 | % | 11.2 | % | ||||||||||||||
Percentage of always current borrowers (Lifetime) (10) | 27.6 | % | 27.8 | % | 34.6 | % | 25.0 | % | 21.2 | % | 26.4 | % | 27.3 | % | ||||||||||||||
Percentage of always current borrowers (12M) (11) | 74.0 | % | 76.6 | % | 77.8 | % | 70.5 | % | 70.4 | % | 72.2 | % | 73.9 | % | ||||||||||||||
(1) | FICO score is used by major credit bureaus to indicate a borrower’s creditworthiness at time of loan origination. |
(2) | Information presented based on the initial year of securitization of the underlying collateral. Certain of our Non-Agency MBS have been resecuritized. The historical information presented in the table is based on the initial securitization date and data available at the time of original securitization (and not the date of resecuritization). No information has been updated with respect to any MBS that have been resecuritized. |
(3) | Excludes Non-Agency MBS issued since 2012 in which the underlying collateral consists of RPL/NPL MBS. These Non-Agency MBS have a current face of $1.2 billion, amortized cost of $1.2 billion, fair value of $1.2 billion and purchase discounts of $702,000 at September 30, 2018. |
(4) | Purchase discounts designated as Credit Reserve and OTTI are not expected to be accreted into interest income. |
(5) | Weighted average is based on MBS current face at September 30, 2018. |
(6) | Information provided is based on loans for individual groups owned by us. |
(7) | Percentage of face amount for which the original mortgage note contractually calls for principal amortization in the current period. |
(8) | Information provided is based on loans for all groups that provide credit enhancement for MBS with credit enhancement. |
(9) | CRR represents voluntary prepayments and CDR represents involuntary prepayments. |
(10) | Percentage of face amount of loans for which the borrower has not been delinquent since origination. |
(11) | Percentage of face amount of loans for which the borrower has not been delinquent in the last twelve months. |
91
The mortgages securing our Legacy Non-Agency MBS are located in many geographic regions across the United States. The following table presents the five largest geographic concentrations by state of the mortgages collateralizing our Legacy Non-Agency MBS at September 30, 2018:
Property Location | Percent of Unpaid Principal Balance | ||
California | 42.5 | % | |
Florida | 7.9 | % | |
New York | 7.3 | % | |
New Jersey | 4.0 | % | |
Maryland | 4.0 | % | |
RPL/NPL MBS
These securities are backed by re-performing and non-performing loans, were purchased primarily at prices around par and represent the senior and mezzanine tranches of the related securitizations. The majority of these securities are structured with significant credit enhancement (typically approximately 50%) and the subordinate tranches absorb all credit losses (until those tranches are extinguished) and typically receive no cash flow (interest or principal) until the senior tranche is paid off. Prior to purchase, we analyze the deal structure in order to assess the associated credit risk. Subsequent to purchase, the ongoing credit risk associated with the deal is evaluated by analyzing the extent to which actual credit losses occur that result in a reduction in the amount of subordination enjoyed by our bond.
CRT Securities
We are exposed to potential credit losses from our investments in CRT securities issued by Fannie Mae and Freddie Mac. While CRT securities are debt obligations of these GSEs, payment of principal on these securities is not guaranteed. As an investor in a CRT security, we may incur a loss if losses on the mortgage loans in the reference pool exceed the credit enhancement on the underlying CRT security owned by us. We assess the credit risk associated with our investments in CRT securities by assessing the current and expected future performance of the associated reference pool.
MSR Related Assets
Term Notes
We have invested in certain term notes that are issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered by us to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. In addition, credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.
Corporate Loan
We have participated in a loan to provide financing to an entity that originates residential whole loans and owns the related MSRs. We assess the credit risk associated with this loan participation by considering various factors, including the current status of the loan, changes in fair value of the MSRs that secure the loan and the recent financial performance of the borrower.
Residential Whole Loans
We are also exposed to credit risk from our investments in residential whole loans. Our investment process for residential whole loans is generally similar to that used for Legacy Non-Agency MBS and is likewise focused on quantifying and pricing credit risk. Non-Performing and purchase credit impaired loans are acquired at purchase prices that are generally discounted to the contractual loan balances based on a number of factors, including the impaired credit history of the borrower and the value of the collateral securing the loan. In addition, as we generally own the master-servicing rights associated with these loans, our process is also focused on selecting a sub-servicer with the appropriate expertise to mitigate losses and maximize our overall return. This involves, among other things, performing due diligence on the sub-servicer prior to their engagement as well as
92
ongoing oversight and surveillance. To the extent that delinquencies and defaults on these loans are higher than our expectation at the time the loans were purchased, the discounted purchase price at which the asset is acquired is intended to provide a level of protection against financial loss.
Credit risk on more recently originated performing loans is mitigated through our process to underwrite the loan before it is purchased and includes an assessment of the borrower’s financial condition and ability to repay the loan, nature of the collateral and LTV, including after-repair LTV for the majority of our Rehabilitation loans.
The following table presents the five largest geographic concentrations by state of our residential whole loan portfolio at September 30, 2018:
Property Location | Percent of Interest-Bearing Unpaid Principal Balance (1) | ||
California | 31.6 | % | |
Florida | 10.7 | % | |
New York | 10.4 | % | |
New Jersey | 6.6 | % | |
Maryland | 3.8 | % | |
(1) | Excludes approximately $8.6 million of residential whole loans for which the closing of the purchase transaction had not occurred as of September 30, 2018. |
Liquidity Risk
The primary liquidity risk we face arises from financing long-maturity assets with shorter-term borrowings primarily in the form of repurchase agreement financings. We pledge residential mortgage assets and cash to secure our repurchase agreements and Swaps. At September 30, 2018, we had access to various sources of liquidity which we estimate to be in excess of $412.1 million, an amount which includes: (i) $104.2 million of cash and cash equivalents, (ii) $188.2 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that are currently pledged in excess of contractual requirements, and (iii) $119.7 million in estimated financing available from currently unpledged Non-Agency MBS and from other Non-Agency MBS and CRT collateral that is currently pledged in excess of contractual requirements. Our sources of liquidity do not include restricted cash. In addition, we have $1.1 billion of unencumbered residential whole loans. We are evaluating potential opportunities to finance these assets including loan securitization. Should the value of our residential mortgage assets pledged as collateral suddenly decrease, margin calls under our repurchase agreements would likely increase, causing an adverse change in our liquidity position. Additionally, if one or more of our financing counterparties chose not to provide ongoing funding, our ability to finance our long-maturity assets would decline or be available on possibly less advantageous terms. As such, we cannot assure you that we will always be able to roll over our repurchase agreement financings. Further, should market liquidity tighten, our repurchase agreement counterparties may increase our margin requirements on new financings, including repurchase agreement borrowings that we roll with the same counterparty, reducing our ability to use leverage.
Prepayment Risk
Premiums arise when we acquire an MBS or loan at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value) or when we acquire residential whole loans at a price in excess of their aggregate principal balance. Conversely, discounts arise when we acquire an MBS or loan at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance. Premiums paid are amortized against interest income and accretable purchase discounts on these investments are accreted to interest income. Purchase premiums, which are primarily carried on our Agency MBS, certain CRT securities and Non-QM loans, are amortized against interest income over the life of the investment using the effective yield method, adjusted for actual prepayment activity. An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the interest income earned on these assets. Generally, if prepayments on Non-Agency MBS and residential whole loans purchased at significant discounts and not accounted for at fair value are less than anticipated, we expect that the income recognized on these assets will be reduced and impairments and/or loan loss reserves may result.
93
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
Management, under the direction of its Chief Executive Officer and Chief Financial Officer, is responsible for maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act) that are designed to ensure that information required to be disclosed in reports filed or submitted under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.
In connection with the preparation of this Quarterly Report on Form 10-Q, management reviewed and evaluated the Company’s disclosure controls and procedures. The evaluation was performed under the direction of the Company’s Chief Executive Officer and Chief Financial Officer to determine the effectiveness, as of September 30, 2018, of the design and operation of the Company’s disclosure controls and procedures. Based on that review and evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that the Company’s current disclosure controls and procedures, as designed and implemented, were effective as of September 30, 2018. Notwithstanding the foregoing, a control system, no matter how well designed, implemented and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s current periodic reports.
(b) Changes in Internal Control over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2018 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.
94
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
There are no material pending legal proceedings to which we are a party or any of our assets are subject.
Item 1A. Risk Factors
For a discussion of the Company’s risk factors, see Part 1, Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. There are no material changes from the risk factors set forth in such Annual Report on Form 10-K. However, the risks and uncertainties that the Company faces are not limited to those set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. Additional risks and uncertainties not currently known to the Company (or that it currently believes to be immaterial) may also adversely affect the Company’s business and the trading price of our securities.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities
As previously disclosed, in August 2005, the Company’s Board authorized a Repurchase Program, to repurchase up to 4.0 million shares of the Company’s outstanding common stock under the Repurchase Program. The Board reaffirmed such authorization in May 2010. In December, 2013, the Company’s Board increased the number of shares authorized for repurchase to an aggregate of 10.0 million shares (under which approximately 6.6 million shares remain available for repurchase). Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization. Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as we deem appropriate (including, in our discretion, through the use of one or more plans adopted under Rule 10b-5-1 promulgated under the 1934 Act), using available cash resources. Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock. The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice.
The Company engaged in no share repurchase activity during the third quarter of 2018 pursuant to the Repurchase Program nor did it withhold any restricted shares (under the terms of grants under our Equity Plan) to offset tax withholding obligations that occur upon the vesting and release of restricted stock awards and/or RSUs.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.
Item 6. Exhibits
The list of exhibits required to be filed as exhibits to this report are listed on page E-1 hereof, under “Exhibit Index,” which is incorporated herein by reference.
95
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 6, 2018 | MFA FINANCIAL, INC. | |
(Registrant) | ||
By: | /s/ Stephen D. Yarad | |
Stephen D. Yarad | ||
Chief Financial Officer | ||
(Principal Financial Officer) | ||
96
EXHIBIT INDEX
The following exhibits are filed as part of this Quarterly Report:
Exhibit | Description | |
Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS* | XBRL Instance Document | |
101.SCH* | XBRL Taxonomy Extension Schema Document | |
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | |
*These interactive data files are furnished and deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
E-1